Fitzgerald Review FNP Flashcards

1
Q

Assessment of optic disc - what cranial nerve?

A

CN II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of low CO

A

Dyspnea w/ exertion

Chest pain

ORTHOPNEA

Syncope or near syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What murmur: Holosystolic, blowing quality, Grade II-III/VI w/ predictable pattern of radiation (axilla)

A

Mitral regurgitation

Blood regurgitates back to left atrium = Low CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is holosystolic murmur

A

Murmur is heard ALL of systole at same intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe incompetent valve

A

valve cannot CLOSE properly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pattern of radiation - aortic regurgitation

A

Radiation to neck/carotid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common target organ damage in HTN

A

LVH, MR is common in LVH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Asthma flare - assess what first?

A

FEV1

Oxygen Sat drops LATE in an asthma flare

Asthma is a disease of AIR TRAPPING, difficulty getting air OUT

Oxygen Sat drops when difficult to get air in, which is LATE in asthma flare

At 90% O2 sat, 60 PaO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe asthma pathophysiology

A

Disease of AIR TRAPPING

Disease of airway inflammation w/ superimposed bronchospasm

Inflammation begets bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where to auscultate renal arterires

A

MCL at level of elbow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bruit what is occuring

A

Turbulent blood flow through at atherosclerotic vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Grade 1 and 2 hypertensive retinopathy

Visual changes

Findings

A

Common in poorly-controlled HTN No visual changes w/ low-grade findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Renal bruit

A

Bruit occassionally noted with renal artery stenosis

Cause of secondary HTN

Usually w/ markedly elevated BP at presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Evidence Hierarchy

A

Systematic review (meta-analysis)

RCT

Cohort Study

Case-control

Case series

Case report

Editorial

Expert opinion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Primary prevention

A

Prevent health problem, most cost-effective

Immunizations

Counseling

Disease prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Secondary prevention

A

Detecting disease early, asymptomatic/pre-clinical

BP checks, mammography, colonoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tertiary prevention

A

Minimize negative disease-induced outcomes

Avoid target organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Burn prevention - hot water

A

Set to no hotter than 120F

At 130F 3rd degree burn at 30 seconds exposure

At 140F 3rd degree burn at 6 seconds exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Diphtheria

A

Pseudomembrane

Upper airway obstruction (cause of death)

Stridor (sound of upper airway obstruction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Herd immunity

A

95% need to be immunized for herd immunity

Measles - droplet - very contagious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Immunization principles

A

Remove artificial barriers - need only focused history prior to receiving vaccines

Re-immunize when in doubt; risk is minimal

Only defer in the presence of moderate to severe illness (with or without fever)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which immunizations cannot be given?

Neomycin Allergy

A

IPV

MMR

Varicella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which immunizations cannot be given?

Streptomycin, Polymyxin B allergy

A

IPV

Vaccinia (smallpox)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which immunizations cannot be given?

Bakers Yeast Allergy

A

Hepatitis B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Which immunizations cannot be given? Gelatin allergy
MMR Varicella
26
Which immunizations cannot be given? Egg Allergy
None Egg allergy NOT a contraindication to flu vaccine
27
Anaphylaxis Treatment Patent Airway
1. Epinephrine (IM preferred d/t more dependable absorption) 1. No contraindication to epinephrine use in anaphylaxis 2. Repeat epinephrine every 5 minutes if symptoms persist or increase 2. Antihistamine (only use WITH epinephrine) 1. Benadryl 2. Ranitidine 3. Biphasic response: observe for 2 hours in an ER or urgent care
28
Tetanus
C. Tetani Obligate anaerobe Grow in the absence of ambient O2 Deep wounds
29
Hep B Why age 19-59 recommendation for previously unvaccinated adults
Not as robust immune response to Hep B vaccine after age 59
30
HPV Type Genital Warts
6, 11
31
LAIV Vaccine
Give age 2-49 years Do not give in pregnant women, immunosupression, history of egg allergy, airway disease, people who have received flu antiviral in the last 48 hours
32
LTBI lifetime risk of developing active TB
5-10% The majority within the first 5 years
33
Hep B Vaccine
Birth 1-2 months 6-18 months
34
RSV vaccine frequency Max age final dose
2, 4, 6 months Max age for final dose 8 months
35
Dtap vaccine Tdap vaccine
Dtap 2, 4, 6 months 15-18 months 4-6 years (Tdap at 11-12 years)
36
Hib vaccine
ActHIB: 3 doses 2, 4, 6 months PedvaxHIB: 2 doses 2, 4, months Booster at 12-15 months
37
Pneumococcal Vaccine
Prevnar PCV 13 4 doses 2, 4, 6 and 12-15 months
38
IPV vaccine
2 months 4 months 6-18 months 4-6 years
39
MMR Varicella
2 doses 12-15 months 4-6 years doses minimum 4 weeks apart May give 2nd dose of MMR before age 4 if 3 months since first dose
40
Hepatitis A
1st dose at 12-23 months 2nd dose 6-18 months later - 6 months minimum time between doses
41
Zoster vaccine
Recommended starting age 60 years per ACIP FDA licensed for adults 50 years and older
42
Adults Pneumonia vaccine
Previously unimmunized 65 years and older - PCV13 then PPSV23 6-12 months later If have received PPSV23 at age 65 or older, PCV13 1 year after PPSV23 dose If PPSV23 received before age 65, give PCV13 1 year after most recent dose of PPSV23, then PPSV23 6-12 months later (and at least 5 years has passed since most recent dose of PPSV23)
43
Pack year history for tobacco
PPD x years smoked
44
Highest rate of suicide in which population
Males \> 65 years
45
Precontemplation stage
Pt not interested in change Unaware of problem Minimizes impact
46
Contemplation stage
Considering change Feels stuck HCP to examine barriers
47
Preparation stage
Some change behaviors Does not have tools to proceed HCP to assist in finding tools, removing barriers
48
Action stage
Ready to go through w/ change Inconsistent in carrying through HCP to work w/ patient encourage healthy behavior, praise positive, acknowledge regression is common but not unsurmountable
49
Maintenance/relaps stage
Has adopted and embraced healthy habit Relapse can occur HCP to continue positive reinforcement Backsliding is common but not insurmountable
50
USA leading cause of death
Heart Disease Cancer a close second d/t rising gero population
51
Leading Cancer Cases and Deaths
**Cases** Male: Prostate, Lung, Colon Female: Breast, Lung, Colon **Deaths** Male: Lung, prostate, colon Female: Lung, breast, colon
52
Next step: unexplained bleeding in postmenopausal woman
EMB
53
Breast Ca Screening
Mammography annually starting age 40 High risk (\> 20% lifetime risk): MRI + mammography annually Yearly MRI not recommended if lifetime risk \< 15% CBE every 3 years for women 20-40 years CBE every year 40 years and older
54
Colon cancer screening General population
FOBT/FIT annually starting at 50 years Colonoscopy if FOBT/FIT positive Preferred FOBT/FIT method: two samples from 3 consecutive specimens collected by pt at home **OR** Flexible sigmoidoscopy every 5 years starting at 50 Colonoscopy if positive OR Double-contrast barium enema every 5 years starting at 50 Colonoscopy if positive OR Colonoscopy every 10 years starting at age 50
55
Colon cancer screening High risk
History of colon cancer, adenomatous polyps, Crohn disease, or Ulcerative Colitis, strong family history (colon cancer of first degree relative before age 60, or 2 or more first-degree relatives at any age). Ulcerative Colitis: start colonoscopy 12 years after onset, then every thereafter Crohns: start colonoscopy 8 years after onset, then every year thereafter
56
Prostate cancer screening
Start discussion at 50 years for men at average risk w/ 10 year life expectancy Prostate cancer grows slowly, if \< 10 year life expectancy, not likely to benefit
57
Endometrial cancer screening
Women at menopause Report unexpected bleeding Abnormal vaginal bleeding is presenting sign in 90% of women with endometrial carcinoma For women with hereditary non-polyposis colon cancer (HNPCC), annual screening with EMB beginning at 35 years
58
Lung cancer screening
Age 55-74 years with 30 pack year smoking history, current smokers, or 15 years or less since quitting: Annual low dose CT until age 74 years
59
Cervical cancer screening
PAP smear starting age 21 every 3 years Cytology + HPV every 5 years starting 30 years of age
60
Erythropoietin source
90% renal, 10% hepatic Diminished in advancing renal failure, usually beginning when GFR \< 49 mL/min
61
First thing to respond after anemia correction (e.g. in iron deficiency)
Reticulocyte count responds in 1 week Hgb in 1 month 1gm/dL per month Ferritin in 4-6 months
62
Drugs then can cause B12/iron malabsorption causing anemia
Chronic PPI use Long-term Metforming use
63
B12 stores
7+ years of B12 stored in liver will take 7+ years to be depleted
64
Most common cause of spit-up and vomiting in young infant
GI immaturity allowing reflux
65
Peak risk for hypoglycemia for short-acting rapid insulin (insulin aspart)
1-3 hours after injection
66
Most important measure in Hep C prevention
Use of single-use injection drug paraphernalia
67
Exenatide contraindication
Gastroparesis
68
Belimumab
B-lymphocyte stimulater-specific inhibitor first biologic agent approved for adults with SLE
69
Cluster Headache
AKA: Migrainous neuralgia, Suicide headaches Only primary headache M \> F Most common in middle-aged men, likely underdiagnosed in women
70
Triptans in pregnancy
Contraindicated in pregnant women d/t potential vasoconstrictor effects
71
Raynaud disease epidemiology
Most often found in women Condition usually appears between age 15 and 45
72
Addison's
Primary adrenal insufficiency Key risk factor: autoimmune conditions E.g. chronic thyroiditis, dermatitis herpetiformis, Graves, hypoparathyroidism, myasthania gravis, Type I DM
73
Next step, microcytic anemia
Ferritin
74
Fatigue, spoon-shaped nails
Iron deficiency anemia
75
Most common for of IDA 4 years and older
Chronic low volume blood loss
76
Most common type of anemia in the elderly
1. Chronic disease 2. IDA 3. Pernicious anemia (distant)
77
Haptoglobin is ordered when considering
Hemolytic anemia
78
Most important source of body's iron supply
Recycled iron content from aged RBCs 85% typically comes from old RBCs
79
B12 Deficiency typical MCV
MCV \> 125 | (most macrocytic)
80
When does RDW normalize after tx
RDW starts to normalize as soon as tx started
81
Iron supplementation How to take enteric coating
On an empty stomach GI upset common Try w/o food, if GI upset, take w/ breakfast and dinner in divided doses BID best frequency Duodenum is where iron is absorbed, after a big dose of iron, intestines cannot absorb more for another 6 hours Enteric coated iron = very little is absorbed as a lot of is released beyond the duodenum
82
Cooley Anemia
Beta thalassemia major Life threatening w/o intervention dx shortly after birth
83
Acute rhinosinusitis
Inflammation of paranasal sinuses/nasal mucosa lasting up to 4 weeks Caused by allergens, environmental irritants, and/or infections Infectious causes: virus (majority), bacteria, fungi
84
ABRS How common
Secondary bacterial infection usually following a viral URI Less than 2% of viral URIs are complicated by ABRS Vast majority will clear w/o abx
85
Acute ABRS Risk for DRSP Factors
Age \< 2 or \> 65 Prior abx in the past month Prior hospitalization within past 5 days Comorbidities Immunocompromised
86
Transillumination for ABRS
Disproven as diagnostic for sinusitis
87
ABRS First line tx
**First Line:** Amoxicillin-Clav 500/125 PO TID or 875/125 BID **Second Line:** Doxy 100 mg BID - (note: DRSP tx failure risk) **In beta-lactam allergy:** Doxy 100 mg BID Levo 500 mg daily Moxi 400 mg daily **If DRSP risk: Respiratory fluroquinolone**
88
CYP450 inhibitors
Erythromycin Clarithromycin Increases toxicity e.g. Clarithro + Statin = 15x statin dose = rhabdo
89
Manifestation of IgE mediated allergy
Hive-form/urticaria Angioedema
90
CYP450 inducers
Pushes substrate OUT the exit pathway = decreased substrate levels E.g. St. John's Wort
91
Presbycusis changes
slowly progressive, symmetric, predominantly high frequency hearing loss
92
Conductive hearing loss
Reversible Something in between sound and auditory apparatus OME: can persist for up to 3 months; treatment is TIME
93
Presbycusis describe
Inability to discriminate human voice in a noisy environment During exam, HCP to: face-to-face Eye-level quiet environment
94
Allergic Rhinitis
allergen-induced upper airway inflammation and hypersensitivity d/t genetic-environmental interactions **s/sx** nasal discharge, sneezing, nasal congestion, anosmia, and nasal/pharyngeal/ocular itch
95
Allergic Rhinitis Tx First Line
First line Intranasal corticosteroids e.g. Flonase 1 spray BID or 2 sprays daily Onset of action within 12-24 hours Optimal efficacy can take 1-2 weeks Very low-dose Low systemic absorption
96
First generation antihistamines
Diphenhydramine, Chlorpheniramine, Brompheniramine, Hydroxyzine Blocks histamine-1 receptor sites Significant SE: sedation, impairs performance, ANTICHOLINERGIC effects Problematic in older adult
97
Ophthalmic antihistamines
Olopatadine (Patanol, Pataday) For ocular allergy symptoms Drop might sting for a few seconds Will not sting once inflammation goes down
98
Oral decongestants
Alpha-adrenargic AGONIST Relieves congestion via vasoconstriction Caution w/ elderly, young children, HTN, bladder neck obstruction, glaucoma, and hyperthyroidism
99
Nasal decongestants
Afrin Effective in ABRS Rebound congestion/rhinitis may occur LIMIT USE TO 5-7 days
100
Anticholinergic effects
Dry as a bone (dry mouth) Red as a beet (flushing) Mad as a hatter (confusion) Hot as a hare (hyperthermia) Can't see (vision changes) Can't pee (urinary retention) Can't spit (dry mouth) Can't shit (constipation)
101
Lymph node concerning for malignancy
Painless Firm Immobile
102
Oral cancer
90% squamous cell
103
CN I
Olfactory
104
CN II
Optic
105
CN III
Oculomotor Eyelid and eyeball movement
106
CN IV
Trochlear Turns eye downward and laterally
107
CN V
Trigeminal Chewing Face, mouth sensation and pain
108
CN VI
Abducens Turns eye laterally
109
CN VII
Facial Facial expressions, secretion of tears, saliva, taste
110
CN VIII
Acoustic Hearing, equilibrium, sensation
111
CN IX
Glossopharyngeal Taste, senses carotid BP
112
CN X
Vagus Senses aortic BP Slows HR Stimulates digestive organs, taste
113
CN XI
Spinal accessory Controls trapezius and sternocleinomastoid Controls swallowing movements
114
CN XII
Hypoglossal Controls tongue movements
115
Describe ophthalmic emergency
Red Eye Painful Acute vision change
116
Macular degeneration
Most common cause of new onset vision loss in elderly F \> M Female retina likes estrogen, post-menopause, eye ages rapidly Central vision loss Test: Amsler grid test
117
Open-angle glaucoma Describe
Thief of the night d/t progressive and aymptomatic presentation Enlarged optic disc cupping Loss of visual fields \>90% of glaucoma cases Gradual blockaage of aqueous flow despite apparently open system
118
Open-angle glaucoma Risk Fx
African ancestry DM Family Hx History of eye trauma/uveitis Advacing age
119
Closed-angle Glaucoma s/sx
Narrow angle glaucoma \< 10% of glaucoma Most serious form s/sx Injected conjunctiva Very painful N&V If drainage is only partially blocked: only warning signs may be blurry vision and colored halos around lights
120
Drugs that increase IOP
Anticholinergics Steroids Sympathomimetic pupil dilating drops TCAs MAOIs Antihistamines Antipsychotic meds Sulfonamides Antispasmolytic agents
121
Open-angle glaucoma Tx
First line: topical prostaglandins Latonoprost (Xalatan) - 1 drop in affected eye daily in the evening Bimatoprost (Lumigan) - 1 drop affected eye daily in the evening - Beta-blockers: Timolol 1 drop BID Alpha-adrenergic agonists: Alphagan 1 drop TID
122
Angle-closure glaucoma Tx
Acute primary attack: Prompt IOP lowering eye drops (Timolol, Iodipine, pilocarpine) Oral or IV acetazolamide or oral glycerold isosorbide: Give two 250 mg Acetazolamide tablets in the office, recheck eye-pressure 30-60 minutes later Systemic medication other than acetazolamide should be given under guidance of an ophthalmologist Once attack is broken, treatment of choice: laser peripheral iridotomy If laser peripheral iridotomy fails to remain patent or if cornea too cloudy, surgical peripheral iridectomy may be necessary
123
Ruptured TM otitis media tx
Ofloxacin otic 10 drops BID x 14 days (Ofloxacin also used for otitis externa 10 drops daily x 7 days)
124
Fungal otitis externa tx
Clotrimazole 1% BID x 14 days then re-assess If fungal elements persist, clean meticulously then treat for another 10-14 days Refer to ENT if persisting
125
Anosmia
Diminished sense of smell, age-related, accelerated by tobacco use
126
Senile cataracts
Lens clouding Progressive vision dimming Risk Fx: tobacco, poor nutrition, sun exposure, systemic steroids Potentially correctable w/ surgery, lens implant
127
Presbyopia
Hardening of lens Near all 45 years and older need reading glasses
128
Suppurative Conjunctivitis common pathogens (nongonococcal/chlamydial)
S. aureus S. pneumo H. influenzae Outbreaks d/t atypical S. pneumo
129
Suppurative conjunctivitis (nongonococcal/chlamydial) Tx
Primary tx: Fluroquinolone ophthalmic solution (preferred in contact lens wearers d/t pseudomonas coverage) Alternative: Polymyxin B w/ trimethoprim or azithromycin 1% opththalmic solution **DOSE:** **0.5 inch of ointment inside lower lid** **OR** **1-2 drops** **QID x 5-7 days** Ointment preferred in kids, those w/ poor compliance as ointment stays on lids Drops preferred in adults who need to read/drive as ointment clouds vision for 20 minutes after admin.
130
Otitis media w/ puctured TM
Do NOT use neomycin containing ointment if ruptured TM **USE:** **Ofloxacin otic drops** **5 drops BID x 3-5 days** **AND** **Amox 500 mg TID x 5-7 days** **If PCN allergy** - Cefdinir 300 mg BID - Cefpodoxime 200 mg BID - Cefuroxime 500 mg BID - Ceftriaxone 2 g IM **If beta-lactam allergy:** - Erythromycin combine with sulfisoxazole - Azithromycin - Clarithromycin **If tx failure:** Cefuroxime 250 mg BID x 10 days Augmentin 875/125 BID x 5-7 days (10 days if severe) -- Avoid acidic/antiseptic agents TM should heal within days Prevent water entry into ear canal while healing Follow up in 4 weeks to reassess and for audiometry ENT referral if persistent perforation or hearing loss \> 4 weeks of injury
131
Exudative pharyngitis Causes
Group A, C, G strep Viral HHV-6 M. Pneumo
132
Strep pharyngitis tx
First line: Penicillin V 500 mg 3-4x/day x 10 days **Alternative:** Erythromycin x 10 days Second generation cephalosporin x 4-6 days Azithromycin x 5 days Clarithromycin x 10 days Note: Up to 35% of S. pyogenes are resistant to macrolides
133
First generation cephalosporins
**Cefazolin**, cephalexine, cephapirin, cefadroxil, cephadrine, cephalotin Active against most gram+ cocci except for enterococci, oxacillin-resistant staph, and PCN-resistant pneumococci Active again most E-coli strains, proteus mirabillis, and klebsiella
134
Second generation cephalosporins
**cefuroxime,** **cefoxitin**, cefotetan, **cefprozil**, cefactor, cefonicid, cefamandole, cefmetazole - somewhat less active against gram positive cocci than first gen more active against certain gram negative bacilli Cefuroxime - active against Haemophilus influenzae Cefoxitin and cefotetan - active against most E. coli, P. mirabillis, and Klebsiella, active against Bacteroides
135
Third generation cephalosporins
**Ceftriaxone, Cefdinir, Cefixime,** Cefotaxime, Ceftazidime, Cefpodoxime, Cefditoren, Cefoperazone, Ceftibuten Marked by stability to the common beta-lactamases of gram-negative bacilli Useful alternatives to aminoglycosides in treating gram-negative infections resistant to other beta-lactams, esp. in patients with renal dysfunction
136
Fourth generation cephalosporin
Cefepime Only one
137
Fifth generation cephalosporin
Ceftaroline
138
Malignant otitis externa | (HIV, DM, chemo)
Oral cipro 750 mg BID for early disease suitable for outpatient Inpatient IV tx in severe disease - Tx typically started IV then orally Riskf or osteomyelitis of skull/TMJ MRI or CT indicated to r/o osteomyelitis often indicated ENT consult w/ surgical debridement should be considered Obtain cultures of ear drainage or results of surgical debridement
139
Otitis externa tx general population/immunocompetent
Fungi rare Pseudomonas, Proteus, Enterobacteriaceae Acute infection often S. aureus Tx: MILD: Acetic acid w/ propylene glycol and hydrocortisone (VoSol) drops MODERATE-SEVERE: Otic drops with ciprofloxacin with hydrocortisone DO NOT USE NEOMYCIN IF TM RUPTURE SUSPECTED
140
Otitis Externa Prevention
Systemic abx seldom needed Ear canal cleansing: decrease risk of infection by use of eardrops 1:2 mixture of white vinegar and rubbing alcohol after swimming
141
Allergic Rhinitis and antihistamines
Will help with itchy/watery eyes, sneezing and rhinorrhea Antihistamines will not help with nasal congestion
142
Derm assessment questions
Is the patient otherwise well? = localized skin infection (acne, rosacea, kp, seborrheic derm) Is patient miserable but not systemically ill? = uncomfortable with itch, burning, pain (severe psoriasis, Norwegian scabies, herpes zoster) Is patient systemically ill? = Systemic disease (varicella, transepidermal necrosis, SJS/erythema multiforme, Lyme disease) Are there primary/secondary lesions? = Where is the _oldest_ lesion and _when_ did it occur? Where is the _newest_ lesion and _when_ did it occur?
143
Primary Lesions vs Secondary
PRIMARY Result from disease process. No alteration from outside manipulation/tx/natural course of disease. Eg. vesicle SECONDARY Lesions altered by outside manipulation/tx/course of disease. Eg. crust
144
Auspitz sign
Psoriasis Pinpoint bleeding when scale is scraped off.
145
Vitiligo
Autoimmune against melanocytes Common w/ other autoimmune diseases (thyroid)
146
Palpable Purpura
NEVER BENIGN "blueberry muffin" appearance e.g. Meninigitis rash
147
Macule
flat, nonpalpable discoloration e.g. Freckle
148
Papule
Solid elevation e.g. raised nevus
149
Umbilicated
Papule with indented center e.g. Molluscum contagiosum
150
Pustule
Vesicle-like lesion with purulent content e.g. Impetigo
151
Patch
\> 1 cm flat, nonpalpable discoloration e.g. Vitiligo
152
Plaque
\> 1 cm Raised lesion, same or different color of surrounding skin, can result from coalescence of papules e.g. Psoriasis
153
Bulla
\> 1 cm Fluid filled (bigger than vesicle) e.g. Necrotizing fasciitis
154
Cyst
Any size Raised, enxapsulated, fluid-filled lesion Always benign e.g. Intradermal cyst
155
Wheal
Any sized Circumscribed area of skin edema e.g. Hives
156
Purpura
Purpura \> 1 cm Petechiae Flat red-purple discoloration caused by RBCs lodged in the skin Do **NOT** blanch (vascular lesion = blanches)
157
Excoriation
Linear, raised, often covered with crust. e.g. scratch marks over pruritic areas
158
Crust
Raised lesions produced by dried serum and blood remnants e.g. scab
159
Lichenification
Skin thickening usually found over pruritic or friction areas e.g. Callus
160
Scales
Raised superficial lesiosn that flake with ease e.g. Dandruff
161
Erosion
Loss of epidermis e.g. area under vesicle
162
Ulcer
Loss of epidermis AND dermis e.g arterial ulcer Chancre
163
Fissure
Narrow linear crack into epidermis, exposing dermis e.g. athletes foot
164
Annular lesion
In a RING e.g. Erythema migrans ("bull's eye") in Lyme disease
165
Scattered lesion
Generalized over body w/o specific pattern or distribution e.g. maculopapular rash in rubella
166
Confluent/coalescent lesions
Multiple lesions bleding together
167
Clustered lesions
Occurring ina group with pattern e.g. Acne-form drug induced rash seen with lithium, phenytoin, and iodine use = anticipated adverse effect
168
Linear lesions
In streaks e.g. Contact dermatitis poison ivy
169
Reticular lesions
Appearing in a net-like cluster e.g. Erythema infectiosum (Fifth Disease/slapped cheek)
170
Dermatomal or zosteriform lesion
Limited to boundaries of a single or multiple dermatomes e.g. Shingles NOTE: If suspected, start on high-dose acyclovir and come back in 24 hours to confirm dx Pain occurs 1-2 days before lesions erupt Suspect in acute shoulder/back pain, skin is "sore" Skin could also itch severely
171
Varicella
Infants vulnerable - vaccine is given at year 2-3 mm vesicles that start on trunk, appear on limbs 2-3 days later Nonclustered lesions at a variety of stages Mild to moderately ill Miserably itchy, risk for bacterial suprainfection of lesions **Tx:** Acyclovir within 24-48 hours of eruption **Prevention:** Varicella vaccine = 80% lifetime immunity first dose, 99% lifetime immunity second dose
172
Zoster (shingles)
Typically 50 years or older Possible in anyone with history of varicella Vesicles in a unilateral dermatomal pattern, slowly resolving with crusting Usually not systemically ill but quite miserable with pain and itch. Complications include postherpetic neuralgia, ophthalmologic involvement, and superimposed bacterial infection. **Tx:** High-dose acyclovir within 72 hours of eruption helps minimize duration and severity of illness **Prevention:** Zoster vaccine
173
Actinic Keratoses (AK)
Predominantly on sun-exposed skin Size ranges On skin surface - red, brown, scaly, often tender but usually minimally symptomatic Occassional flesh-colored - more easily felt than seen **Most common precancerous lesion though possibly represent early-stage SCC** **1 in 100 will progress to SCC** Tx: Topical 5-FU, 5% imiquimod cream, topical diclofenac gel or photodynamic therapy with topical delta-aminolevulinic acid Cryosurgery w/ liquid nitrogen, laser resurfacing, chemical peel
174
Basal cell carcinoma
More common than SCC Sun-exposed area Arises de novo (of new) Papule, nodule w/ or w/o central erosion Pearly or waxy appearance, usually relatively distinct borders w/ or w/o telengiectasia Metastatic risk low
175
Squamous cell carcinoma
Less common than BCC Sun-exposed areas Can arise from AK or de novo Red, conical hard lesions w/ or w/o ulceration Less distinct borders Metastatic risk greater (3-7%) Greatest metastatic risk = lesion on lip, oral cavity, genitalia
176
ABCDE Malignant Melanoma
A - Asymmetric B - Irregular borders C - Color not uniform D - Diameter usually 6mm or \> E - Evolving (new) lesion or change in a longstanding lesion, particularly in a nevus or other pigmented lesion E - Elevated (not consistently present) \* Majority of melanoma are de novo
177
Psoriasis vulgaris tx
medium-potency topical corticosteroid
178
Rosacea tx
Topical metronidazole
179
Pityriasis rosea
Acute, self-limited, erythematous skin disease Most likely viral Herald patch X-mas tree pattern Prodrome might occur but typically asymptomatic aside from itching Most cases do not require tx, may use medium-potency topical corticosteroid for itching Acyclovir may be useful in severe disease in shortening length of disease
180
Acanthosis nigricans
cutaneous manifestation of hyperinsulinemia puberty = worsenign insulin resistance can regress w/ control of disease e.g. after gastric bypass
181
Erysipelas
Infection of upper dermis, superficial lymphatics Streptococcus pyogenes (aka GABHS)
182
Cellulitis
Infection of dermis and subcutaneous fat Streptococcus pyogenes, less commonly MSSA beta-lactamase producing, MRSA (resistance via altered protein-binding sites)
183
Cutaneous abscess, furuncle
Skin infection involving hair follicle and surrounding tissue Carbuncles = cluster of furuncles connected subcutaneously, causing deeper suppuration and scarring Staph aureus (MSSA, MRSA)
184
Nonpurulent skin infection
**Necrotizing infection/Cellulitis/Erysipelas** Moderate = inpatient for IV PCN or Ceftriaxone, Cefazolin, or Clindamycin Mild = Oral Rx of PCN VK or Cephalosporin or Dicloxacillin or Clindamycin Dicloxacillin = PCN stable in beta-lactamase Clindamycin = most common abx assoc. w/ c-diff; take with probiotic
185
Purulent skin infection
**Furuncle/Carbuncle/Abscess** Mild = I & D Moderate = I & D and C & S Empiric therapy with Bactrim, Doxy Defined Rx MRSA = Bactrim MSSA = Dicloxacillin or Cephalexin \*Keflex = First gen $4
186
Brown Recluse Spider Bite
"Red, white, and blue" Central blistering with surrounding gray to purple discoloration at bite site Surrounded by ring of blanched skin surrounded by large area of redness
187
Most common cause of new onset ulcerating skin lesion across North America
MRSA
188
Nafcillin
Narrow spectrum Beta-lactamase resistant PCN Use of not risk factors for MRSA
189
Rocky mountain spotted fever s/sx and dx
Tick-borne Most cases occur in spring or early summer Early in disease: fever, malaise, arthralgias, headache, nausea w/ or w/o vomiting; children might present w/ abd pain Rash between day 3 and 5 of illness Early disease = empiric tx based on clinical judgment and epidemiological likelihood Later disease = dx via skin bx or serological testing
190
Rocky mountain spotted fever Tx
Start within 5 days of symptom onset Doxycycline 200 mg/day in two divided doses Tx should continue until 3 days of patient being afebrile Doxy: risk of _dental staining_ in children Doxy typically tolerated well except for _N&V_, give antiemetics/antimotility agents as needed Doxy assoc. w/ _photosensitivity_ = counsel about skin protection Pregnancy: use chloramphenicol if available
191
Lyme disease
Erythema migrans (central erythema, ring remains flat, blanches, does not desquamate) **Tx:** Doxy 100 mg BID x 10-21 days Amox 500 mg every 6-8 hours for 21 to 30 days Cefuroxime 500 mg BID x 20 days Use Amox/Ceftin for children **Prophylaxis:** Within 72 hours of tick removal: Doxy 200 mg x 1 dose
192
CA-MRSA tx
Bactrim DS = 2 tablets x 5-10 days Rifampin can be added - use w/ caution CYP450 inducer If can't have sulfa (bactrim), use: Doxy Minocycline To cover staph and strep use Bactrim with a beta-lactam (cephalosporin)
193
Babies
Avoid sun exposure Lightweight long pants, long-sleeved shirts, brimmed hats May apply sunscreen 15 spf or \> minimal amt If sunburned - apply cold compresses to affected area
194
Sun safety Children \> 6 months and adults
Hat w/ 3 inch brim or bill facing forward Sunglasses that block 99 to 100% of UV, cotton clothing w/ tight weave Stay in shade limit sun exposure during peak intensity hours 10 and 4 Use SPF 15 or \> on both sunny and cloudy days Protect against UVB and UVA rays Apply enough sunscreen 1 oz (30 mL) per sitting for older child and adult Reapply every 2 hours or after swimming/sweating Extra caution near water, sand, snow (reflects UV rays)
195
Hypothyroidism s/sx
Skin = decreased cell turnover, decreased subum = thick and dry Hung-up patellar reflex, slow arc out, slower arc back Overall hyporeflexia Mentation = slow thoughts Weight change (5-10 lbs gain largely fluid) Stool = constipation Mentrual = menorrhagia Heat/cold tolerance = easily chilled
196
Hypothyroidism etiology
Hashimoto thyroiditis (most common) = autoimmune Post-radioactive iodine (RAI) = s/p Graves disease tx or thyroid ca tx Select medication use = lithium, amiodarone, interferon
197
Hyperthyroidism s/sx
Excessive cellular energy release Skin = increased cell turnover = smooth, silky Hyperreflexia Mentation = mind racing Weight change = loss 10 lbs on average Stool pattern = frequent, low volum, loose Mentrual = oligomenorrhea Heat intolerance
198
Hyperthyroidism Etiology
Graves disease (most common) = autoimmune, multisystem presentation (exophthalmos, tachycardia, proximal muscle weakness, goiter) Toxic adenoma (benign metabolically active nodule) Thyroiditis (viral or autoimmune, post-partum, drug-induced, often transient, usually accompanied by thyroid tenderness) Select medication use (Amiodorane, interferon)
199
TSH Normal values
0.4 to 4.0 mIU/mL
200
TSH test evaluates what
Reflects anterior pituitary lobe's ability to detect amount of circulating free thyroxine (T4) TSH receptors found in thyroid follicular cells Receptor stimulation = increases T3 and T4 production/secretion Single most reliable test to dx all common forms of hypo/hyperthyroidism in the ambulatory setting
201
Free T4
NL = 10-27 pmo/L Unbound, metabolically active portion of thyroxine About 0.025% of all T4
202
Total T4
Rarely indicated Total of protein-bound and free thyroxine Often altered in the absence of thyroid disease
203
Free T3
Rarely indicated unbound, metabolically active portion of triidothyronine (T3) T3 4x more active than T4 About 20% of circulating T3 is from thyroid, 80% is from conversion of T4 to T3
204
Total T3
Rarely indicated Reflects total protein-bound and free triidothyronine (T3) Often altered in the absence of thyroid disease
205
Antiperoxidase antibody (antimicrosomal, antithyroid, thyroperoxidase)
Test to help detect autoimmune thyroid disease Measures an antibody against peroxidase, an enzyme held within the thyroid
206
Levothyroxine replacement
Need increases when metabolic need needs increases 50% or \> increased need in pregnancy Increase dose by 33% as soon as pregnancy confirmed Use ideal body weight in obesity, actual body weight in healthy weight/underweight Check TSH after 6-8 weeks Levothyroxine = long half-life, takes 3-5 half-lives to reach steady state + few more weeks for body to acclimate T3 = short half life (Armour Thyroid T3/T4 preparation) Levothyroxine: Take with water on an empty stomach same time every day Should not be taken within 2 hours of cation such as calcium, iron, aluminum, magnesium
207
Hyperthyroidism Test results and Tx
Low TSH, high free T4 Tx: Beta-adrenergic antagonist with B1, B2 blockade (propranolol, nadolol) if not contraindicated to counteract tachycardia, tremor Antithyroid medication: Propylthiouracil (PTU) Methimazole (Tapazole) \*Consult with endo: black box warning for acute liver failure -- Radioactive iodine (RAI) with end-result thyroid ablation and hypothyroidism
208
Subclinical hypothyroidism
Elevated TSH w/ normal free T4 AACE recommends tx of patients with TSH \> 5 if patient has goiter or if thyroid antibodies are present Presence of sx = tx
209
Goal TSH
0.5 to 2.0 Symptom resolution Measure TSH at 6 months then annually or when symptomatic -- If TSH \> 4 Increase dose by 12.5 to 25 mcg/day If TSH Decrease dose by 12.5 to 25 mcg/day
210
Thyrotoxicosis arrhythmia
atrial fibrillation
211
Risk of malignancy thyroid nodule
5% | (similar to breast bx rates)
212
Malignant thyroid nodule characteristics
history of head or neck irradiation Size \> 4 cm Firmness, nontender Immobile Persistent, nontender cervical
213
Thyroid nodule
If palpable nodule (clinically evident) Order TSH and U/S TSH suppressed = metabolically active nodule = thyroid scan HOT nodule = always benign = tx with RAI COLD nodule = fine-needle aspiration bx TSH not suppressed = fine-needle aspiration bx
214
Headache Red Flags
SNOOP S - systemic sx (fever, weight loss), secondary risk fx (HIV, ca, pregnancy, anticoagulation, HTN) N - neurologic signs (confusion, impaired alertness, nuchal rigidity, HTN, papilledema, cranial nerve dysfunction, abnormal motor) O - onset abrupt or w/ exertion, "thunderclap" h/a = subarachnoid hemorrhage; onset of h/a with exertion = increased ICP O - onset age \> 50 or P - previous onset history = new onset; first h/a \> 30 years
215
Tension h/a
Pressing, non-pulsatile pain Lasts 30 minutes to 7 days Mild to moderate intensity Usually bialteral F:M ration 5:4 More than one of the following suggests migraine and not tension: Nausea, photophobia, phonophobia
216
Migraine w/o aura
Lasts 4-72 hours Usually unilateral, occassionally bilateral Pulsating Moderate to severe Aggravation by normal activity such as walking During headache 1 or more of the following: Nausea and/or vomiting, photophobia, phonophobia F:M ration 3:1 Positive family hx in 70-90%
217
Migraine w/ aura
Migraine type h/a w/ or after aura Focal dysfunction of cerebral cortex or brain stemp causes 1 or \> aura sx developing over 4 minutes, or 2 or more sx occurs in succession Sx can include: feeling of dread/anxiety, unusual fatigue, nervousness, excitement, GI upset, visual or olfactory alteration No aura sx should last \> 1 h - if this occurs, consider alternate dx Positive family hx in 70-90%
218
Cluster h/a
H/a tends to occur daily in groups or clusters Lasts several weeks to months then disappears for months to years Usually occurs at characteristic times of year, at the same time of day Common time: 1 hour into sleep, "alarm clock" headache Pain awakens the person h/a often located behind 1 eye with a steady, intense ("hot poke in the eye") sensation Severe pain in a crescendo pattern lasting 15 min to 3 hours Suicide headache Most often with ipsilateral autonomic signs such as lacrimation, conjunctival injection, ptosis, and nasal stuffiness F:M ration 1:3 to 1:8 Family hx of cluster h/a 20%
219
Pressing non-pulsatile pain h/a
Tension
220
Usually bilateral h/a
Tension
221
Pulsating pain
Migraine
222
Hot poker feeling in one eye h/a
Cluster
223
Nausea and photophobia w/ h/a
Migraine
224
Usually unilateral h/a
Migraine (90% favor one side) Cluster
225
Nasal stuffiness w/ conjunctival injection h/a
Cluster
226
Lifestyle modifications for primary h/a
Highly effective, infrequently used Recognize and avoid triggers (chocolate, ETOH, certain cheeses, MSG, stress, perfume, too much or too little sleep, hunger, altered routine) Encourage regular exercise Attend to posture at workstation Use tinted lens to minimize glare and bright lights
227
Analgesic use in primary h/a
NSAIDs, APAP, others Limit use to 2 tx days/week to avoid analgesic rebound h/a
228
Triptans Ergot derivatives
Selective serotonin receptor agnosists Select ergot derivatives Migrainef specific Caution use in pregnancy, CVD, uncontrolled HTN d/t potential vascular effect Helpful in tension-type h/a that does not respond to analgesic tx Also used in tx of cluster h/a (as is high flow O2)
229
Primar h/a prophylactic (controller) medications
Beta-blockers (propranolol) TCAs (nortriptyline, amitriptyline) Antiepileptic (gabapentin, valproate, topiramate) Lithium (specific to cluster h/a) Nutritional supplements (butterbur, feverfew, coenzyme 10, Mg, riboflavin) = effective and recommended CCBs = relatively ineffective
230
Indiations for primary h/a prophylaxis
Any or all of the following: Use of any product \> 3x/week 2 or \> migraines per month that produce disabling sx for 3\> days Poor sx relief from various abortive tx Presence of select concomitant medical condition including HTN, hemiplegic, or basilar migraine Goal: reduce h/a frequency and severity, allow h/a medications to be more effective in controlling h/a sx
231
NP when to refer
Beyond scope Likely has dx that need to be supported/clarified by specialist (e.g. RA, SLE) Compex health condition for which input into ongoing care from a specialist is warranted (e.g. HF or angina pectoris to cardiologist) Failure to respond to standard, evidence-based care (e.g. pt w/ low back pain who has failed to respond to standard therapies and pain mgmt)
232
CT w/o contrast of head
Reveals: Acute hemorrhage Chronic hemorrhage Edema, shift Atrophy Ventricular size **Emergent image to r/o bleed: _CT w/o contrast_**
233
CT w/ contrast of head
Reveals: tumor, abscess
234
MRI of head
Soft tissue imaging typically needs abnormal CT before MRI is considered for head Reveals: Tumor, hemorrhage of days-weeks duration, carcinomatous meningitis, AV malformation, posterior fossa lesions Sometimes done first to look for brain mets
235
Migraine and OCPs
Migraines w/ aura = HIGH risk of STROKE on OCPs w/ estrogen
236
Giant Cell Arteritis
Autoimmune vasculitis that affects medium-large vessels as well as temporal artery Inflammation and swelling of arteries leads to decreased blood flow and assoc. sx Disease most commonly occurs 50-85 years of age F \> M **Clinical sx:** Tender/nodular pulseless vessel (usually temporal artery) accompanied by severe unilateral h/a 50% will have visual impairment (transient visual blurring, diplopia, eye pain, sudden loss of vision) CRP and ESR usually markedly elevated - order first **Definitive dx: temporal artery bx** Color duplex U/S can be used as an aleternative/complement bx **Tx:** High-dose systemic corticosteroids 1-2mg/kg/day until disese stabilized followed by careful reduction in dose and continued for 6 months to 2 years ASA can be used to reduce risk of stroke GI cytoprotection (PPI or misoprostol) should be provided to minimize adverse effects of long-term corticosteroid tx
237
Typical BP pain response
SBP elevated but DBP is at/close to baseline
238
Riboflavin and Magnesium for migraine prevention
Riboflavin 500 mg Magnesium 250-350 mg for 6-8 weeks -- Mg - might loosen stools Riboflavin - glow urine
239
GCA mgmt
NSADs & Steroids risk for gastritis = PPI minimize bone resorption = add low-dose biphosphonate Use opioid analgesics as needed Refer to neurosurgery for bx and neuro for mgmt
240
Pain on chewing
Jaw claudification in GCA
241
Potential dietary triggers primary h/a
sour cream, ripened cheeses, sausage, salami, pizza, MSG, Herring, any pickled/fermented, marinated food, yeast products chocolate, nuts, nut butters Broad beans, lima beans, fava beans, snow peas, onions Citrus fruits, Bananas, caffeinated beverages, ETOH, aspartame/phenylalanine
242
Lifestyle triggers, primary h/a
Menses, ovulation, pregnancy Illness of any kind Intense/strenuous activity or exercise Altered sleep Altered eating patterns Bright/flickering lights Odors, fragrances, tobacco smoke weather, seasonal allergies Excessive/repetitive noises High altitudes Medications (SSRI, SNRI, other psych meds, analgesic overuse, hormonal contraception, hormonal tx post menopause) Stress or stress letdown
243
GERD Dx
Typical sx of heartburn/regurg H. pylori screening not recommended in typical GERD Upper endoscopy not required in typical GERD sx
244
When to order upper endoscopy in GERD
Alarm findings: dysphagia, odynophagia, unintended weight loss, hematemesis, black or blood stools, chest pain, choking Repeat endoscopy not indicated in patients w/o Barrett's esophagus in the absence of new sx
245
GERD mgmt
Empiric tx with PPI Protracted PPI use assoc w/ B12, Ca, Mg, Fe malabsorption, possible increased fracture and C-diff associated diarrhea risk If no response to PPI - refer for evaluatiion Weight loss if overweight Elevate head of bed 3-4" blocks 2-3 hours Avoid meals within 2-3 hours of bedtime Lowest effective dose if long-term including on-demand and intermittent tx H2RAs can be used as maintenance in pts w/o erosive disease 8-week PPI course = tx of choice in healing erosive esophagitis **PPI tx should be once-a-day, before first meal of day (traditional release PPIs such as omeprazole = 30-60 minutes before meal)** **May use twice-daily doising/adjust dose timeing if sx are nocturnal or variable schedule** **No major differences between different PPIs** **Maintenance PPI tx for pts w/ sx after PPI is dicontinued or in pts with complications such as erosive esophagitis and Barrett's**
246
H. pylori and which ulcers?
95% of all **duodenal** ulcers = H. pylori
247
Neutrophilia
Elevated in Bacterial infection NL :
248
Lymphocytosis
Elevated in Viral infection NL:
249
Monocytosis
Elevated in Debris removal Good sign during recovery after illness NL :
250
Eosinophilia
Elevated in Allergens, parasites ("worms, wheezes, and weird diseases") NL:
251
Basophilia
elevated in Anaphylaxis, not fully understood NL:
252
Blumberg's sign
LATE peritoneal sign Deep palpate area of abd tenderness Pain upon release = peritoneal inflammation AKA: rebound tenderness
253
Markle's Sign
Stand on tiptoes, then let bodyweight fall quickly onto heels Positive = abd pain increases and localizes Indicative of peritoneal inflammation In kids: "show me how you hop"
254
Murphy's sign
Painful arrest of inspiration triggered by palpating edge of inflamed gallbladder
255
45 y/o male Drinks 8-10 beers/day 12 hour history of acute onset epigastric pain radiating to back w/ bloating, N&V Epigastric tenderness, hypoactive bowel sounds, abdomen distended and hypertympanic Elevated lipase, amylase Dx?
Acute Pancreatitis "Boring epigastric pain to the back" ETOH use
256
64 y/o F 3-day hx of intermittent LLQ abd pain w/ feer, cramping, nausea, 4-5 loose stools/day Soft abdomen, +BS, LLQ tenderness w/o rebound Leukocytosis, neutrophillia Dx?
Acute Diverticulitis - Cover for anaerobes and gram negative bacteria: Cipro + Flagyl
257
34 y/o M 3 month hx of intermitten upper abdominal pain described as epigastric burning, gnawing pain 2-3 h PC, relief w/ foods, anatacids. Awakens 1-2 AM w/ sx Tender epigastrum, LUQ Slightly hyperactive BS Dx?
Duodenal ulcer - Check for H. Pylori RELIEF w/ FOOD
258
52 y/o F Recently laid off, 3-4 Ibuprofen/day for 2-3 months to help w/ headaches 1 month hx of intermittent nausea, burning, and pain, limited to upper abdomen, worse w/ eating Tender epigastrum, LUEQ, hyperactive BS Dx?
Erosive gastritis - D/C NSAIDs May check H. Pylori WORSE w/ FOOD
259
21 y/o F 2 month hx of intermittent crampy abd pain, diarrhea, weight loss, fatigue 3 day hx of increasing discomfort, fever, tenesmus (sensation of incomplete bowel emptying) Pale conjunctiva, tachycardia, slightly hyperactive BS, diffus abd tenderness w/o rebound Normocytic, normochromic anemia, leukocytosis w/ neutrophilia
Inflammatory Bowel Disease - TOXIC MEGACOLON - anemia, leukocytosis w/ neutrophilia Need hospital admission
260
Pancreatic ca risk fx
Hx of chronic pancreatitis Tobacco use DM
261
Most efficient route of transmission for hep C
Blood transfusion Vertical transmission (mom to nursing infant) = uncommon
262
Vertical transmission
Mom to nursing infant
263
Horizontal transmission
Person to person e.g. sexual contact
264
Hep A transmission
Fecal-oral
265
HBsAg positive
Hep B surface antigen + = HBV is present
266
Anti-HBc positive
Anti-Hep B core = ongoing Hep B infection
267
Infectious hepatitis liver enzymes
ALT \> AST Acute hep B infection = markedly elevated LFTs
268
Hep A transmission
ingestion of fecal matter via close person to person contact w/ infected person Sexual contact w/ infected person Ingestion of contaminated food/drinks
269
Hep A risk fx
travelers to regions w/ intermediate/high rates of hep A Sex contacts of infected persons household members or caregivers of infected persons Household members or caregivers of infected persons Men who have sex w/ men user of certain illegal drugs persons w/ clotting factor disorders
270
Hep A incubation period
15 to 50 days Avg: 28 days
271
Viral hepatitis clinical sx
fever, fatigue, loss of appetite, N&V, abdominal pain, gray-colored BMs, Joint pain, jaundice
272
Hep A risk for chronic infection
None Most recover w/ no lasting liver damage Rarely fatal No chronic disease
273
Hep A test for acute infection
IgM anti-HAV
274
Hep B transmission
Contact w/ infectious blood, semen, body fluids birth to infected mother sexual contact w/ infected person sharing of contaminated needles, syringes or other injection drug equipment Needlesticks or other sharp instrument injuries
275
Hep B risk fx
infants born to infected mothers sex partners of infected persons multiple sex partners STDs Men who have sex w/ men Injection drug users household contacts of infected persons Health care and public safety workers exposed to blood hemodialysis patients Residents and staff of facilities for developmentally disabled persons Travelers to regions with intermediate or high rates of Hep B
276
Hep B incubation period
45 to 160 days avg: 120 days
277
Hep B risk for chronic infection
\> 90% of infants 25-50% of children 1-5 years 6-10% older children and adults Most persons recover from actue disease w/ no lasting liver damage Acute illness rarely fatal
278
Hep B test for acute infection
HBsAg in acute AND chronic + IgM anti-HBc + in acute infection only
279
Hep C transmission
Contact w/ infectious blood sharing of contaminated needles, equipment LESS commonly through: sexual contact birth to an infected mother needlestick or other sharp instrument injuries
280
Hep C risk fx
curren or former injection drug user recipient of clotting factor concentrates before 1987 recipients of blood transfusions before July 1992 Long-term hemodialysis Persons w/ known exposures to HCV HIV infected Infants born to infected mothers
281
Hep C incubation period
14 to 180 days avg: 45 days
282
Hep C risk for chronic infection
75-85% of newly infected persons will develop chronic infection 15-25% will clear virus
283
Hep C acute illness
Uncommon Those who do develop acute illness recover w/ no lasting liver damage No serologic marker for acute infection
284
Hep C and chronic liver disease
60-70% of chronically infected patients will develop chronic liver disease 5-20% develop cirrhosis over a period of 20-30 years 1-5% will die from cirrhosis of liver ca
285
Hep B test for chronic infection
HBsAg also positive in acute infection and additional markers as needed IgM + in acute infection ONLY
286
Hep C test for chronic infection
Screening assay (EIA or CIA) for anti-HCV Verify by more specific assay (NAT for HCV RNA)
287
Hep B screening
All pregnant women Unvaccinated Born to endemic regions Infants born to HBsAg positive mothers Injection drug users Men who have sex w/ men Patients with elevated LFTs Hemodialysis patients HIV infected patients Donors of blood, plasma, organs, tissues or semen
288
Hep C screening
Persons born from 1945-1965 Person who currently inject drugs or in the past Recipients of clotting factor concentrates before 1987 Recipients of blood or donated organs before July 1992 Long-term hemodialysis Known exposure HIV Born to infected mothers - do not test before age 18 months Patient w/ s/s of liver disease (LFTs) Donors of blood, plasma, organs, tissues, or semen
289
Hep A vaccine
2 doses 6 months apart Recommended for all children at age 1 year Travelers Men who have sex w/ men Clotting factor disorders
290
Hep B vaccine
Infants and children: 3-4 doses over 6-18 month schedule Adult: 3 doses over a 6 month period Recommended for all infants at birth At risk populations
291
Hep A Tx
No medication available Supportive
292
Hep B Tx
Acute: no medication available, supportive Chronic: Regular monitoring for signs of liver disease progression, some patients treated w/ antivirals
293
Hep C tx
Acute: Antivirals and supportive tx Chronic: Regular monitoring for s/s of liver disease progression, some patients treated w/ antivirals Interferon alfa or peginterferon can be considered if HCV RNA has not cleared from serum in 3-4 months If HCV RNA has not cleared after 3 months of tx, ribavirin can be added - some authorities starting ribavirin w/ peginterferon from start Most patients recover in 3-6 months
294
IBS dx
Clinical **Abdominal discomfort or pain that has 2 of the following:** **Relieved with defecation** **Onset associated w/ change in frequency of stool** **Onset associated w/ change in appearance of stool** Other sx: abnormal stool frequency, abnormal stool form, abnormal stool passage, passage of mucus, bloating or abdominal distention, other somatic or psychological complaints common 2/3 are women
295
IBS tx
**Antispasmodics (anticholinergic) agents:** Dicyclomine 10-20 mg 3-4x/day Hyoscamine 0.125 mg 4x/day **Antidiarrheals:** Loperamide 2 mg 3-4x/day Cholestyramine 2-4 g orally with meals - Fiber supplementation - may cause increased bloating Osmotic laxatives TCAs - Notriptyline 10 mg orally at bedtime, increase to 25-50 mg at bedtime as tolerated Alternative - Trazodone 50 mg at bedtime
296
Ulcerative Colitis Dx
IBD Affects colon only - idiopathic inflammatory condition mucosal surface of colon More common in non-smokers and former smokers - severity may worsen in patients who stop smoking **Essentials for dx:** Bloody diarrhea Lower abd cramps and fecal urgency Negative stool cultures Anemia - low serum albumin Sigmoidoscopy key to dx Clinical findings: Bright red blood on DRE Tenesmus
297
Toxic megacolon
Colonic dilation of \> 6 cm on radiographs w/ signs of toxicity Occurring in Heightens risk of perforation **(Ulcerative Colitis)**
298
Ulcerative colitis testing
Sigmoidoscopy establishes diagnosis Colonoscopy should not be done in fulminant disease d/t risk of perforation; perform after improvement to determine extend of disease Stool cultures (-) HCT, ESR, serum albumin
299
Ulcerative Colitis Tx - Mild
**Mild to moderate** Oral 5-ASA (mesalamine, balsalazide, sulfasalazine) - best for tx of diseases extending past sigmoid colon. Sx improvement in 50-75% of patients Mesalamine 2.4-4.8 g/day; improvement in 3-6 weeks, some require 2-3 months Sulfasalazine - low cost but higher side effects - start at 500 mg BID gradually increase over 1-2 weeks to 2 g BID Folic acid 1 mg once daily should be given to all patients taking sulfasalazine Corticosteroids to patients who do not improve within 4 weeks of 5-ASA tx Do not use antidiarrheals during acute phase of illness, useful at night time when taken prophylactically in pts w/o access to toilet - May use mesalamine rectal suppositories 1000 mg once daily for proctitis, 4 g per rectum at bedtime for proctosigmoiditis for 3-12 weeks = 75% will improve
300
UC and colon ca
colon ca occurs in 0.5-1% of patients per year of patients who have had colitis for \> 10 years folic acid 1 mg daily decreases risk of colon cancer colonoscopuyevery 1-2 years in patients w/ extensive colitis, beginning 8-10 years after dx
301
Ulcerative Colitis - Severe Tx
**Moderate to severe:** Corticosteroid improves 50-75% Prednisone 40-60 mg daily for 1-2 weeks, taper by 5-10 mg per week **Severe:** 48-64 mg IV or hydrocortisone 300 mg IV in four divided doses or by continuous infusion Infliximab 5 mg/kg IV Discontinue all PO intake Avoid opioid and anticholinergics Restore circulating volume w/ fluids/blood Correct electrolytes **Fulminant colitis and toxic megacolon:** NG suction, roll patients from side to side on the abdomen Serial abd radiographs to look for worsening dilation
302
Crohn Disease dx
Essentials for dx: Insidiuous onset Intermittent bouts of low-grade fever, diarrhea, RLQ pain RLQ mass and tenderness Perianal disease w/ abscess/fistulas Radiographic or endoscopic evidence ofulceration, stricturing, or fistuals in the small intestine or colon 1/3 of patients will have perianal disease Smokers are at increased risk Transmural disease might involve any of the GI tract
303
Crohn disease labs/tests
CBC, ESR, CRP Anemia may be d/t chronic inflammation, blood loss, iron deficiency, or B12 malabsorption Leukocytosis occurs in abscesses Obtain stool cultures barium upper GI series w/ small bowel follow through capsuled video imagin of small intestines CT eneterography colonoscopy Biopsy of intestine reveals granulomas in 25%
304
Intestinal obstruction s/sx
postprandial bloating, cramping pains, loud borborygmi Narrowing small bowel may occur as a result of inflammation, spasm, or fibrotic stenosis
305
Crohn's tx
Antidiarrheal agents Loperamide 2-4 mg 4x daily PRN, do not use in active severe colitis Broad spectrum abx if bacterial overgrowth Cholestyramine 2-4 g 1-2x/day before meals to bind the malabsorbed bile salts Similar tx to UC (mesalamine, prednisone, cipro+flagyl)
306
H. pylori tx
**If H pylori:** Omeprazole 20 mg bid Clarithromycin 500 mg bid Amoxicillin 1 gm bid x 14 days. **If resistance:** Omeprazole 20 mg bid Bismuth salicylate 2 tabs qid Tetracycline hcl 500 mg qid Flagyl 500 mg qid x 14 days.
307
Diverticulitis dx
Acute abd pain and fever LLQ tenderness and mass Leukocytosis **s/s** mild to moderate abd pain, aching usually LLQ Constipation or loose stools low-grade fever N&V Palpable LLQ mass Peritoneal signs in pts w/ free perforation
308
Peptic Ulcer Disease dx
Upper endoscopy w/ gastric biopsy for H. pylori is diagnostic
309
Diverticulitis tx - MILD
Clear liquid diet Broad spectrum oral abx with anaerobic activity Augmentin 875/125 BID or Flagyl 500 mg TID + Cipro 500 mg BID OR Bactrim DS BID x 7-10 days
310
Diverticulitis tx - SEVERE
NPO IV fluids NG suction if ileus **IV abx** monotx with 2nd generation ceph (cefoxitin), piperacillin-tazobactam, or ticarcillin clavulanate OR combo tx with flagyl/clinda + aminoglyside/3rd generation ceph x 7-10 days
311
Diverticulitis prevention
High fiber diet
312
Diverticulitis when to admit
severe pain or inability to tolerate oral intake s/s of sepsis/peritonitis CT scan showing signs of complicated disease (abscess, perforation) Failure to improve with outpatient mgmt Immunocompromised or frail, elderly patient
313
Non-invasive testing for H. Pylori
Fecal antigen or urea breath tests PPIs may cause false negative urea breath/fecal antigen tests and should be held for at least 7 days before serology testing not recommended for patients w/ low pre-test probability, cannot differentiate between current/past infections
314
H. pylori and gastic cancer
2-6x higher risk for gastric cancer in presence of H. pylori 90% of gastric adenocarcinoma of stomach have positive H. pylori
315
Mitral regurgitation Describe
Best auscultated w/ diaphragm Lower border of the right scapula Systolic murmur High pitched murmur
316
Levothyroxine dosing
Ideal body weight used even in presence of obesity 75-125 mcg of levothyroxine or about 1.6 mcg/kg daily Elderly: 75% of adult needs
317
Spleen normal weight, size, and location
"Rule of odds" 7 oz 1 x 3 x 5 inches located between ribs 9 and 11 - \> 50% of patients with IM will develop splenomegaly Risk of splenic rupture greates in the 2nd and 3rd weeks of illness Risk continues for at least 1 month after symptoms resolve Prudent to get U/S to ensure resolution of splenomegaly
318
High purine foods | (Avoid in gout)
scallops, mussels organ meats and game meats beans spinach asparagus oatmeal baker's and brewer's yeasts
319
Infectious endocarditis abx prophylaxis
Hx of infectious endocarditis = increased risk of infectious endocarditis assoc. w/ dental procedure **Prophylaxis:** Clindamycin 600 mg Cephalexin 2g Azithromycin 500 mg Clarithromycin 500 mg all 30-60 minutes before procedure
320
GERD alarm sx
Dysphagia Odynophagia (painful swallowing) GI bleed Unexplained weight loss Persistent chest pain
321
Expected findings in bacterial meningitis
Pleocytosis (WBC \> 5 cells/mm in CSF) - found in infectious meningitis (viral, bacterial, fungal or protozoan) **Bacterial meningitis:** CSF glucose decreased (normal level 40% of plasma) CSF protein elevated Elevated CSF opening pressure
322
Expected findings in viral or aseptic meningitis
Normal CSF glucose level Modest elevation in CSF protein
323
3rd degree burns describe
pain may be minimal, but usually surrounded by areas of painful first and second degree burns white and leathery
324
2nd degree burns describe
Raw and moist Painful
325
Most potent risk factor for arterial occlusive disease caused by extensive atherosclerosis
**Tobacco use** Other risk fx: DM, HTN, HL
326
Heatstroke tx
_Aggressive rehydration_ w/ careful monitoring d/t risk of pulmonary edema from reduced CO _Hyperkalemia_ is common d/t release of CK w/ tissue damage Rapid body cooling is _discouraged_ as this can stimulate cutaneous vasoconstriction inhibiting heat loss
327
STEMI mgmt
Adequate pain control with IV morphine if nitroglycerin not immediately effective or if pulmonary congestion or severe agitation are present ASA (160-325 mg) chewable, nonenteric should be given as soon as possible and continued indefinitely in patients who can tolerate it Supplemental O2 in patients in respiratory distress or cyanosis Beta-blocker should be given if no contraindications exist, with first dose IV
328
Dihydropyridine CCBs
Potent vasodilators Little to no negative effect on cardiac contractility/conduction Short acting - Nifedipine Long-acting w/ no cardiac depressant activity - Amlodipine Side effects: Headaches, dizziness, lightheadedness, flushing, and peripheral edema d/t vasodilation
329
Non-dihydropyridine CCBs
Verapamil, Diltiazem Less potent vasodilators but have greater depressive effect on cardiac conduction and contractility compared to dihydropyridines Contraindicated in patients who are taking beta-blockers, severe HF, sick sinus syndrome, and 2nd or 3rd degree AV block
330
Troponin I
More specific and sensitive than EKG in diagnosing non-Q-wave MI More specific and sensitive than CK-MB in diagnosing unstable angina and non Q-wave MI Available quickly through rapid assay **Increases rapidly within the first 12 hours after MI and remains elevated for about 192 hours**
331
CK-MB
not as sensitive/specific as Troponin I in diagnosing unstable angina Increased within 6-12 hours of MI and begins to decrease in 24 to 48 hours, returns to normal in 60 hours
332
Lateral epicondylitis
Tennis elbow Painful outer aspect of lower humerus Results from injury of extensor tendon at the lateral epicondyle Hand grip is often weak on affected side by elbow ROM is usually normal Counterforce brace worn to the back of the forearm can help relief symptoms
333
CAP likely organisms
Strep pneumo (gram+) M. Pneumo (Atypical) C. Pneumo (Atypical) Respiratory viruses (Influenza A/B, RSV, adenovirus, parainfluenza) Inpatient Tx: All of the above Legionella sp. (Atypical) H. Influenze (gram -)
334
Most common cause of fatal CAP
Streptococcus pneumoniae Gram + diplococci
335
Strep pneumo tx CAP
**Non-resistant:** macrolides standard dose amox (1.5-2.5g/day) select cephs tetracyclines including doxy **DRSP** High dose amox (3-4g/day) Respiratory fluroquinolones
336
Greatest impact on HIV transmission
Viral load at time of infection is greatest risk factor in contracting HIV
337
Typical SSRI symptoms
mild h/a, nausea, insomnia, restlessness, agitation Typically dose related and will resolve within 2 weeks Eat small bites when nauseous APAP for h/a Change drug classes if sx too distracting/bothersome
338
shingles vaccine
Approved starting age 50 Recommended officially at age 60 Contains significantly more virus than the chickenpox vaccine Contains 14x the number of plaque-forming units of virus than the varicella vaccine
339
ACOG recommendation on TSH in pregnant women
Routine screening for hypothyroidism is not performed during pregnancy ACOD recommendes screening if women has personal hx of hypothyroidism, famil hx, or is symptomatic ACOG also recommends screening if another disease is present assoc. w/ thyroid dysfunction (e.g. gestational DM)
340
Quinolone abx CV risk
All quinolones have potential to produce QT prolongation Prescribe w/ caution in older adults
341
Hesselbach's triangle
**Hesselbach's triangle** forms the landmark for **direct inguinal hernia** The _inguinal ligament,_ _rectus muscle,_ and _epigastric vessels_ form the triangle Most common groin hernias in men and women Inguinal surgical repair is themost common procedure performed in the US
342
Common complaint in older pts w/ cataracts
sunlight sensitivity
343
Most common site for indirect inguinal hernia
Internal inguinal ring Can occur in men and women Most are probably congenital, sx may not be obvious until later in life Indirect hernias are more common on the right side
344
acute, painless groin swelling high yield test?
Ultrasound of scrotum Ddx: inguinal hernia, hydrocele, varicocele U/S will yield quick, relaible information w/ dx accuracy of 93% for groin problems
345
Carotid bruit significance
Pts w/ audible carotid bruit are more likely to die from cardiovascular disease than cerebrovascular disease Poor predictor of carotid artery stenosis or stroke risk In pts w/ significant carotid artery stenosis, only 50% have an audible carotid bruit Value is that it is a good marker of generalized atherosclerosis Other vessels should be evaluated
346
Best tx for isolated systolic HTN
Amlodipine - long acting CCB Dihydropyridines -- Thiazides are not potent enough and effect is not additive when combined with CCBs
347
ACE inhibitors in HF Monitor what?
Potassium level in 1 week ACEIs work in the kidney - can impair renal excretion of potassium esp in kidney impairment Common practice - monitor K, BUN, Cr 1 week after initiation of ACEI and w/ increase of dosage in a patient w/ HF and who receives an ACEI
348
Goal postprandial glucose in older adults
349
MRI in back pain
MRI w/o contrast - provides info about soft tissues, like the lumbar discs Use contrast if patient has had hx of previous back surgery - contrast would be helpful to distinguish scar tissue from discs
350
H. Influenzae tx
Gram-negative bacillus 30% produce beta-lacatamase **Effective abx:** Cephalosporins Augmentin Macrolides Resp. fluoroquinolones tetracyclines including doxy
351
Common respiratory pathogen in smokers
H. Influenzae (gram -)
352
M. pneumo and C. pneumo tx | (atypicals)
atypical = not revelaed by gram stain **Effective abx:** Macrolides Respiratory fluoroquinolone Tetracycline inluding doxy **Ineffective:** beta-lactams (PCNs, cephs) beta-lactams are not effective as they work by destroying cell-wall - does not work w/ atypicals
353
Atypical CAP transmission
M. Pneumo and C. Pneumo Largely cough transmitted Often seen in people who have recently spent extended time in close proximity long incubation period (3 weeks)
354
Legionella sp. Transmission Tx
Not revealed by gram stain Transmission by inhaling mist or aspirating liquid that comes from infected water source No evidence of person-to-person spread of disease **Effective abx:** Macrolide Resp. fluoroquinolone Tetracyclines including doxy **Ineffective:** beta-lactams
355
Petit mal seizures Describe
Absence seizure Blank stare 3-50 seconds w/ impaired level of consciousness Usual age of onset 3-15 years
356
Myoclonic seizures describe
awake or momentary loss of cosciousness with abnormal motor behavior lasting seconds to minutes one or more muscle groups causes brief jerking contractions of the limbs and trunk, occiassional flinging the patient
357
Focal or simple seizures describe
aka jacksonian seizures awake state w/ abnormal motor, sensory, autonomic, or psychic behavior movement can affect any part of body, localized or generalized
358
Complex partial seizures describe
accompanied by an aura (unusual sense of smell, taste, visual or auditory hallucinations, or stomach upset) followed by a vague stare and facial movements, muscle contractions/relaxation, autonomic signs Can progress to loss of consciousness
359
Bursae Function
Act as cushions between tendons and bones body contains more than 150 bursa fluid-filled sacs lined by synovial tissue, which produces fluid that lubricates and reduces friction between tendons and bones
360
Levodopa and Parkinson disease mgmt
Minimizes sx of Parkinson disease Tends to be less effective w/ more adverse effects as disease progresses Most patients who take Levodopa for more than 5-10 years develop dyskinesia
361
Medications that may precipitate gout by causing hyperuricemia
Thiazide diuretics Niacin ASA Cyclosporine ETOH
362
Causes of secondary gout conditions
Conditions w/ increased catabolism and turnover e.g. psoriasis chronic hemolytic anemia Conditions w/ decreased renal uric acid clearance: e.g. intrinsic kidney disease and renal failure
363
Smallpox Describe
Last US case 1949 Last worldwide case 1970s Caused by variola virus Most contagious w/ onset of rash Infected person remains contagious until last small pox scab falls off
364
resting state normal stomach pH
pH: 2 Production: 1-2 mEq/hour in resting increases to 30-50 mEq/hour after a meal
365
Minimum diagnostic for CAP
CBC w/ diff CXR Additional testing based on patient presentation and comorbidity
366
Likely causative pathogen CAP Previously healthy No recent systemic abx (within 3 months)
Strep pneumo low DSRP risk Low risk of H. influenzae Atypical pathogens (M. pneumo, C. pneumo) Resp viruses (influenza A/B, adenovirus, RSV, parainfluenza) Tx: Macrolide or Doxy will cover non-DSRP and atypicals
367
Likely causative organisms CAP Comorbidities (COPD, DM, renal, HF, asplenia, alcoholism, immunosuppressing conditions/medications, malignancy) Systemic abx in past 3 months
Strep pneumo w/ DRSP risk H. influenzae (gram -) Atypicals (M. pneumo, C. pneumo, Legionella) Resp viruses **Tx:** Respiratory fluroquinolone (moxi, gemi, levo) **OR** Advanced macrolide or Doxy + beta lactam such as high dose amox (3-4g/day), HD amox-clav, Ceftriaxone, cefpodoxime (vantin), cefuroxime (ceftin)
368
CYP34A inhibitors abx
Erythromycin Clarithromycin - Erythro - limited gram neg coverage, poor tolerance d/t GI adverse effects
369
pulse pressure significance
wide = Good circulating fluid volume narrow = dehydration
370
Physical Findings PNA
In gero - tachypnea Strep pneumo and Legionella = most likely to result in pleuritic chest pain Consolidation - dullness to percussion, increased tactile fremitus (increased w/ increased tissue density) Bronchial or tubular breath sounds often w/ late inspiratory crackles that do not clear w/ cough Expect 4-6 weeks minimum of continued abnormal breath/lung findings even w/ successful tx
371
Pleural inflammation (pleurisy)
Associated w/ pneumonia, less commonly w/ PE (would be a late finding in PE) Sharp, localized pain (pt can pinpoint), worse w/ deep breath, movement, cough Audible pleural friction rub, from movement of inflamed pelura layers - sound similar to stepping into fresh snow - may be both during inspiration and expiration
372
Acute bronchitis likely pathogen
Respiratory tract viruses 90% Bacteria - M. Pneumo, C. Pneumo, B. pertussis 10%
373
Acute bronchitis tx
Anticholinergic bronchodilatero (Atrovent) Inhaled beta-agonist (Albuterol) short course of oral corticosteroids - Prednisone 40 mg orally daily x 3-5 days - addresses lower airway inflammation, cheapest, and most effective Consider use of macrolide of tetracycline when abx indicated
374
Define Asthma
Common chronic disorder of the aiways Variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation Inflamamtion causes the bronchospasm
375
Asthma s/sx, dx
Recurrent cough, wheeze, SOB, and/or chest tightness s/sx occur or worsen at night, or with exercise, viral respiratory infections, aeroallergens, and/or pulmonary irritants (e.g. second hand smoke) **Spirometry needed to make dx of asthma** **Peak flow meter is used for monitoring** Airflow obstruction that _is at least partially reversible_: Increase in FEV1 12% or \> from baseline post SABA use
376
Asthma visit frequency
well-controlled: 3-6 months not well-controlled: 2-6 weeks
377
ICS in Asthma
Mometasone, Fluticasone (Flovent), Budesonide (Pulmicort), Beclomethasone (QVAR), Ciclesonide Preferred controlled tx for persistent asthma Requires consistent daily use for optimal effect Prevents inflammation Helps stop at least 8 inflammatory mediators - Most PCPs are NOT well-versed in the relative potency of ICS and prescribe an appropriate dose for the patient's clinical presentation
378
ICS/LABA in asthma
Symbicort, Advair, Dulera Preferred tx for moderate and severe persistent asthma Increased death in asthma pts using LABA ICS w/ LABA should NOT be used in pts whose asthma is well-controlled with an ICS alone
379
Leukotriene receptor antagonists Leukotriene modifiers
Montelukast (Singulair) Zafirlukast (Accolate) Additional benefit w/ _allergic rhinitis_, most often used _in conjunction_ with ICS not useful as solo therapy
380
How much is systemically absorbed ICS
20% of a relatively small dose in ICS
381
LTRAs vs ICS in antiinflammatory effect
ICS at least 2-3x more potent than LTRAs LTRAs only prevents Leukotriene whereas ICS prevents at least 8 inflammatory mediators
382
SABA in Asthma
acute reliever for acute bronchospasm muscle relaxer = zero antiinflammatory effect Albuterol (proventil), salbutamol, pirbuterol, levalbuterol (Xopenex) **Up to 3 tx at 20 minute intervals as needed** All asthma pts should have ready access Drug of choice for preventing exercise-induced bronchospasm (EIB) - 2 puffs 30 minutes before exercise Use of \> 2 days/week (except for exercise) = poor inflammatory control
383
SABA how to use
1. Make sure canister fits firmly in actuator 2. Shake inhaler well 3. take cap off mouthpiece, look inside for foreign objects, take out if any 4. Hold inhaler w/ mouthpiece down 5. Breath out 6. Put mouthpiece around mouth and close lips around it 7. Push canister all the way down while breathing deeply and slowly through mouth 8. Hold breath for about 10 seconds 9. Breath out as lowsly as long as you can 10. If more sprays are prescribed, **wait 1 minute, shake inhaler again** 11. Put cap back on mouthpiece, snap firmly into place -- Clean inhaler at least once a week Store w/ mouthpiece pointing down Prime inhaler - shake and point away from face x 4 Prime if first time, not used for 14 days, or if it is dropped -- How to clean 1. Take canister out of actuator, take cap off 2. Hold actuator under faucet and run warm water through it x 30 seconds 3. Turn the actuator upside down and run water through mouthpiece x 30 seconds 4. Shake off as much water from the actuator 5. Let actuator air-dry overnight 6. when dry, shake well again and spray once before using
384
Systemic corticosteroids in Asthma
Aggressive tx of inflammaiton during asthma flare e.g. Prednisone 40-60 mg/day x 3-10 days Taper usually not needed w/ the dose and duration During asthma flare, increase use of rescue drug
385
Most common reason for asthma flare
Viral respiratory infection Typically 5-7 days viral infection would clear
386
Anticholinergics in asthma
Bronchodilator via blockage of cholinergic receptors aka Muscarinic Antagonist Emerging role in asthma tx Well-established in COPD Used primarily for prevention, not tx, of bronchospasm Atrovent - ipratropium bromide - SAMA Spiriva - Tiotropium bromide - LAMA
387
Theophylline in asthma
mild to moderate bronchodilator cheap but requires blood draws for monitoring multiple drug-drug interaction potential
388
Intermittent Asthma
sx 2d/week or less nighttime awakening 2x/month or less SABA use 2d/week or less No interference w/ normal activity Normal FEV1 between exacerbations FEV1 \> 80% predicted FEV1/FVC normal
389
Mild persistent asthma
sx \> 2 days/week but not daily Nighttime awakening 3-4x/month SABA \> 2days/week but not daily Minor activity limitation FEV1 \> 80% predicted FEV1/FVC normal
390
Moderate persistent asthma
Daily sx Nighttime awakening \> 1x/week but not nightly SABA daily Some limitation w/ activity FEV1 \> 60 but FEV1/FVC reduced by 5% Step 3 tx, consider short course of oral corticosteroids
391
Severe persistent asthma
sx throughout day nighttime awakenings often 7x/week SABA several times/day Extreme activity limitation FEV1 FEV1/FVC reduced \> 5% Step 4 tx + consider oral corticosteroids
392
Step 1 asthma
Intermittent asthma SABA PRN
393
Step 2 asthma
Mild persistent **Low dose ICS** + SABA PRN alternatives: Cromolyn, LTRA, nedocromil, thophylline
394
Step 3 asthma
Moderate persistent Low-dose ICS + LABA or Medium dose ICS Alternative: low-dose ICS+LTRA/theophylline/Zileuton
395
Step 4 asthma
Severe persistent Medium dose ICS + LABA Alternative: Medium-dose ICS + LTRA/theophylline/Zileuton
396
Step 5 asthma
High dose ICS + LABA AND Omalizumab for patients who have allergies
397
Step 6 asthma
High dose ICS + LABA + oral corticosteroids AND consider Omalizumab for patient who have allergies
398
When to step up/down in asthma
Step Up if needed - first, check adherence, environmental control, and comorbid conditions Step Down - if possible and asthma is well controlled at least 3 months
399
Findings in diseases of air-trapping
e.g. asthma, COPD Hyperresonance Decreased tactile fremitus = decreased tissue density Wheeze (expiratory first, inspiratory later) Low diaphragm Increased AP diameter ("barrel chest")
400
COPD describe
Preventable, treatable disease w/ significant extrapulmonary effects Pulmonary component is characterized by airflow limitation that is not fully reversible Usually progressive and associated w/ abnormal inflammatory response of lung to noxious particles or gasses Dx should be considered in any pt w/ progressive dyspnea, chronic cough, sputum production, and/or hx of exposure to risk fx (tobacco, pollution, occupational)
401
COPD dx
Spirometry is required for dx Use age-related variables to avoid over-dx FEV1:FVC Classification of severity determined by FEV1 - Alpha-1 antitrypsin deficiency screening - perform when COPD develops in pts of Caucasian descent under 45 or w/ strong family hx of COPD
402
COPD and common arrhythmia
long-standing COPD = high pulmonary artery pressures = right atrial and ventricular hypertrophy = atrial fib
403
Mild COPD Describe
GOLD 1 FEV1 \> 80% predicated
404
Moderate COPD Describe
GOLD 2 FEV1 50-80%
405
Severe COPD Describe
Symptomatic FEV1 30-50% predicted
406
Very severe COPD Describe
GOLD 4 Symptomatic FEV1
407
Medications in COPD
SABA prn for relief of bronchospasm LABA - protracted duration of bronchodilation, used on a daily set schedule LAMA - protracted duration of bronchodilation, minimized risk of COPD exac, used on a daily set schedule ICS - antiinflammatory, minimized risk of COPD exac, used on a daily set schedule Theophylline - bronchodilator, used on a daily set schedule PDE-4 inhibitor (roflumilast) - minimized risk of COPD exac, used on a daily set schedule
408
GOLD 1-2 COPD tx low risk less sx 1 or
First choice: SAMA or SABA prn -- SAMA: Atrovent SABA: Proventil Second choice: LAMA, LABA or combined SAMA+SABA Alternative: Theophylline
409
GOLD 1-2 COPD tx Low risk More sx 1 or fewer exac/year
LAMA or LABA 2nd choice: LAMA + LABA Alternative: PDE-4 inhibitor, SABA and/or SAMA, Theophylline (do not use w/ roflumilast)
410
GOLD 3-4 COPD tx High risk Less sx 2 or more exac/year
ICS + LABA or LAMA 2nd choice: ICS+LAMA, ICS+LABA+LAMA, ICS+LABA+PDE4 inhibitor etc. Alternative: Carbocysteine (mucolytic) SABA and/or SAMA, theophylline
411
Theophylline in COPD
Do not use with PDE4 inhibitor roflumilast
412
Oxygen in COPD When
O2 delivery to organs, baseline PaO2 at rest to 60 mmHg at sea level or higher and/or SaO2 90% or higher **Indications for O2 therapy in COPD** PaO2 PaO2 55-59 mmHg or SaO2 = 89% in the presence of cor pulmonale, right heart failure, or polycythemia (HCT \> 56%)
413
COPD exacerbation Define
Event in the natural course of disease Change in the patient's baseline dyspnea, cough, and/or sputum beyond day to day variability sufficient to warrant change in mgmt
414
COPD exacerbation TX
SABA and/or SAMA prn Consider adding LABA or LAMA if patient currently not using one **If baseline FEV1** Add systemic corticosteroid - Prednisone 40 mg/day x 5-10 days studies show shorter steroid courses equally effective as longer courses Consider adding ICS if not currently using Encourage smoking cessation = associated w/ reduction of COPD exac, and reduction in rate of lung function loss **Antibiotic therapy** LIkely indicated if 3 cardinal sx: **Increased dyspnea, increased sputum volume, and increased sputum purulence** CXR - only w/ fever and/or low SaO2 to r/o concomitant PNA
415
Abx potentially associated w/ QT prolongation and increased risk of CV death
Macrolides
416
Abx w/ potential for tendon rupture, particularly when taken w/ systemic corticosteroid
Respiratory fluoroquinolones
417
Abx for COPD Flare
Causative pathogens in 30-50% include H. influenzae, H. parainfluenzae, S. pneumoniae, M. catarrhalis Less common: atypical, other gram+ and gram- organisms **Mild to moderate** Abx usually not indicated, if prescribed, consider: Amox - vulnerable to H. Flu and M. cat Doxy - first choice TMP-SMX - not as great H. flu coverage **Severe COPD exac** Consider: Amox-clav Cephalosporin (cefdinir, cefpodoxime, others) Azithromycin - risk for QT prolongation Clarithromycin - CYP450 inhibitor Fluoroquinolone w/ DRSP actibity (Moxi, Levo) - risk for tendon rupture
418
Inhaled anthrax
s/sx Low grade fever, nonproductive cough, nonspecific presentation Widened mediastinum d/t hemorrhage visile on CXR or thoracic CT Tx: Fluroquinolone Expert consult
419
Cutaneous anthrax
Most common form pustular skin lesion that eventually forms ulcer w/ eschar tx: Fluoroquinolone expert consult
420
Post-infectious cough tx
Atrovent If no relief add ICS if inadequate response, PO prednisone last line: codeine+dextromethorphan
421
Botulism
Muscle paralyzing Food-borne Sx: double vision, blurred, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, muscle weakness, moves DOWN body, shoulders affected first Most recover - weeks to months Tx supportive care, antitoxin (CDC, California department of health)
422
Type 1 DM
Autoimmune process involving beta-cell destruction = insulin deficiency short history of significant sx: unexplained weight loss, ketonuria, polydipsia, polyphagia, polyuria usually dx in acute ill child or young adult
423
Type 2 DM
Insulin resistance w/ eventual insulin deficiency Few if any sx Usually dx during routine screening
424
DM screening criteria
All adults who are overweight BMI 25 or \> and have additional risk fx: physical inactivity First-degree relative with DM2 High-risk ethnicity Women w/ hx of giving birth to baby \> 9 lb or GDM Hx of GDM - screen women at 6-12 weeks postpartum HTN HDL 250 PCOS IFG or IGT on previous testing Clinical conditions assoc w/ insulin resistance (severe obesity, acanthosis nigricans) Hx of CVD -- In the absence of above criteria, begin screening at 45 years If normal, repeat every 3 years, more frequent depending on risk status
425
DM dx
Fasting glucose 126 or \> Random glucose 200 or \> w/ sx 2h plasma glucose of 200 or \> after 75 g glucose load (most expensive) A1c 6.5 or \> Repeat A1C if asymptomatic adult with glucose 200 or Repeat not needed if sx or if glucose \> 200
426
Pre-DM
IFG = 100 to 125 mg/dL IGT= 140 to 199 mg/dL on 75g OGTT A1C = 5.7 to 6.4
427
DM Goals
A1C Fasting 70-130 mg/dL Peak postprandial (1-2h after meal) Bedtime 90-150 mg/dL - A1C A1C - Obtain A1C at least twice a year in patients who are meeting tx goals and who have stable glycemic control A1C quarterly in pts whose therapy has changed or who are not meeting glycemic goals
428
A1C and Estimated Average Glucose
6% = 126 7% = 154 8% = 183 12% = 298
429
Biguanide
Metformin Brand: Glucophage **Insulin sensitizer** No inherent hypoglycemia risk = minimal action on fasting and postprandial glucose **90% renally eliminated** **D/C at GFR** risk of **lactic acidosis** in impaired renal function/comorbidities/frailty add MVI - long-term use B12 malabsorption Anticipated A1C reduction 1-2% - **Radiocontrast use, surgery, or any potential to alter hydration status:** _omit Metformin for the day of and for at least 48 hours post study/procedure._ Reinitiate when baseline hydration/renal function are re-established
430
Thiazolidinedione (TZD, glitazones)
Pioglitazones (Actos), Rosiglitazone (Avandia) Anticipated A1c reduction 1-2% **Insulin sensitizer** No inherent hypoglycemic risk = minimal action on fasting/postprandial glucose Monitor ALT periodically, rare risk hepatic toxicity **Edema risk,** especially when used w/ insulin or SU **Can exacerbate HF** **Use w/ insulin or nitrates not recommended** Pioglitazone use (Actos) use \> 1 year possibly assoc. w/ **bladder ca**
431
Sulfonylrea (SU)
Glipizide (Glucotrol), Glyburide (DiaBeta), Glimepiride (Amaryl) $4 list Anticipated A1C reduction 1-2% **Increases insulin release** **Hypoglycemia risk** esp. in elders, impaired renal function, nocturnal, fasting and 4-6h after meals Typically less effective after 5 years d/t failing beta cells May also be less effective in older adults, presence of severe hyperglycemia Glipizide preferred in elderly over Glyburide
432
Meglitinides
Repaglinide (Prandin), Nateglinide (Starlix) Anticipated A1C redution 1-1.5% **Increases insulin release** **Hypoglycemia risk 2-3 h after medication**, action on postprandial glucose only **Take 1-30 minutes before meal** Results in quick **insulin burst w/ onset of action 20 minutes** after dose taken No additional benefit if used with SU Can e used in presence of severe sulfa allergy (no sulfa molecule) Use w/ caution in hepatic/renal impairment
433
Dipeptidyl peptidase-4 inhibitor (DPP-4)
Sitagliptin (Januvia), Saxagliptin (Onglyza), Linagliptin (Tradjenta), alogliptin (Nesina) Anticipated A1C reduction 0.6-1.4% **Increases insulin release** Minimal to no hypoglycemia risk = action largely on postprandial glucose **Adjust dose in renal impairment** Well tolerated Weight neutral Indicated to improve glycemic control _in combination_ w/ insulin sensitizers or other insulin releasers **Monitor for pancreatitis** after intitiation and dose increases Has not been studied in patients w/ hx of pancreatitis
434
GLP-1 agonist
Incretin mimetics Exenatide (Bydureon, Byetta), Ligralutide (Victoza) Anticipated A1C reduction 1-2% **Increases insulin release** Little inherent hypoglycemia risk **Slows gastric emptying, often leading to appetite suppression and weight loss** Stimulates insulin release in response to increased plasma glucose **Major side effect: N/V** better w/ dose adjustment, continued use **Contraindicated in gastroparesis** Adjunct use in DM2 when not adequately controlled with biguanide, SU Exenatide - not FDA approved as add-on tx w/ insulin glargine D/C if acute pancreatitis sx develop (persistent abd pain w/ vomiting) **Exenatide - do not use if hx of prancreatitis** **Do not prescribe if CrCl** Caution in CrCl 30-50 mL/min when increasing dose from 5-10 mcg
435
Alpha-glucosidase inhibitors
Acarbose (Precose), Miglitol (Glyset) Anticipated A1C reduction 0.3-0.9% **Delays intestinal carbohydrate absorption** by reducing postprandial digestion of starches and disaccharides via enzyme action inhibition **Little inhered hypoglycemia risk** **Taken with first bite of meal** Helpful in mgmt of postprandial hyperglycemia Does not enhance insulin secretion or sensitivity **GI adverse effect** - avoid use in IBS, impaired renal function Increased gas! - Carbs are broken down more slowly
436
Sodium glucose contransporter-2 (SGLT2)
Canagliflozin (Invokana), Dapagliflozin (Jardiance) Anticipated A1C reduction 0.7 - 1% Lowers plasma glucose levels by **increasing the amount of glucose excreted in urine** Hypoglycemic risk r/t glucose offload; increased when used w/ insulin and insulin secretagogues **Adverse effects = genital mycotic infection (10% in F, 5% in M), UTI, increased urination** Modest weight loss of 4-7 lbs **Dose adjustment or discontinuation required in renal impairment** d/t risk of adverse effects, electrolye imbalances, and less therapeutic effect Can be used as add-on tx w/ metformin, SU, and others
437
When to start insulin
Type I - all pts at dx Type II At time of dx to help achieve initial glycemic control When 2 or more agents at optimized doses are inadequate to maintain glycemic control when acutely ill In critically ill pts type I or II - BG levels should be kept at 140-180 mg/dL
438
Basal insulin percentage
50%
439
Humalog Lispro insulin
Short acting Onset 15-30 minutes Peak 30 minutes - 2.5 hr Duration 3-6.5 hr Give within 15 min or right after meals
440
Insulin Aspart Novolog
Short acting Onset 10-20 minutes Give 5-10 minutes before meals Peak 1-3 hr Duration 3-5 hr
441
Insulin glulisine Apidra
Short acting Onset 10-15 min give within 15 minutes or right after meals Peak 1-1.5 hr Duration 3-5 hr
442
Regular insulin Humulin R Novolin R
Short acting Onset 30 min-1 hr Peak 2-3 hr Duration 4-6 hr
443
NPH Novolin N Humulin N
Intermediate acting Onset 1-2 hr Peak 6-14 hr Duration 16-24 hr
444
Insulin glargine Lantus
Long-acting Clinical effect 1 hr No peak Duration 24 hours
445
Insulin detemir Levemir
Long-acting Onset 1-2 hr Peak 6-8 hr (minimal) Dose dependent duration 12 hr at 0.2 units/kg 20 hr at 0.4 units/kg
446
Metabolic syndrome components
Large waistline Hypercholesterolemia Low HDL High BP High glucose
447
Meningomyocele
Protrusion of the membranes that cover the spine and spinal cord itself through a defect in the bony encasement of the vertebral column
448
Myelocele
Protrusion of the spinal cord through a defect in the vertebral arch
449
Omphalocele
abdominal wall defect intestines, liver, and occassionally other organs remain outside of the abdomen in a sac
450
What shoulder movement to test supraspinatus, anterior and lateral deltoid, and pectoralis major?
Shoulder abduction
451
DM quality indicators/additional care considerations
Daily ASA: 1-2 baby aspirins; Plavix 75 mg daily if ASA allergy in men \> 50 and women \> 60 w/ DM and 1 or more CVD risk fx (HTN, family hx, etc.) BP control to include ACEI or ARB Statin usually indicated; esp. for age \> 40 or w/ hx of ACS Check fasting lipid profile annnually Check serum creatinine, calculated GFR, urine microalbumin annually Limit trans and saturated fats 150 min/week of moderate activity, 30 min 5x/week, resistance exercise 3x/week Vigorous exercise potentially contraindicate in the presence of proliferative or severe nonproliferative retinopathy d/t risk of vitreous hemorrhage or retinal detachment Annual dilated eye exam minimum Visual foot exam every visit Comprehensive lower extremity sensory exam annually - 10g monofilament w/ 1 or more of the following: vibration using 128 Hz tunning fork, pinprick sensation, ankle reflexes, or vibration threshold Review goals periodically
452
Metabolic Syndrome
**Defined as ANY 3 of the following:** **Waist circumference** Men \> 102 cm (\>40in) Women \> 88 cm (\>35 in) **Triglycerides ≥ 150 mg/dL** **HDL** Men Women **Blood Pressure ≥ 130/80 mmHg** **Fasting glucose ≥ 110 mg/dL**
453
Creatinine increase
Only increases when about 50% of renal function has been destroyed
454
Nonproliferative diabetic retinopathy
microaneurysms, macular edema visual loss d/t macular edema
455
Proliferative diabetic retinopathy
new fragile vessels form
456
DM retinopathy w/ fluid leak/bleed/macular edema vision changes and tx
New onset blurry vision "floaters" "holes" "swiss cheese" vision Tx tight BG control photocoagulation Vitrectomy if disease progresses after photocoagulation
457
HTN target organ damage examples
Stroke, vascular (multi-infarct) dementia (20% of all dementias) Atherosclerosis, MI, LVH, HF HTN nephorpathy, renal failure HTN retinopathy w/ risk of blindness
458
Grade 1 HTN retinopathy
Narrowing of terminal branches No vision change or permanent fidings
459
Grade 2 HTN retinopathy
Narrowing of vessels w/ severe local constriction No vision change or permanent findings
460
Grade 3 HTN retinopathy
Preceding signs w/ striate hemorrhages and soft exudates Potential for visual change and permanent findings Black spots in visual field pending HTN crisis - 911
461
Grade 4 HTN retinopathy
Papilledema w/ preceding signs w/ striate hemorrhages and soft exudates Potential for visual change and permanent findings pending HTN crisis - 911
462
Weight reduction in HTN and HL
Maintain normal body weight SBP reduction **5-20 mmHg** per 10 kg weight loss
463
DASH eating plan for HTN and HL
Rich in fruits and vegetables, low-fat dairy, reduced saturated and total fat ## Footnote **SBP reduction 8-14 mmHg**
464
Dietary sodium restriction in HTN and HL
## Footnote **SBP 2-8 mmHg reduction**
465
Aerobic physical activity for HTN and HL
Decreases insulin resistance/increases insulin sensitivity Increases HDL and lowers TG Moderate to vigorous physical activity 40 min/day 3-4x/week No more than 48 hours w/o exercise (CVD benefit wears off) **SBP reduction 4-9 mmHg**
466
Moderate ETOH consumption in HTN and HL
M F SBP reduction 2-4 mmHg
467
BP goal DM/CKD tx Black vs Nonblack tx
**60 y and older** **If DM goal Black: Initiate thiazide and/or CCB Nonblack: Initiate thiazide, ACEI/ARB, or CCB -- _CKD:_ Initiate ACEI/ARB _all races_ - may combine w/ other drug classes**
468
BP titration
**After initiation, wait 1 month, if not at goal:** Reinforce medication and lifestyle changes Maximize medications **wait 1 month,** if still not at goal, titrate meds (maximize dose of first drug, add second drug, maximize second drug etc.) Reinforce medication and lifestyle changes **wait 1 month,** if still not at goal Reinforce medication and lifestyle changes Add addition medication class (beta-blocker, aldosterone antagonist) and/or refer to HCP w/ expertise in HTN mgmt
469
Thiazide diuretics
HCTZ, chlorthalidone MOA: low-volume sodium depletion = PVR reduction w/ high dose (e.g. HCTZ 25 mg/day) potential negative impact on HL, glucose control **Monitor for Na, K, Mg depletion** **Calcium sparing - monitor for hypercalcemia** Lower observed rate of fractures in women who are long-term thiazide users Less effective w/ advancing renal impairment, esp if GFR Loop diuretics remain effective w/ lower GFR Only use loop diuretics to off-load fluid, not for BP control
470
ACEIs and ARBs
**ACEIs:** Lisino**_pril_**, Enela_pril_ (Vasotec) **ARBs:** Lo**_sartan_** (Cozaar), telmi**_sartan_** (Micardis) **Attenuates angiotensin II (potent vasoconstrictor that also stimulates catecholamine release)** ACEIs minimize production ARBs block its action - **Adjust dose in renal insufficiency** **Do not use in bilateral renal artery stenosis** Modest **hyperkalemia** risk, esp. w/ inadequate fluid intake, when used w/ aldosterone antagonist ACEI induced cough: can use ARB as an alternative Angiodema risk w/ ACEI use, less w/ ARB **Do not use in pregnancy (Category D)** Renally eliminated
471
Calcium channel blockers CCBs
MOA: causes vasodilation **Dihydropyridine (DHP):** Amlod**ipine** (Norvasc), felod**ipine** (Plendil) **Nondihydropyridine (non-DHP):** Diltiazem, verapamil Ankle edema particularly with DHPs **NonDHP: caution w/ BB and untreated heart block** **NonDHP: CYP450 3A4 inhibitor** Avoid use/use w/ caution in HF, renal, hepatic impairment
472
Betablockers
Atenolol, metropolol, propranolol MOA: Block adrenergic beta1 receptor sites, blunt catecholamine response Non-cardioselective BBs (propranolol, nadolol) also block beta2 receptor sites Use w/ caution in untreated heart block Lower dose cardioselective beta-blocker tx usually acceptable in COPD, asthma - monitor for worsening airway obstruction when discontinuing, taper dose over a 10-14 day period to allow previously blocked receptors to acclimate Ok to use BB if pt has pacer
473
Aldosterone antagonist
Spironolactone (Aldactone), eplerenone (Inspra) MOA: Block effects of aldosterone, therefore better regulating of Na+ and water homeostasis and maintenance of intravascular volume Aldosterone = increases sodium reabsorption **Hyperkalemia risk,** particularly w/ ACEI/ARB, volume depletion, including excessive diuresis **Gynecomastia risk** w/ prolonged use (androgen blocker) Caution in renal impairment
474
Centrally-acting BP agents
Clonidine (catapres) Methyldopa (aldomet) - use in pregnancy w/ primary HTN category B/C MOA: works at brain BP control center Sedation risk Abrupt clonidine withdrawal = rebound HTN risk Not mentioned in JNC-8
475
Cumin and coriander
No documented drug interactions Lowers BP in large doses Ok to use
476
Lipid affected by non-fasting state
Triglycerides
477
Saturated fats
Solid at room temp Avoid tropical oils such as palm and coconut oil
478
Dietary options to decrease LDL
Increase intake of plant sterols and stanols to 2g/day (Take Control and Benecol margarine) Viscous or soluble fiber to 10-25 g/day (oatmel, oat bran) OAT = best grain for fat and constipation
479
HL fat intake
Reduce saturated fat to Avoid trans fats Reduce total cholesterol intake to Dietary fat to 25-25% of total daily caloric intake
480
Omega-3 in HL
Increase intake of omega-3 fatty acids (EPA and DHA) w/o CHD: oily fish 2x/week Include oils and food risk in a-linolenic acid (flaxseed, canola, soybean oils, walnuts) w/ CHD: 1 g of EPA+DHA/day preferably from oily fish (4 oz of salmon) EPA+DHA in consultation w/ HCP
481
High dose statin
**21-75 y/o** **and** clinical ASCVD **or** LDL 190 and higher If 40-75 y/o DM and 7.5% 10 year ASCVD risk = high dose statin tx If 7.5% or higher ASCVD risk, and 40-75y/o no DM = use moderate-to-high statin tx **High dose statin lowers LDL-C by approx. 50%**
482
Moderate dose statin
indicated if \> 75 y/o with clinical ASCVD or DM 40-75 y/o LDL
483
Statin Tx LDL reduction
**High dose LDL reduction 50%** Atorvastatin (Zocor) 40-80 mg daily Rosuvastatin (Crestor) 20-40 mg daily **Moderate dose LDL reduction 1/3 (30-49%)** Atorvastatin 10-20 mg daily Rosuvastatin 5-10 mg daily Simvastatin 20-40 mg daily Pravastatin 40-80 mg daily Lovastatin 40 mg daily ($4) **Low dose LDL reduction 1/4 (** Pravastatin 10-20 mg daily Lovastatin 20 mg daily
484
Statin Tx considerations HMG CoA reductase inhibitor
LDL reduction 18-55% HDL increase 5-15% TG decrease 7-30% Check baseline hepatic function DM2 risk slightly increased w/ statin use, esp at high dose, CVD benefit outweighs small risk Cognitive impairment rarely reported, if it occurs, lower dose or try another statin Caution w/ concomitant use of **grapefruit juice (intestinal CYP450 34A inhibitor)** w/ use of these **3 statins (simvastatin, atorvastatin, lovastatin)** **Adverse effects: rhabdo, myositis** - rare, most often noted w/ higher statin dose, or in combination w/ fibrate, renal impairment, multiple comorbidities, low body weight, advanced age Do not use simvastatin at 80 mg dose d/t rhabdo risk
485
Grapefruit juice
intestinal CYP450 34A inhibitor caution w/ use of these 3 statins (simvastatin, atorvastatin, lovastatin)
486
Bile acid resins (sequestrants)
E.g. Cholestyramine (Questran), colestipol (Colestid), colesevelam (WelChol) LDL reduction 15-30% HDL increase 3-5% TG increase if 400 or \> Thickens stool! Nonsystemic w/ no hepatic monitoring required minimal effect on TG untill 400 and \> Adverse effects: **GI distress,** constipation, decreased absorption of other drugs if resin taken within 2 hours of many medications
487
Selective cholesterol absorption inhibitor
E.g. Ezetimibe (Zetia) LDL decreases 15-20% HDL increases 3-5% Minimal effect on TG Most often prescribed w/ another agent such as a statin Adverse effects: few d/t limited systemic absorption No dose adjustment in renal/hepatic absorption (Vytorin) - ezetimibe combined w/ simvastatin
488
Niacin
E.g. Niaspan, generic niacin HDL increases 15-35% **TG decreases 20-50%** LDL decreases 5-25% Particularly effective against highly atherogenic LDL lipoprotein (a) Adverse effects: **Flushing** (take ASA 325 1 hour before dose), hyperglycemia, hyperuricemia, upper GI distress, hepatotoxicity (rare) **Contraindication:** active liver disease, severe gout, peptic ulcer
489
Fibric acid derivatives (Fibrates)
E.g. Gemfibrozil (Lopid), fenofibrate (TriCor), fenofibric acid (Trilipix) HDL increases 10-20% **TG decreases 20-50%** LDL decreases 5-20% Adverse effects: dyspepsia, gallstones, myopathy, including rhabdomyolysis if taken w/ statin _Fenofibric acid_ the only fibrate FDA labeled for use w/ statin but still carries the myositis warning **Contraindicated** in severe renal or hepatic disease
490
Fish Oil (omega-3 fatty acid)
**At 4g/dose:** TG decreases 20-30% Increases HDL 1-5% 4g = 1 lb of salmon/day Adverse effects: **Increased risk of bleeding d/t modest antiplatelet effect**, GI upset, fishy taste (can be minimized by freezing capsules, taking w/ food, avoiding hot beverages immediately post ingestion)
491
Heart Failure Classes
Class I = no sx Class II = sx w/ moderate activity Class IIIa = sx w/ ordinary activity Class IIIb = sx w/ minimal activity Class IV = sx at rest w/ no activity
492
HF Class I
No sx Tx: primary prevention, treat risk factors
493
HF Class II
Sx w/ moderate activity Tx: Add ACE/ARB and BB if not already taking
494
HF Class III
Class IIIa = Sx w/ ordinary activity Class IIIb = sx w/ minimal activity Tx: Add diuretics, Digoxin, Nitrates, Hydralazine Consider biventricular pacing and implantable defibrillator
495
HF Class IV
Sx at rest, w/ no activity Tx: Hospice, heart transplant, chronic inotropes (Dobutamine clinic), permanent pump (LVAD)
496
Stage A HF
At high risk for HF but w/o structural heart disease or sx of HF e.g. HTN, atherosclerotic heart disease, DM, obesity, metabolic syndrome or pts using cardiotoxins, family hx of cardiomyopathy Tx: ACEI or ARB for vascular disease or DM Statins as appropriate
497
Stage B HF
Structural heart disease but w/o s/sx of HF e.g. pts w/ previous MI, LV remodeling including LVH and low EF, asymptomatic valvular disease Tx: ACEI/ARB, BB as appropriate In selected pts: ICD, revascularization or valvular surgery as appropriate High risk of sudden cardiac death
498
Stage C HF
Structural heart disease w/ sx e.g. known structural heart disease and HF s/sx Cardiology input/consult **Preserved EF Tx:** Diuresis to relieve sx of congestion, tx comorbidities **Reduced EF Tx:** Routine use: diuretics for fluid retention, ACEI/ARB, BB, aldosteronen antagonists In selected pts: Hydralazine/isosorbide dinitrate, ACEI and ARB, Digitalis, CRT, ICD, revascularization or valvular surgery
499
Stage D HF
Refractory HF pts w/ marked HF sx at rest recurrent hospitalizations despite GDMT Tx: Advanced care measures, heart transplant, chronic inotropes, temporary of permanent MCS, experimental surgery or drugs, palliative care and hospice, ICD deactivation
500
Physiologic murmur describe
Grade 1-3/6 Early to midsystolic heard best at LSB but usually audible over precordium No radiation beyong precordium Softens or disappears w/ standing Increases in intensity w/ activity, fever, anemia, S1 and S2 intact, normal PMI Heard in 80% of thin, healthy adults if examined in soundproof room Asymptomatic w/ no report of chest pain, HF sx, palpitations, syncope, activity intolerance
501
Aortic stenosis murmur describe
Gr 1-4/6 Harsh systolic murmur Usually crescendo-decrescendo heard best at 2nd RICS apex Softens w/ standing Radiates to carotids May have diminished S2 slow-filling carotid pulse Narrow pulse pressure Loud S4 Heaving PMI Greater the degree of stenosis, later the peak of murmur Dx: transthoracic echocardiogram, order when systolic murmur In younger adults - usually congenital bicuspid valve In older adults - usually calcific, rheumatic Dizziness, syncope ominous signs, pointing to severely decreased CO
502
MRPASS wins MVP
Mitral Regurgitation Physiologic Aortic Stenosis Systolic Mitral Valve Prolapse
503
MSARD
Mitral Stenosis Aortic Regurgitation Diastolic
504
Aortic Sclerosis describe
Gr 2-3/6 systolic ejection murmur heard best at 2nd RICS Full carotid upstroke, not delayed No S4 No sx Benign thickening and/or calcification of aortic valve leaflets, no change in valve pressure gradient AKA: **"50 over 50" murmur** Found in 50% of those older than 50
505
Aortic regurgitation murmur
Gr 1-3/4 high-pitched blowing diastolic murmur Heard best at 3rd LICS May be enhanced by forced expiration, leaning forward Usually w/ S3 wide pulse pressure sustained thrusting apical impulse more common in men usually from rheumatic heart disease but occassional d/t tertiary syphilis
506
Mitral stenosis
Gr 1-3/4 diastolic murmur low-pitched late diastolic heard best at apex and localized Short crescendo decrescendo rumble, like bowling ball rolling down alley or distant thunder Often w/ opening snap, accentuated S1 in mitral area Enhanced by left lateral decubitus, squat, cough, immediately post-Valsalva Nearly all rheumatic in origin Protracted latency period, then gradual decrease in exercise tolerance leading to rapid downhill course d/t low cardiac output AF common
507
Infective endocarditis prophylactic abx indication
Maintenance of optimal oral health and hygiene more important than prophylactic abx to reduce risk of IE Conditions where prophylactic abx w/ dental procedures is reasonable: Prosthetic cardiac valve of prosthetic material use for cardiac valve repair Previous IE Congenital heart disease Unrepaired cyanotic CHD, including palliative shunts and conduits Completely repaired CHD w/ prosthetic material or device during the first 6 months of procedure Repaired CHD w/ residual defects at site or adjacent to site of prosthetic patch/device Cardiac transplantation in recipients who develop cardiac valvulopathy
508
IE prophylactic tx before dental/oral/respiratory tract/esophageal procedures
Give 30-60 minutes before procedure **Adults** Amox 2 g PO Ampicillin 2 g IM or IV Cefazolin or ceftriaxone 1 g IM or IV Clindamycin 600 mg Cephalexin 2 g Azithromycin or clarithromycin 500 mg **Children** Amox 50 mg/kg PO Ampicillin 50 mg/kg PO Cefazolin or ceftriaxone 50 mg/kg IM or IV Clindamycin 20 mg/kg Cephalexin 50 mg/kg Azithro/clarithro 15 mg/kg
509
Atrial septal defect
Gr 1-3/6 systolic ejection murmur at pulmonic area Widely split S2, right ventricular heave Typically w/o sx until middle age, then present w/ HF Persistent ostium secundum in mid-septum Will resolve w/ ASD correction
510
Pulmonary HTN
Narrow splitting S2, murmur of tricuspid regurgitation SOB nearly universal Seen with RVH, RAH, as identified by ECG, echo Secondary PH may be a consequence of Redux (fen-phen) use
511
Mitral regurgitation
Gr 1-4/6 high-pitched blowing systolic murmur, often extending beyond S2 Sounds like long "haaaa", "hoooo." Heard best RLSB Radiates to axilla Often laterally displaced PMI Decreased w/ standing, valsalva increased by squat, hand grip Found in ischemic heart disease, endocarditis, RHD W/ RHD, often w/ other valve abnormalities (AS, MS, AR)
512
Mitral Valve Prolapse
Gr 1-3/6 late systolic crescendo murmur w/ honking quality heard best at apex Murmur follows midsystolic click Click moves forward to earlier systole w/ valsalve or standing, resulting in longer sounding murmur W/ hand grasp or squat, click moves back further into systole, resulting in shorter murmur Often seen w/ minor thoraci deformities such as pectus excavatum, straight back, and shallow AP diameter Chest pain sometimes present
513
Normal vaginal pH
3.8-4.2 in reproductive age
514
Candida vulvovaginitis
pH White curd-like discharge usually no odor Micro: mycelia, budding yeast, pseudohyphae w/ KOH prep Itching/burning, discharge **Tx** Fluconazole 150 mg orally x 1 If complicated: Fluconazole 150 mg orally every 72 hours x 3 doses If recurrent: 150 mg once daily for 10-14 days
515
Bacterial Vaginosis
pH \> 4.5 Thin, homogenous, white, gray, adherent often increased discharge Fishy amine odor (+KOH whiff test) \> 20 clue cells/HPF Few or no WBCs Foul odor, itching occassionally present Tx: - need strong anaerobe coverage Metronidazole 500 mg BID x 7 days No ETOH during tx Metrogel (topical metronidazole) Clindamycin vaginal cream or ovules (Cleocin) Oral tinidazole (Tindamax)
516
Height and age for adult seat belts
57 inches 8-12 years
517
Fluconazole is a cytochrome what?
P4502CP inhibitor
518
S. pneumo resistance mechanism
altered protein binding sites
519
Loss of posterior tibial reflex indicates a lesion in what?
L5
520
Tx of tremor and tachy in ETOH witdrawal
Clonidine
521
What is apraxia
impairment of motor activities despite intact motor function
522
bladder cancers superficial w/o mets
despite successful initial tx, local reccurrence is common
523
Glucosamine and chondroitin
cannnot recommend in OA per evidence
524
Evista and osteoporosis
risk of osteoporosis is reduced selective estrogen receptor modulator
525
Which SSRI might interact w/ Warfarin?
Fluoxetine Prozac
526
Risk of which thyroid disorder in Down Syndrome
Hypothyroidism
527
SNRI example and mechanism
Effexor SNRIs increase the levels of norepinephrine and dopamine in the brain
528
How many systems are reviewed in an ROS
10
529
Clean catch urine instructions
clean genital/urinary area w/ cleansing wipe void some urine before beginning collection collect from middle of stream
530
5HT3 antagonist
Alosetron In IBS - blockage of 5-HT3 receptors (ligand-gated ion channels) may reduce pain, abdominal discomfort, urgency, and diarrhea
531
Describe bronchial breath sounds
high, loud, hollow-sounding
532
Clinically significant stenosis - obstruction of at least what percentage of a major coronary artery or one of its major branches?
70%
533
Obturator sign
evaluation for acute appendicitis Rotating right hip through full ROM, positive if pain w/ movement/flexion of hip
534
Gabapentin side effects
**drowsiness, blurred vision, tremors, tiredness** usually not cause for concern Stomach upset and vomiting not typically associated w/ gabapentin
535
CHF follow up schedule
every 1-2 weeks until symptom free, then every 3-6 months
536
Faun tail nevus
Tufts of hair on a child overlying spinal column may be sign of spina bifida occulta
537
Presumptive sign of pregnancy
Amenorrhea Fatigue, nausea, breast changes, urinary frequency, slight increase in body temp Probable signs of pregnancy: goodell's sign, hegar's sign
538
Uterus growth in pregnancy
1 cm per week after 4 weeks of gestation 6-8 weeks: pear 8-10 weeks: orange 10-12 weeks: grapefruit
539
Goodell's Sign
Softening of cervix d/t increased vascularization
540
Hegar's sign
Nonsensitive sign of pregnancy softening and compressibility of lower segment of uterus via bimanual exam in early pregnancy
541
Chadwick's sign
Bluish discoloration of cervix early sign of pregnancy 6-8 weeks after conception
542
35 y/o abd pain, upper right side, back pain, unexpected weight loss Most likely dx
Gallstones
543
Ulcerative colitis lifestyles changes
Vitamin supplements and iron Avoid dairy Eat nutritious diet - low-residue, low-fat, high-protein, high-calories foods Avoid smoking, caffeine, pepper, ETOH
544
BUN:Cr ration of \>20:1 Most likely dx
Acute glomerulephritis Also - UA will show renal casts and RBCs
545
Nitrites in UA significance
a surrofate marker for bacteriuria Indicates bacterial reduction of dietary nitrates to nitrites by select gram-negative uropathogens including E. coli and Proteus spp.
546
SSRI commonly associated side effects
decreased libido and weight gain TCAs have more weight gain Jitteriness and restlessness are commonly associated w/ SSRI use
547
Anemia Hgb threshold M and F
Hgb Hgb
548
TIA describe
All s/s of TIA including numbness, weakness, and flaccidity, visual changes, ataxia, or dysarthria resolve usually within minutes but certainly by 24 hours after onset consider stroke if \> 24 hours
549
HTN f/u
Once BP is stabilized f/u should be every 3-6 months Normotensive pts: every 1-2 years
550
Misoprostol
Prostaglandin analogue Specifically designed for gastric protection with NSAID use
551
Herpes keratitis
Damage to corneal epithelium d/t herpes virus (shingles) Acute onset eye pain, photophobia, blurred vision in affected eye w/ rash
552
Xanthelasma
Raised and yellow soft plaques located under the eyebrow they can be on the upper or lower lids of the eyes and are located on the nasal side
553
Patient w/ IBS taking both hysocyamine and antacid how to take
take antacid AFTER hysocyamine and after a meal
554
Most common cause of new onset fecal incontinence in elderly
constipation risk fx: \> 80 years, impaired mobility, neurologic disorders including dementia
555
Sulfa allergy and HCTZ
HCTZ is contraindicated HCTZ has a sulfonamide ring in its chemical structure
556
When to order PET scan
Positron emission tomography Shows brain function and highlights abnormal tissue Often done after abnormal CT Evaluates for brain tumor
557
Toxic shock syndrome
Women w/ dx of TSS should not use tampons or diaphragms in the future **s/sx of TSS:** high fever, myalgia, N&V, diarrhea, diffuse sunburn-like rash, hypotension, agitation, and confusion
558
PEF determination factors
Based on HAG Height Age Gender
559
Basal cell ca
Low metastatic risk Early recognitition and intervention is recommended Untreated BCC can lead to significant deformities and altered function
560
Prostatodynia
No fever Dyuria, decreased urinary flow, post-void dribbling, hesitancy may be associated w/ back pain or pain in testicles
561
Acute gastroenteritis BRATY diet
Bananas Rice Applesauce Toast Yogurt
562
MMR vaccine
Safe during lactation contraindicated in pregnancy risk exists in theory
563
Max dose Lisinopril
40 mg/day
564
Obesity waist circumference M and F
M \> 40 in F \> 35 in
565
Moro reflex
startle reflex Disappears at 4-6 months
566
S4 heart sound
Low-frequency Heard late in diastole rare in infants and children always pathological Seen in condition w/ decreased ventricular compliance
567
Folliculitis tx
Mupirocin 2% BID x 10 days and cover with DSD Gentamicin - apply BID to TID Isoretinoin 0.5-1mg/kg/day PO in divided doses Anhydrous ethyl elcohol w/ 6.35 aluminum chloride, apply TID before abx ointment
568
Senile purpura
Aka vascular purpura common and benign condition in the elderly normal labs
569
Total cholesterol values
Normal Borderline 200-239 High \> 240
570
Acute lymphocytic leukemia points of teaching
ALL accounts for about 80% of childhood leukemia Noted for presence of lymphoblasts which replace normal cells in bone marrow T lymphocyte type of ALL has poorest prognosis B cell = Better prognosis
571
Most cost-effective, sensitive, specific test for H. Pylori
organism-specific stool antigen testing H. pylori transmitted via oral-fecal and oral-oral route spiral shaped organism
572
Beclomethasone dose HFA
Low: 80-240 mcg Medium: \>240-480 mcg High: \> 480 mcg
573
Secondary HTN evaluation
Test = Dx CT angiography = coarctation of the aorta 24-hour urine mentenephrine and normetanephrine = Pheochromocytoma Doppler flow study, magnetic resonance angiography = Renovascular HTN Estimated GFR = CKD
574
Tennis ball uterus size how many weeks
8 weeks -- Uterus, nonpregnant, size of lemon and is mobile, firm, and notender 8 weeks = size of tennis ball or orange 12 weeks = size of softball or grapefruit 20 weeks = fundus at umbilicus
575
Still's murmur
Usually detected at 3-6 years of age Best heard at middle left sternal border or between the left lower sternal border and apex when patient is supine
576
Time frame for suture removal
Arms, hands = 5-10 days Over a joint = 7-14 days
577
Atrophic Vaginitis
Etiology: Estrogen deficiency pH \> 5 Scant, white-clear discharge Absent KOH amine odor Few or absent lactobacilli Lactobacilli decreases w/ estrogen decrease common complaints: itching/burning, discahrge, but often w/o sx Tx: Topical and/or vaginal estrogen if symptomatic and/or recurrent UTI Oral estrogen as solo intervention likely inadequate
578
Risk fx of lumbar radiculopathy
\> 50 Male Overweight Cigarette smoking
579
what are clue cells
vaginal epithelial cells w/ adherent bacteria
580
Achilles tendon reflex loss what nerve root is affected
L5 and S1
581
Most common site of cervical radiculopathy
C6 and C7
582
Most common site of lumbar disc herniation
L4 to L5 and L5 to S1
583
Genital herpes
HHV2, less commonly HH1 Common to be asymptomatic or have atypical sx Asymptomatic transmission common Classic presentation: painful, ulcerated lesions marked lymphadenopathy w/ initial lesions In women: thin vaginal discharge if lesions at vagina or introitus **Tx:** **Acyclovir** initial episode: 200 mg 5x/day x 10 days or 400 mg 2x/day x 7-10 days Recurrence: 200 mg 5x/day x 5 days - being at earliest signs of disease - or 400 mg TID x 5 days or 800 mg BID x 5 days or 800 mg TID x 2 days Famciclovir **Valtrex** Initial episode: 1 g BID x 10 days Recurrence: 500 mg BID x 3 days Reduction of transmission: 500 mg daily
584
Nongonococcal urethritis and cervicitis
Chlamydia, ureaplasma, mycoplasma genitalium Friable cervix Irritative voiding sx Mucopurulent discahrge Often w/o sx Micro: large number of WBCs in discharge Tx Azithromycin 1 g x 1 dose Alternative: Doxy Erythro Ofloxacin Levofloxacin
585
Gonococcal urethritis and vaginitis
Gram neg w/ propensity to produce beta-lactamase Irritative voiding sx Occassional purulent discharge often w/o sx Micro: large number of WBCs in discharge Tx Ceftriaxone 250 mg IM x 1 dose + Azithromycin x 1 dose or Doxy x 7 days Severe beta-lactam allergy: Azithro 2 g x 1 dose
586
Trichomoniasis
Parasite Men almost never have itch Women seldom have itch classic sx: dysuria, itching, vulvovaginal irritation, dyspareunia, yellow-green vaginal discharge, occassionally frothy (30%), cervical petechial hemorrhages ("strawberry spots") Often w/o sx Micro: motile organisms and large number of WBCs Alkaline pH Tx: Oral metronidazole or tinidazole as 1 x dose Avoid consuming ETOH for 24 hours after metronidazole or 72 hours after tinidazole Dose: Flagyl 2 g x 1 dose
587
Syphilis organism
Treponema pallidum
588
Syphilis primary stage
Chancre, firm, round, PAINLESS genital and/or anal ulcers w/ clean base and indurated margins localized lymphadenopathy 3 weeks duration resolve w/o tx
589
Syphilis Secondary Stage
Nonpruritic skin rash, often involving palms and soles as well as mucous membrane lesions Fever, lymphadenopathy, sore throat, patchy hair loss, headaches, weight loss, muscle aches, fatigue Resolution w/o tx possible
590
Syphilis Latent stage
Variable presentation Gumma - rare Occurs when primary and secondary sx have resolved
591
Syphilis Tx
**Benzathine penicillin G 2.4 million units IM as 1 x dose** (x 3 weeks if Latent syphilis) **Alternative tx if allergic to PCN:** Doxy 100 mg BID x 2 weeks Tetracycline 500 mg QID x 2 weeks (x 4 weeks if latent) Ceftriaxone 1 g IM or IV every 24 hours x 8-10 days
592
Genital warts
Condyloma acuminata HPV commonly HPV-6, -11 causing genital warts Infection w/ multiple HPV types common verruca-form lesions can be subclinical **Tx** Podofilox, liquid nitro, croprobe, trichloroacetic acid, podophyllin resin, surgical removal or imiquimod (Aldara) Imiquimod for external warts only **Imiquimod 5% cream apply at bedtime 3x/week for up to 16 weeks. Wash are w/ soap and water 6-10 hours after application** If pregnant: Trichloroacetic acid and cryoprobe
593
Nongenital warts HPV types
HPV types 1, 2, 4
594
HPV types associated w/ GU malignancies
HPV types 16, 18, 31, 33
595
Pelvic inflammatory disease define
Infection of upper female reproductive tract, including uterus, fallopian tubes, adjacent pelvic structures Causative organisms: N. gonorrhoeae, C. trachomatis, bacteroides, Enterobacteriaceae, streptococci
596
PID clinical findings
Irritative voiding sx fever, abd pain, CMT, vaginal discharge possible sequelae include tubal scarring w/ subsequent increased risk for ectopic pregnancy and/or infertility
597
PID tx
Ceftriaxone 250 mg IM x 1 dose + Doxycycline 100 mg BID x 14 days w/ or w/o Metronidazole 500 mg BID x 14 days Metronidazole for anaerobes - studies show better outcomes when Metronidazole is added
598
Balanitis
Inflammation of the glans common in candida to also have scrotal involvement vs jock itch (tinea cruris) typically no scrotal involvement
599
UTI uncomplicated acute usual pathogens
E. coli (gram neg, most common) S. saprophyticus (gram pos.) Enterococci (gram-pos)
600
Acute uncomplicated UTI tx
**1.) Bactrim DS BID x 3 days** if resistance \> 20% or sulfa allergy **2.) Macrobid 100 mg BID x 5 days or Fosfomycin 3g x 1 dose** + **Pyridium** OTC 2 tabs total 190 mg TID w/ or after meals x 2 days Rx 200 mg TID x 2 days w/ abx **Alternative** Ciprofloxacin 250 mg BID x 3 days Ciprofloxacin ER 500 mg daily x 3 days Levofloxacin 250 mg daily x 3 days Moxifloxacin 400 mg daily x 3 days + Pyridium (turns urine orange!)
601
Acute uncomplicatated pyelonephritis
Usual pathogens: E. coli, enterococci Obtain urine and blood cultures prior to initiating abx Moderately ill: suitable outpatient Usually F, 18-40 y, fever 102 or higher, CVA tenderness **Tx** **Ciprofloxacin 500 mg BID x 7 days** **Ciprofloxacin ER 1000 mg daily x 7 days** **Ofloxacin 400 mg BID x 7 days** **Levofloxacin 250 mg daily x 5 days** **One IV dose often given d/t GI upset** **Alternative:** Amox-Clav x 14 d Cephalosporin x 14 d TMP/SMX DS x 14 d
602
Epididymoorchitis 35 y/o and younger
Usual pathogen: Gono/chlamy Irritative voiding sx Fever, painful swelling of epididymis and scrotum (typically asymmetrical) Infertility potential post-infection Prehn sign = relief w/ discomfort w/ scrotal elevation + **Tx:** Ceftriaxone 250 mg IM x 1 dose + Doxy 100 mg BID x 10 days Advise scrotal elevation to help w/ sx
603
Epididymoorchitis \> 35 y OR insertive partner in anal intercourse
Causative organism: Enterobacteriaceae (coliforms) (Gram negative) Irritative voiding sx Fever, painful swelling of epididymis and scrotum Intertility potential post infection **Primary tx:** Ciprofloxacin 500 mg daily x 10-14 days Levofloxacin 750 mg daily x 10-14 days **Alternative** IV ampicillin w/ sulbactam (the IV augmentin) 3rd gen cephalosporin other parenteral agents as indicated by severity of illness
604
Acute bacterial prostatitis 35 years and younger
Gono/chlamy Irritative voiding sx, suprapubic pain, perineal pain, fever tender, boggy prostate leukocytosis "sitting on a rock" **Tx** Ceftriaxone 250 mg x 1 dose + Doxy 100mg BID x 10 days
605
Acute bacterial prostatitis \> 35 low risk for STI
Enterobacteriaceae (coliforms) Irritative voiding sx, suprapubic/perineal pain, fever tender, boggy prostate leukocytosis **Tx:** Ciprofloxacin 500 mg BID x 14 days or Ofloxacin 200 mg daily x 14 days
606
Normal prostate
firm, smooth size of walnut about as firm as tip of nose
607
Acute prostatitis
Tender, boggy, indurated About as firm as cheekbone
608
Prostate cancer
nodular, firm Usually malignant lesions are not palpable until disease is advanced Order testicular U/S then refer to urology
609
Bladder cancer risk fx
Textile worker (dyes) Smoking Intermittent painless gross hematuria (90%) 10% microscopic hematuria
610
Treatable causes of urinary incontinence
Delirium Infection (urinary) Atrophic urethritis and vaginitis Pharm (diuretics) Psychological disorders (depression) Excessive urine output (HF, DM) Restricted mobility Stool impaction
611
Urge incontinence
**Most common in elders** Strong senstation to empty the bladder that cannot be suppressed Coupled w/ involuntary loss of urine **Tx:** **Anticholinergics (antimuscarinics)** Detrol (tolterodine) Ditropan (oxybutynin) Vesicare (solifenacin succinate) Enablex (darifenacin) Toviaz (fesoterodine fumarate) **Alternative:** B3 agonist (receptors found in gallbladder, urinary bladder, brown adipose tissue) Mirabegron (Myrbetriq) Botulinum toxin injections
612
Stress incontinence
Most common form in women Rare in men, occassionally noted post prostate/bladder sx Loss of urine w/ incrase in intaabdominal pressure such as coughing, sneezing, exercise Tx: Support to area w/ vaginal tampon, urethral stents, periurethral bulking agent injections, and pessary use Kegel most helpful in younger pts Pelvic floor rehab w/ biofeedback, electerical stim, bladder training Surgery = for well-chosen candidates
613
Functional incontinence
Assoc. w/ inability to get to toilet or lack of awareness of need to void pts w/ mobility issues/altered cognition worsened by unavailability of a helper to assist in toileting activities Tx: Ameliorated by having assistant aware of voiding cues to help w/ voiding activities
614
Transient incontinence
Assoc. w/ acute event such as delirium, UTI, medication use, restricted activity Tx of underlying process (e.g. d/c med)
615
ASCUS w/ HPV + no hx of abn cytology Last screening 2 yrs ago next step?
Colposcopy
616
Paraphimosis
Retracted foreskin that cannot be brought forward to cover the glans Emergency!
617
Varicocele
Palpable "nest of worms" scrotal mass Only evident in standing position
618
Hydrocele
Collection of serous fluid causes **_painless_** scrotal swelling easily recognized by transillumination
619
Phimosis
Foreskin cannot be pulled _back_ to expose the glans
620
Scrotal pain and loss of cremasteric reflex
Testicular torsion Emergency!
621
Cryptorchidism
Testicle located in inguinal canal or abdomen Standard: wait until 1 year of age for intervention
622
ART initiation in tx-naive pts to reduce risk of disease progression
Recommended for all HIV infected individuals to reduce risk fo disease progression Start ART CD4 ART at CD4 \> 500 (moderate recommendation) All pregnant women regardless of CD4 (strong recommendation)
623
ART initiation in tx-naive pts to prevent transmission
_Strong recommendation_ for ART to be used in individuals to prevent transmission (e.g. perinatal transmission, heterosexual transmission, transmission risk groups such as sex workers etc.) PMCT - prevention of mother to child transmission PrEP - pre-exposure prophylaxis (HIV-negative pts at high risk for exposure) - ART reduces transmission by up to 92% PEP - post exposure prophylaxis
624
Acute bronchitis pathogens
M. pneumo C. pneumo B. pertussis _Not Strep pneumo!_
625
intranasal corticosteroid for AR onset of sx relief
few days to a week after starting
626
RSV in AOM
RSV is implicated in causing AOM
627
HIV/AIDs and copper IUD
HIV 2 for initiation and 2 for continuation AIDS 3 for initiation and 2 continuation
628
Sarcoidosis primary tx
Systemic corticosteroids
629
ARF precipitating factors
Anaphylaxis Infection MI **NOT DM1**
630
Poikilocytosis define
Alteration in shape of RBCs
631
Most common serious complication of cholecystitis
pancreatitis
632
Fragile X syndrome in males characteristic
Large forehead elongated face large or protruding ears flat feet larger testes low muscle tone intellectual disability most common cause of autism in either gender Girls 50% have normal cognitive function Girls w/ milder features
633
Routine HBV vaccination started in what year
1996
634
HIV screening
Recommended 15-65 y Men who have sex w/ men Active injection drug users Behavioral risk fx (unprotected sex, infected sexual partners, bisexual orientation, sex worker) **Dx:** Repeated reactive immunoassay followed by confirmatory western blot or immunofluorescent assay
635
Mood disorder tx goal
Remission of sx for 4-5 months or more Aimed at virtual elimination of a person's sx of depression/anxiety restoration of psychosocial and occupational function Consider long-term tx if 2nd or later episode
636
Electroconvulsant therapy (ECT) indication
urgent need for response pts who are suicidal or refusing food and nutritionally compromised psychotic sx or catatonia
637
SSRIs
From most to least energizing: Fluoxetine (Prozac) Sertraline (Zoloft) Citalopram (Celexa) Escitalopram (Lexapro) Paroxetine (Paxil) **Serotonin = smooths mood**
638
SSNRIs
**S**_S_**NRI** Venlafaxine (Effexor) Duloxetine (Cymbalta) desvenlafaxine (Pristiq) **Norepinephrine = Focus** Occassional reports of being energizing, helpful in anxious and/or resistant depression **SNRI** - Strattera (ADHD)
639
SDRI
Selective Dopamine Reuptake Inhibitor Bupropion (Wellbutrin) Potentially activating, usually used as add-on tx w/ SSRI
640
Antidepressants and suicidality
use of antidepressants increased risk of suicidality in children, adolescents and young adults 24 y/o and younger Short term studies have shown no increase in pts \> 24 y/o reduction in risk in pts \> 65 compared to placebo
641
Anxiolytics
Benzodiazepines buspirone (Buspar) - effective when given w/ high enough dose and long-enough (at least 6 weeks) Potentially helpful in alleviating hypervigilance associated w/ anxiety but use does not decrease worry
642
Antidepressant sexual adverse effects
SSRI and SNRI = 40% SDRI = 20% Anorgasmia, ED, impaired libido
643
SSRI w/ most anticholinergic effect Avoid in gero
Paroxetine (Paxil) Increase in constipation, dry mouth, confusion in gero
644
SSRI w/ most drug-drug Long half-life Avoid in gero
Fluoxetine (Prozac) Half life 82 hours, metabolite = 7-15 days CYP450 Isoenzyme inhibition One of the oldest in the market
645
SSRI assoc. w/ QT prolongation Max dose in gero 20 mg/day
Citalopram (Celexa) QT prolongation risk increased w/ increased dose
646
SSRIs ordered from least drug-drug to most (CYP450 isonenzyme inhibition) Preferred in polypharm = first in list
Escitaloporam (Lexapro) Citalopram (Celexa) Sertraline (Zoloft) - Paroxetine (Paxil) Fluoxetine (Prozac)
647
TCA associated w/ what adverse effect
TCAs = cardiac and neurotoxic May cause cardiac dysrhythmias and seizures
648
SSRI common issues
Lag of a number of weeks in onset of SSRI therapeutic effect is expected Frontal headache is a common short-term problem w/ early SSRI use
649
Trust vs mistrust
Erikson Infant 0-1 year Task: reliable caregiver Pathologic outcomes: depression, substance abuse, psychosis
650
Autonomy vs shame and doubt
Erikson Toddler 1-3 years Task: need to learn to explore world. Parent should not be too smothering or too neglectful Pathologic outcome: paranoia, obsessions, compulsions, impulsivity
651
Initiative vs guilt
Erikson Preschool 3-6 years Task: ability to do things on his/her own Pathologic outcomes: Conversion disorder, phobia, psychosomatic disorder
652
Industry vs inferiority
Erikson School age 6-11 years Task: self-worth, compared to others Pathologic outcomes: creative inhibition, inertia
653
Identity vs role confusion
Adolescent 12-20 years Task: who am I Pathologic outcome: delinquent behavior, gender identity issues, borderline personality disorder, psychotic episodes
654
Intimacy vs Isolation
Young adult hood 21-40 years Task: forming loving relationships Pathologic outcomes: schizoid personality disorder
655
Generative lifestyle vs stagnation/self absorption
40-60 years Task: accept self, establish and guide next generation Pathologic outcome: mid-life crisis
656
Ego integrity vs despair
65 years and older Task: sense of accomplishment/integrity Pathologic outcome: extreme alienation, despair
657
Delirium
_sudden state_ of rapid changes in brain function confusion, changes in cognition, activity, LOC Precipitated by acute underlying cause Abrupt onset over hours to days Impaired but variable recall Usually reversible to baseline **Often worse as the day progresses (sundowning)** Usually change in psychomotor activity Perceptual disurbances including hallucinations Speech content incoherent, confused, w/ wide variety of inappropriately used words
658
Dementia
Slowly developing impairemnt of intellectual or cognitive function progressive and impairs w/ normal functioning Variety of causes Insidious onset Cannot be related to precise date Gradual change in mental status reports of good and bad days Memory loss esp. w/ recent events Duration of months to years Chronically progressive and irreversible Disturbed sleep-wake cycle lacks hour-to-hour variability Often day-night reversal no psychomotor involvement until later in disease No perceptual disturbance until later in disease Earlier stages - word searching, progressing to sparse speech content Mute in later disease
659
Delirium etiology
D - drugs E - Emotional (mood disorders) L - Low PO2 (hypocemia from CAP, COPD etc) I - Infection (UTI most common, then CAP) R - Retention of urine/feces R = Reduced sensory input (blindness, deafness) I - Ictal or postictal state (ETOH withdrawal) U - Undernutrition M - Metabolic (poorly controlled DM, hypo/hyperthyroid M - Myocardial patients S - Subdural hematoma (can be result of minor head trauma d/t brain atrophy and fragile blood vessels)
660
Delirium tx
Treat underlying cause Infection, medication, and fractures are most common
661
Dementia etiology
Alzheimer 50-80% Vascular (multi-infarct) 20% Parkinson's 5% Miscellaneous: HIV, dialysis encephalopathy, neurosyphilis, NPH, Pick's disease, Lewy body, frontotemporal dementia, others \*30% of Alzheimers also have vascular dementia - consider if quick deterioration
662
Evaluation of new onset mental status change
Bun, Cr Glucose Calcium, Sodium Hepatic enzymes B12, Folate TSH RPR/VDRL CBC w/ diff UA, C&S - highest yield ECG As directed by patient risk fx and presentation: CT, MRI (fall, etc) PET scan (tumor) Toxic screen CXR - resp ESR - inflamm HIV other
663
Alzheimer tx - slow decline
**Vitamin E 1000 IU BID** **OR** **Selegiline 5 mg BID** No benefit to using BOTH at the same time
664
Gold standard imaging for PVD
MRA
665
Most potent risk for PVD
Tobacco use
666
Mild to moderate Alzheimers tx
**Cholinesterase inhibitors** donepezil (Aricept) rivastigmine (Exelon) galantamine (Razadyne) Clear though minor time-limited benefits by increasing availability of acetylcholine Allows pts to stay longer in their home
667
Moderate to severe Alzheimers tx
N-methyl-D-aspartate receptor antagonist memantine **Namenda** Through effect on glutamate, helps create an environment that allows for storage and retriebal of information Used in earlier disease w/ cholinesterase inhibitor -- \*Aricept (donepezil) also approved for use in advanced AD
668
Dementia and depression
40% of pts w/ dementia also have depression standard antidepressant tx is indicated keep in mind drug-drug
669
Alzheimer's and antipsychotic
If environmental manipulation fails to eliminate agitation or psychosis, consider tx w/ antipsychotic **Second-generation antipsychotic** best studied for this indication (aka atypical antipsych) Increased risk for stroke and cardiovascular events in older adults w/ dementia **Worsens insulin resistance = increased clot risk**
670
Zolpidem (Ambien) in gero
Increase fall and fracture risk
671
Nitrofurantoin (Macrobid) in gero
Potential lack of efficacy in impaired renal function of Cr Cl
672
Amitriptyline in gero
TCA Significant risk of orthostatic hypotension
673
Diclofenac (Voltaren) in gero
(NSAID) Potential to promote fluid retention
674
Sertraline (Zoloft) in gero
Increased risk for hyponatremia Check electrolytes in 1 month after starting
675
Syncope etiology
Transient loss of consciousness Vasovagal, cardiac outflow obstruction (hypertrophic cardiomyopathy, valvular, especially high-grade aortic stenosis, aortic dissection, dysrhythmia) Orthostatic hypotension
676
Typical head growth infant
In the first year of life is 12 cm 6 cm in the first 3 months 3 cm in the 4th to 6th months and 3 cm in the 6th to 12th months Subsequent head growth is about 0.5 cm/year for 2-7 year olds
677
CAP hospitalization criteria
No resources for self-care at home Age 60 and older PO2 of RR \> 30 breaths
678
Pts with CHF refer to cardio
Pediatric pts Pregnant women Lactating women
679
Myoclonic seizure
awake state or momentary loss of consciousness w/ abnormal motor behavior lasting seconds to minutes
680
Waddell sign
a group of physical signs that may indicate non-organic or psychological component to chronic low back pain
681
Myocardial ischemia ECG
inverted T wave and T wave depression
682
Myocardial injury ECG
ST elevation w/ tall peaked T wave
683
Myocardial infarction ECG
pathologic Q wave
684
Carbamazepine and OCPs
Carbamazepine induces estrogen metabolism = OCP failure
685
Pump and dump
less than helpful way to reduce drug levels in mother's milk creates area of lower drug concentration in empty breast which enables drug to diffuse from area of high concentration to area of low concentration (breast milk)
686
Mitral regurgitation
HIGH-pitched, pansystolic murmur heard best at apex radiates to axilla Loid-blowing Use diaphragm of stethoscope
687
Course of bacterial conjunctivitis
with treatment 2-5 days without treatment 5-7 days
688
Complete resolution of sx in Osgood-Schlatter disease
through physiologic healing takes 12-24 months
689
Typical physiologic changes during pregnancy
Cardiac output increases by 1/3 the last two trimesters Heart is displaced upward to the left in the late second to third trimester Thyroid can enlarge by as much as 15%
690
Oral iron therapy drug interactions
Levodopa = decreased effect of both iron and levodopa, separate medications by as much time as possible, increase Levodopa dose if needed Tetracyclines: decreased tetracycline and iron effect Antacids: decreased iron absorption Caffeine: decreased iron absorption
691
SSRI dosages
Prozac 20-80 mg daily Zoloft 50-200 mg daily Celexa 40-60 mg daily Lexapro: 10-20 mg daily
692
Systolic CHF - which drug
ACEIs decrease mortality and prolong survival in clients w/ CHF Prescribe for all pts with systolic dysfunction unless contraindicated
693
Primary tx for dysmenorrhea
NSAIDs Oral contraceptives Generally, use one agent then add the other if one does not work alone
694
Normal WBC count in urine
695
Stage I Lyme
Early Localized disease fever, chills, myalgia, headache erythema migrans 1 week after tick bite (7-10 days) Common in areas of tight clothing (groin, thigh, axilla)
696
Stage II Lyme
Early disseminated infection weeks to months later Bacteremia (50-60% of pts w/ erythema migrans) Secondary skin lesions within days to weeks of original infection in 50% of pts malaise, fatigue, fever, h/a, neck pain, generealized achiness common w/ skin lesions Myopericarditis w/ atrial of ventricular arrhythmias 4-10% Neurologic 10-15% Aseptic meningitis w/ mild h/a and neck stiffness sensory or motor radiculopathy and mononeuritis multiplex occur less frequency Panophthalmitis (rare)
697
Stage III Lyme
Late persistent infection Months to years later Musculoskeletal manifestations in 60% Monoarticular or oligoarticular arthritis of knee or other weight-bearing joints Chronic arthritis develops in about 10% of pts Neurologic manifestations (rare) Subactue encephalopathy Intermittent paresthesias often in stocking glove distribution radicular pain Severe encephalomyelitis Cutaneous manifestation Usually bluish-red discoloration of distal extremity w/ associated swelling Lesions atrophic and sclerotic
698
PAD
Leg pain/numbness during activities (intermittent claudication) Persistent infections or sores on leg/feet Pale/bluish color to skin May be asymptomatic Etiology: plaque in arteries limiting blood flow **Main risk fx: SMOKING** Other risk fx: HTN, age, HL, elevated BG **Dx: ABI , doppler U/S or MRI to assess bloodflow** Treadmill test to evaluate severity of sx Arteriogram to identify blocked arteries **Tx:** Smoking cessation, physical activity, weight loss, contol BP, HL, BG Antiplatelets (ASA) to prevent blood clots **Cilostazol and Pentoxifylline** to reduce PAD sx, surgery to improve blood flow
699
Venous insufficiency
Common sx: burning, swelling, throbbing, cramping, aching, and heaviness in the legs, restless legs and leg fatigue, telengiectasias (spider veins) Etiology: congenital absence of/or damage to venous valves resulting in reflux through superficial veins, thrombus formation can also cause valve failure Exam: Duplex U/S can be used to assess blood flow in veins and eliminate other causes **Tx:** Physical activity, weight loss Use of compression stockings to decrease swelling Various techniques to remove the refluxing superficial vessels (e.g. sclerotherapy or ablation)
700
Peripheral neuropathy
Gradual onset of numbness and tingling in hands/feet Burning pain, sharp/electric-like pain, muscles weakness, extreme sensitivity to touch Etiology: damage to nerves extending to peripheral system, DM most common cause. Others: traumatic injuries, infections, toxins Dx: EMG or nerve biopsy **Tx:** NSAIDs mild pain antiseizures and antidepressants Lidocaine patch Opioids (when other tx fail) TENS can help relieve sx
701
Vertical diplopia results from damage to which cranial nerves?
CN III or IV
702
Horizontal diplopia is suggestive of damage to which cranial nerves?
CN III or VI
703
Myrdriasis
Dilation of the pupils
704
Miosis
Constriction of the pupils
705
When do ovaries become nonpalpable
3-5 years after menopause
706
Acholic stools
Clay or putty colored Occur briefly in viral hepatitis but are more common w/ obstructive jaundice
707
How long after Syphilis exposure do sx appear?
10 days to 3 months after pathogen exposure primary sx appear
708
Rectal exam: tender, purulent, reddened mass
anal abscess esp. w/ fever and chills
709
CN involved in closing mouth
CN V Trigeminal nerve - innervates the masseter, temporalis, and the internal pterygoids
710
thick curved extension of the superior border of the scapula
coracoid process
711
Axiohumeral group of muscles produce what movement
internal rotation of shoulders
712
Posterior and medial surface of the knee swelling is suggestive of
Semimembranous bursitis
713
Swelling 1-2 inches below the knee joint on the medial surface is suggestive of
anserine bursitis
714
swelling over the tibial tubercle is suggestive of
infrapatellar bursitis
715
swelling over the patella suggests
prepatellar bursitis
716
Housemaid's knee from excessive kneeling
prepatellar bursitis
717
Ankle reflexes level nerve root
S1
718
Patellar reflex nerve root
L 2, 3, 4
719
Supinator and biceps reflex nerve root
C5 and C6
720
Triceps reflex nerve root
C6 and C7
721
Average incubation period for meningococcal infection
3-4 days (range 1-10 days) also the period of communicability Bacteria can be found for 2-4 days in the nose and pharynx and for up to 24 hours after starting abx
722
Thrombosed external hemorrhoid tx
Will resolve in 1-2 weeks w/o surgical intervention Surgical excision of overlying skin can provide rapid symptomatic relief Cool compresses, sitz baths, stool softener, analgesics can be used if surgical intervention is not available
723
Most common presenting sign of bladder cancer
Gross painless hematuria Mircroscopic hematuria in about 20% Irritative voiding sx occassionally Abnormal abd mass only w/ advanced disease
724
Post renal azotemia
cause by compromised renal function and hydronephrosis 5% of all renal failure Urea nitrogen and creatinine elevation urinary retention and outflow obstruction Intervention: relieve urinary outflow obstruction Renal function returns to baseline if promptly detected
725
Low back pain Cauda equina syndrome s/sx
Bladder dysfunction, perineal sensory loss, anal laxity Neurological deficit in lower extremities Lower extremity motor weakness
726
Grand mal seizures
aka tonic-clonic seizures rigid extension of arms and legs followed by sudden jerking movements w/ loss of consciousness bowel/bladder incontinence is common w/ postictal confusion
727
Lung cancer screening
Annual screening w/ low-dose computed tomography Age 55-74 w/ smoking hx of at least 30 packs/year Current smokers or who have quit in the past 15 years
728
Chancroid organism
Haemophilus ducreyi
729
Mild cognitive impairment
Decline in condition more than expected for age No change in ADLs 3-19% in those \> 65 First sx: memory loss Risk Fx: Age, low education level, h/o depression, lack of exercise, African ancestry, HTN, HL, ApoE allele Multiple etiologies Tx: Acetylcholinesterase inhibitors may delay but not prevent Good health habits Volunteer or stay cognitively active \> 50% will progess to dementia within 5 years Depression doubles risk
730
Alzheimer's dementia
50-70% of all dementia at age 85 11% of M and 14% of F First sx: memory loss Risk fx: Age, female, AA and Hispanics \> Caucasian, Down Syndrome, being a mother of a child w/ Down, genetic vulnerability Acquired risk fx: HTN, lipoproteins, cerebrovascular disease, altered glucose metabolism and brain trauma Biological: neuritic plaques, neurofibrillary tangles, synaptic loss throughout cerebral cortex and limbic system Tx: Mild to Moderate AD: Acetylcholinesterase inhibitors Moderate to severe AD: NMDA receptor antagonists SGAs w/ caution Reminiscence therapy, personalized music, social interactions, redirection, reassurance, family support Average lifespan after dx is 6-9 years
731
Vascular dementia
Often co-occurs w/ AD = mixed dementia, likely the second most common dementia As solo cause: third most common dementia at 8-15% First sx: often, but not sudden, variable, apathy, falls, focal weakenss, disorientation, anxiety/depression Risk fx: increasing age, male, HTN, HL, smoking, DM Bio: cortical and subcortical infarcts Tx: Cholinesterase inhibitors may help Treat vascular risks Physical activities Intellectually stimulating social activity Shortens lifespan by 3 years
732
Lewy Body dementia (DLB)
15-20% of late-onset dementia Fluctuating presentation, visual hallucinations, may present as a psych disorder, REM, sleep disorder, delirium, parkinsonism, repeated and unexplained falls Risk fx: more common in men, ApoE allele found more often in pts w/ DLB Bio: Lewy bodies are dense intracellular neuronal inclusions found in the cortical, subcortical area of the brain EEG can help distinguish DLB and AD, but not betweent VaD and AD or diffuse DLB Tx: First-generation antipsychotic use can result in neuromuscular sensitivity SGAs helpful w/ psychosis w/o adverse effects Treat depression Anticholinesterase use can benefit memory Variable course, generally more rapid than AD Time from dx to death 6 years Mean age of dx 68, death by 75
733
Frontotemporal dementias (FTDs)
Group of related disorders that cause degeneration of the frontal and temporal lobes (e.g. Pick's dementia) Insidious onset and gradual progression Personality changes cause more problems than cognitive Apathy, poor judgment/insight, speech/language, hyperorality Familial risk possible Bio: Pick's disease has marked frontal and temporal atrophy **Tx** Symptomatic psych tx (SSRI for depression, psychostimulant for apathy, risperidone for problem behaviors) Protect pts from his or her indiscretions Generally slow progression
734
Gout etiology and uric acid
10% uric acid overproduction 90% urate under-excretion - made worse by renal insufficiency, ETOH, use of loop or thiazide, ASA, other medications, and purine-rich foods including organ meats, forms of seafood including sardines and achovies, spinach, oatmeal
735
McMurray Test
Tests for meniscal tear
736
Talar Tilt
Tests for ankle instability
737
Tinel's sign
tests for carpal tunnel
738
Phalen's sign
tests for carpal tunnel
739
Lachman Test
ACL tear The Lachman test is performed by placing the knee in 30 degrees of flexion and then stabilizing the distal femur with one hand while pulling the proximal tibia anteriorly with the other hand, thereby attempting to produce anterior translation of the tibia. An intact ACL limits anterior translation and provides a distinct endpoint. Lack of a distinct endpoint suggests ACL injury.
740
Straight leg raise
Tests for lumbar nerve root compression
741
Spurling's Test
Test for cervical nerve root compression The Spurling maneuver is used to detect cervical radiculopathy. Several positions of the head may be tested to provoke nerve irritation. First, the maneuver is performed with the head held in a neutral position. The examiner taps or presses down on the top of the head. If this fails to reproduce the patient's pain, the procedure is repeated with the head rotated to the affected side and hyperextended.
742
Drop-arm test
Rotator cuff evaluation The integrity of the supraspinatus tendon can be assessed with the active painful arc test and the "drop arm" test. The active painful arc test (not to be confused with the Neer test, an impingement test performed passively and described separately) simply involves having the patient actively abduct their arm in the scapular plane from a neutral position. Pain with active abduction beyond 90 degrees marks a positive test. The drop arm test assesses the ability of the patient to lower his or her arms from a fully abducted position. A positive test occurs when the patient is unable to lower the affected arm with the same smooth coordinated motion as the unaffected arm
743
Empty can test or Jobes test
Jobe's test (or the "empty can" test) assesses supraspinatus function. The patient places a straight arm in about 90 degrees of abduction and 30 degrees of forward flexion, and then internally rotates the shoulder completely. The clinician then attempts to adduct the arm while the patient resists. Pain _without_ weakness suggests tendinopathy; pain _with_ weakness is consistent with tendon tear.
744
Finkelstein test
DeQuervain's tenosynovitis
745
Polymyalgia Rheumatica and GCA
Pain and stiffness in shoulders and hips frequently coexists w/ giant cell arteritis Responds to low dose prednisone tx of 10-20 mg/day whereas GCA can cause blindness and requires high-dose prednisone tx (40-60mg/day) Affects pts \> 50 **Polymyalgia** = fever, malaise, weight loss, anemia and markedly elevated ESR, muscle pain much greater than muscle weakness **GCA** = h/a, scalp tenderness, visual sx, jaw claudication, throat pain, temporal artery may be nodular, enalrged, or pulseless Fever can be as high as 40C and accopanied w/ rigors and sweats
746
Polymayalgia Rheumatica Tx
Inflammation of unknown origin affects muscles and joints \> 50 years Sx: aches in shoulder, neck, upper arms, lower back, hips, and thighs Sx tend to come quickly and are worse in the morning w/ improvement during the day No specific dx test, CRP and ESR are typically elevated MRI or U/S of shoulder an dhip can detect inflammation Tx: Low-dose corticosteroid 10-15 mg/day until sx are relieved (typically within 2-3 weeks), followed by tapering to find lowest dose necessary to suppress sx Tx can continue up to 2-3 years
747
Spinal Stenosis
50 y and \> **Standing discomfort w/ improvement in sx with bending forward** Pseudoclaudication (leg pain that worsens w/ activity and improves w/ rest) Bilateral LE numbness/weakness in the majority For sx persisting \> 1 month = consider MRI, EMG, nerve conduction velocity (NCV) Tx: PT NSAIDs epidural corticosteroid injection Surgery
748
Reactive arthritis
aka Reiter's syndrome Can't see Can't pee Can't climb a tree Most commonly in young men Arhtitis most commonly asymmetric and frequently involves large weight bearing joints (knee and ankle) Systemic sx: fever and weight loss common at onset Urethritis, conjunctivitis, uveitis, mucocutaneous lesions Tx: NSAIDs maintstay of tx Pts who do not respond to NSAIDs, try sulfasalazine 1000 mg BID or methotrexate 7.5 to 20 mg per week Anti TNF agents may be effective in refractory cases For chronic reactive arthritis assoc. w/ chlamydial infection, combination abx taken for 6 months is more effective than placebo Most signs of disease disappear within days or weeks Arthritis may persist for several months or become chronic Refer to rheumatology for progressive sx despite therapy
749
Osgood-Schlatter
Irritation of the patellar tendon on the tibial tuberosity during a growth spurt Patellar swelling and pain in adolescents who participate in sports involving running and jumping Repeated stress causes inflammation below patellar tendon where it attaches to tibia Sx: pain, swelling, and tenderness in one or both knees Can be mild to debilitating Can be constant or only when performing certain activities X-ray can be used to evaluate patellar tendon **Tx:** NSAIDs and PT Strengthening exercises for quads can help stabilize knee joint Sx typically resolve at completion of growth spurt
750
Prepatellar bursitis
Thickening of synovial tissue w/ excessive fluid within the bursa resulting in knee pain and swelling Caused by joint overuse, trauma, infection, or arthritis Focal tenderness and swelling Abrupt onset ROM full but limited by pain **First line tx: bursal aspiration** Alternative tx: Minimizing offending activity ICE to area for 15 minutes 4x/day NSAIDs If no improvement in 4-8 weeks, intrabursal corticosteroid injection should be performed
751
Meniscal tear
Disruption of meniscus - C-shaped fibrocartilage pad located between the femoral condyles and tibial plateaus Often found in athletes d/t twist type knee injury Effusion w/ knee tightness and stiffness ROM limited by discomfort Larger tears often report knee locks, makes popping sound, or "gives out" Dx: MRI can be used to identify type and extent of tear McMurray test and Apley grinding test are highly specific but not sensitive Tx: Rest, elevation, ice, analgesia Aspiration can be considered if no improvement after 2-4 weeks Arthroscopy for debridement and repair should beb considered at 4-6 weeks w/ no improvement or earlier if joint locking and effusion are problematic
752
lumbar-sacral strain
Spasm, irritation of LS spine supporting muscles Most common reason for low back pain Spasm, ache, stiffness, position, activity, rest typically impacts pain Paraspinal muscle tenderness and spasm LS curve straightening Decreased LS flexion Neurological exam WNL **Tx:** NSAID/APAP Physical conditioning/therapy Limiting potentially harmful activities Heat or ice as indicated by pain response Muscle relaxers can be helpful but all sedting, some w/ abuse potential
753
Lumbar radiculopathy
Irritation or damage of neural structures such as disks L4-L5, L5-S1 most common sites of disk bulge Sharp, burn, electric-shock sensation Worse when increased spinal fluid pressure Sneeze, cough, straining evokes sharp pain Dx: Signs of LS strain + altered neuro exam Abnromal straight leg raise Sensory loss altered DTRs Tx: NSAID, APAP Physical conditioning/therapy Specialty eval if rapidly evolving defect, persistent neurological defect w/o resolution after 4-6 weeks of coservative tx
754
What nerve root Foot dorsiflexion Knee jerk reflex medial calf sensation
L4
755
What nerve root Great toe dorsiflexion Medial foot sensation
L5
756
What nerve root Foot eversion Ankle jerk reflex Lateral foot sensation
S1
757
Osteoporosis
BMD -2.5 SD or below If fractures, deemed severe or "established" osteoporosis
758
Osteopenia
BMD -1.0 to -2.5
759
BMD testing
F 65 and \> M 70 and \> Postmenopausal, menopausal transition M 50-69 w/ risk fx Adults w/ condition (e.g. RA) or taking a medication (long-term glucocorticoid) assoc. w/ low bone mass or bone loss Risk Fx: Lifestyle (low calcium intake, ETOH abuse, sedentary) Genetic (CF, Gaucher's disease) Hypogonadal states (androgen insensitivity, hyperprolactinemia) Endocrine disorders (DM, adrenal insuff.) GI disordres (celiac, IBD) Hematologic (multiple myeloma, leukemia) Rheumatoid and autoimmune disorders (lupus, RA) CNS disorders (MS, epilepsy) Misc. other conditions and diseases (AIDS/HIV, CHF) Drugs (long-term corticosteroids, some anticonvulsants, thyroid hormones)
760
Osteoporosis Tx
Tx Who: Tx if BMD Postmenopausal women and men 50 and \> w/ low bone mass and 10-year hip fracture probabilty of 3% or more or all major osteoprosis-related fracture of 20% or more Hx of hip or vertebral fx Tx Options: Biphosphonates (Alendronate, ibandronate, risedronate, zoledronic acid) Calcitonin (Miacalcin) Estrogens or hormone tx (Evista) Parathyroid hormone All should be given w/ Vit D and Ca Vit D 800-1000 IU/d Ca 1000 mg/d F \> 50y and M \> 80y should have Ca 1200 mg/d
761
Calcium sources
Dairy and nondairy Spinach sardines tofu almonds
762
OA dx
X-ray is used to distinguish OA from other types of arthritis Imaging will show narrowing of joint space, change in bone, and presence of bone spurs (osteophytes) Sx: pain, tenderness, stiffness (more prominent in the morning), reduced ROM and crepitus frequently present Erythema and warmth usually absent
763
Early-term
37-38 weeks plus 6 days sleepy baby wake to feed every 2 hours
764
Full-term baby
39 weeks to 40 weeks plus 6 days
765
Late term baby
41 weeks to 41 weeks and 6 days Wide awake baby
766
Post-term baby
42 weeks and beyond Induction considered at 41 to 42 weeks
767
Newborn feeding
Formula: 1.5-3 oz every 2-3 hours Breastfeeding: every 1.5-3 hours, no more than 4 hours w/o feeding, minimum 8-12 feedings/day
768
Infant feeding 2 months
Formula: 4-5 oz every 2-4 hours Breastfeeding: 7-9x/day, dictated by infant
769
Infant feeding 4 months
Formula: 4-6 oz every 3-4 hrs Breastfeeding: 6-8x/day, dictated by infant and if supplemental feedings
770
Infant feeding 6 months
Formula: 6-8 oz every 4-5 hours Breastfeeding: 4-6x/day, dictated by infant, supplemental feedings
771
Solids and infant feeding
May start 4-6 months Solids not really needed until 1 year of age
772
Newborn teaching
Baby should make at least 6 wet diapers a day Newborns often lose up to 10% of birthweight in the first week of life Should be back up to birth weight by 2 weeks Breastfed baby usually ahs 4 or more bowel movements/day Frequent soft stools are normal Best vision range 8-12" - distance from breast & mom's face Bluish scleral tint normal until few months old Newborn's eyes are quite light and glare sensitive If object moves toward newborn's eye, baby will likely react w/ defensive blink reflex (present at birth) Well-developed sense of smell Hear high-pitched voices best Will react to cry of other neonates Visual preference for human face Place baby in a face-up position for sleep
773
2 months
Can lift self up on 2 arms from tummy Responds 2 sounds Smiles when smiled 2
774
4 months
Reaches 4 a toy or other object Smiles 4 fun Rolls from tummy to back
775
6 months
Looks like number 6 when sitting up Rolls from back to tummy and back
776
8 months
Once able to sit up, child can transfer objects from hand to hand with ease
777
12 months
Stands tall like the number 1 and walks on 2 legs
778
18 months
Can name single word objects Says "no" a lot, like an 18 y/o Acts like an 18 y/o by copying work that adults do
779
2 years
Builds a 2 block tower with ease Can walk up to 2nd floor with help (stairs) Speaks in 2 word sentences Follows 2 step commands
780
3 years
Rides a TRIcycle Build a 3 block tower w/ ease Can draw a circle Speaks in 3 word sentences
781
4 years
Speaks in 4 word sentences Can build a 4 block tower w/ ease Can draw a cross
782
5 years
Speaks in 5 word sentences Can draw a square
783
6 years
Can draw a triangle Speak in 6 word sentences
784
Tooth eruption
Lower central incisors first at 6-10 months Upper central incisors 8-12 months Lateral incisors 9-13 months First Molar 13-19 months Second Molars 23-31 months
785
Physiologic galactorrhea
Onset day 3-4 of life Maternal hormonal influences are likely cause Breast engorgement will resolve w/o intervention within the first two months of life
786
Foreskin retraction in children
In most instances, foreskin is not easily retractable until the child is about 3 years old Ok as long as urine comes out as a steady stream
787
Communicating hydrocele
Incomplete sealing of peritoneal cavity at inguinal area during gestation, leaving communication between abdominal cavity and scrotum Fluid-filled scrotal sac; transilluminates, nontender, testes normal **Size varies w/ position** (larger in dependent upright position, and smaller after laying flat such as awakening) Due to communication, infant at **risk for herniation** of abdominal contents **Referral to pediatric urologist or surgeon**
788
Hernia incarceration/strangulation s/sx
Risk fx: femoral hernia, advanced age, recurrent hernia s/sx: Painful to palpation Fever Erythema of groin skin s/sx of bowel obstruction (N&V, abd pain and bloating) Systemic sx if strangulation and bowel necrosis has occurred Peritonitis typically does not occur because ischemic/necrotic tissues is trapped within hernia sac, however, if spontaneously or unwittingly reduced, peritoneal signs may be present
789
Non-communicating hydrocele
Sealing of abdominal cavity during gestation w/ residual trapped peritoneal fluid in scrotal sac **s/sx** fluid-filled scrotal sac, transilluminates, no change in scrotal size w/ position change, same at bedtime and on awakening **Tx** Reassurance, no risk of herniation, no special skin care needed Usually resolves by age 2 years w/o intervention Referral only if size interferes w/ activity/comfort
790
Correct latch-on
Mouth covers areola Lips are flanged out no dimpling of the baby's cheeks No clicking sound w/ sucking
791
newborn jaundice
usually seen first in the face then progress caudally to trunk and extremities encourage at least 8-12 feedings at the breast per day while avoiding dextrose and water feedings - this will help minimize newborn's risk of hyperbilirubinemia Onset of jaundice within the first 24 hours of life is pathologic until proven otherwise
792
Pyloric stenosis
thickening of the pylorus muscle preventing food from moving from the stomach to small intestines Nonbilious vomiting (often projectile) or regurgitation Dehydration and malnutrition Jaundice Approx. 4:1 M:F ratio Baby eager to eat again immediately post emesis Condition usually present 3 weeks of life **Dx: U/S to detect thickened pyloric muscle** An enlarged pylorus ("olive") can often be palpated in the RUQ of abdomen Tx: **surgery** stadard of care
793
Intussusception
Caused when a section of intestines invaginates into adjoining intestinal lumen, causing bowel obstruction If left untreated, is uniformly fatal in 2-5 days S/Sx Vomiting, abdominal pain, passage of blood and mucus Lethargy Palpable sausage-shaped abdominal mass Sx often preceded by URI Usually in the first year of life Currant jelly loose stools Sudden onset colicky, severe, and intermitted abd pain Dx: U/S to identify target and pseudokidney signs **Contast enema is the traditional and most reliable dx approach** Plain x-ray only identifies about 60% of cases Tx: Non-operative include hydrastatic or pneumatic enemas, surgical reduction needed if unsuccessful or if obvious perforation is present
794
Time Out
Short-term isolation to decrease undesirable behavior Child sits in special place, easily observed by parent/caregiver, uninteresting, and only used for time out. Avoid use of bed, bedroom, or any place where child could be frightened **Start at 18-24 months** **1 minute/year of life** **Set timer**
795
Percentage of speech intelligible by people not in daily contact with 3.5 y/o child
nearly 100%
796
What age? Able to verbalize what to do when cold, hungry, tired Can draw person w/ no torso Knows first and last name
4.5 year old Simple abstract problem solving
797
What vaccine, most likely mild fever of 1-2 days in a 6 month old
Pneumococcal conjucate 13-valent (PCV13)
798
When to screen for autism per AAP
18 months and 24 months | (formal screening)
799
Infant born to HBs-Ag positive mother
Give hep B immunization and hep B immuneglobulin to newborn
800
Developmental Red Flags
No big smiles or other warm/joyful expression by 6 months No back-and-forth sharing of sounds/smiles/other facial expressions by 9 months Lack of response to name, no babbling or baby talk and/or no back and forth gestures such as pointing, waving, reaching by 12 months No spoken words by 16 months No meaningful two-word phrases that don't involve imitating or repeating by 24 months
801
Most important time to screen for hearing defects
First days of life
802
Down Syndrome features
Flat facial profile Poor Moro reflex Hypotonia Hyperflexible joints Excessive skin on neck Slanted palpebral fissures Pelvic dysplasia Anomalous auricles Dysplastic middle phalanx of the fifth finger Single palmar crease Likelihood of DS when 6 features = 90%
803
Car seat rear-facing
Infants to 2 years Rear-facing car seat until 2 years of age or until child reaches the highest weight or height allowed by the car safety seat's manufacturer
804
Car-seat for toddlers/preschooler
Convertible seats and forward-facing seats w/ harnesses All children 2 years or older, or those younger than 2 years who have outgrowing rear-facing weight/height limit should use forward-facing safety seat w/ harness for as long as possible
805
School-aged children car seat
Booster Belt-positioning booster seat until vehicle seat belt fits properly (typically when they reached 4' 9" in height and are between 8-12 years old in age)
806
Older children and seat belts
Always use lap and shoulder seat belts in the rear seats for optimal protection
807
Tanner Stages summary
Tanner 1 - pre-pubescent Tanner 2 - earliest stages Tanner 3 - growth spurt Tanner 4 - peak of growth spurt Tanner 5 - Adult
808
Tanner 2 to Menarche
2 years Tanner 4 - menarche
809
Tanner 1
pre- puberty
810
Tanner 2
Testes enlarge scrotal skin reddening w/ change in texture sparse growth of long, slightly pigmented pubic hair at bease of penis - Breast buds and papilla elevated Downy pigmented pubic hair along labia majora
811
Tanner 3
Increase in penile length but minimal change in width "pencil penis" further scrotal enlargement pubic hari darker, coarse, covers greater area **Onset of growth spurt** - Breast mound enlargement darker, coarser pubic hair on mons, labia majora onset of growth spurt
812
Tanner 4
Increase in penile length and width w/ development of glans further darkening of scrotal skin adult-type pubic hair w/ no spread to medial surface of thighs - Areola and papilla elevated to form a second mound above level of rest of breast adult-type of pubic hair w/ no spread to medial surface of thighs **menarche**
813
Tanner 5
**Full adult** genitalia adult type hair w/ spread to medial surface of thighs, possible abdomen - Recession of areola to mound of breast Extension of pubic hair to medial thigh
814
1st menses to full adult height in females
1 year
815
Breast budding to full adult height in females
3 years
816
Tanner 2 to full adult height in males
4 years
817
Puberty
Physical changes leading to sexual maturation and reproductive capability Puberty occurs during, but is not synonymous with, adolescense
818
Gynecomastia
Usually found in Tanner Stage 3 Usually resolves in 6-12 months
819
Fragile X Syndrome
Most common cause of autism in either gender 1 in 4000 males 1 in 8000 females Occurs in all racial/ethnic groups Males: large forehead, prominent jaw, tendency to avoid eye contact, large testicles, large body habitus, learning and behavioral differences (hyperactivity, developmental disability common) Females: Significantly less common w/ fewer prominent findings, usually w/ less severe developmental issues Blood testing available for carrier state or for dx Antenatal dx possible w/ amnio, CVS or preimplantaion dx
820
Klinefelter Syndrome
XXY male Only males affected Low testicular volume, hip and breast enlargement, infetility Most developmental issues, language impairment most commonly Most common form of sex hormone aneuploidy 1 in 500-1000 some w/o sx Blood testing available for carrier state or for dx Antenatal dx w/ amnio, CVS, or preimplantaion dx
821
Turner Syndrome
XO female Found in 1 in 2000-2500 females Short stature (5 feet or under) Usually evident by 5 years of age wide, webbed neck No ovaries Broad, shield-shaped chest Absent menses Infertility Often noticeable at birth Narrow high-arched palate Retrognathia low set ears edema of hands and feet Females who are classified as Turners mosaic w/ chromosonal changes in some but not all cells, typically w/ milder features High rate of spontaneous pregnancy loss in XO F fetus Blood testing for dx, antenatal dx w/ amnio, CVS, or preimplantaion dx
822
Acne Vulgaris pathophys
Follicular epidermal hyperproliferation w/ subsequent follicle plugging, excess subum production, presence of P. acnes, accompanying inflammation Leads to keratolytic and antibacterial tx Affects 80% of all teens w/ 20% having severe and subsequent scarring Affects skin areas where sebaceous follicles located: face, upper chest, back
823
Benzoyl Peroxide
Antibacterial against P. acnes as well as a comedolytic 2.5% as effective as higher strength and less likely to irritate skin Inexpensive OTC Most helpful in mild acne, usually w/ keratolytic acne wash w/ salicylic acid 2%
824
Tretinoin (retinoic acid) gel, cream
Keratolytic normalized hyperkeratinization Decreases cohesion between epidermal cells Increases epidermal turnover Significant antiinflammatory effect Indicated in all acne types Mild to moderate skin irritaion w/ redness and dryness - improves over time, expect 6 weeks therapy prior to noting improvement **Photosensitizing, use sunscreen**
825
Topical abx for acne
Clindamycin, Erythromycin, Dapsone Antibacterial against P. acnes, anti-inflammatory Indicated in tx of mild to moderate acne Most effective for mild ane Less effective than oral abx for moderate-severe acne often used in combination w/ comedolytic such as benzoyl peroxide and/or tretinoin
826
Oral abx or acne
Doxy, Minocycline, Erythro, TMP/SMX, Azithro (500 mg every 5 days) Antibacterial against P. acnes, anti-inflammatory Indicated for moderate inflammatory acne, usually when topical tx has been inadequate Once skin is clear (usually after 3 months of continuous tx), taper off slowly over a few months while adding topical abx agents Rapid discontinuation will result in return of acne Long-term tx or repeat tx usually needed
827
COC for acne
Reduction in adrogen levels, decreased sebum production Best suited for females w/ moderate to severe acne About 3 months of use prior to significant acne improvement With discontinuation, acne usually returns
828
Isotretinoin (Accutane)
Mechanism of action not well understood Likely inhibits sebaceous gland function Indicated for cystic severe acne that does not respond to other tx usual course of tx is 4-6 months discontinue when nodule count is reduced by 70% Repeat course only if needed after 2 months off drug Careful monitoring for mood destabilization and/or suicidal thoughts menthal health risk is low Prescriber and pt must be properly educated in use of drug and fully aware of adverse reactions profile: cheilitis, conjunctivitis, hypertriglyceridemia, xerosis, photosensitivity, potent teratogenicity Females of childbearing age must use two types of highly effective contraception 1 month prior to, during, and 1 month after use of isotretinoin iPLEDGE program is designed to prevent pregnancies in patients using isotretinoin by using iPLEDGE prescribers pharmacies, and signin iPLEDGE card
829
Mild Acne
Tx: Topical retinoid alone often helpful Consider adding topical abx or benzoyl peroxide
830
Moderate acne
20-100 comedones 15-50 inflammatory lesions 30-125 total lesions Tx: Oral abx with topical retinoid
831
Severe acne
\> 5 cysts \> 100 total comedones \> 50 total inflammatory lesions \> 125 total lesions Tx: Oral abx w/ topical retinoid if ineffective: Oral isotretinoin (Accutane) For large, painful cysts, consider intralesional corticosteroid injection
832
Most common cause of adolescent death in US
Accidental injury
833
CRAFFT screening test
For adolescent substance abuse Car - have you ridden in a car driven by someone who has been high/using drugs/ETOH? Relax - Do you ever use ETOH/drugs to relax, feel better about yoruself, fit in? Alone - Do you ever use alone? Forget - Do you ever forget things you did while using ETOH or drugs Friends - Do your family/friends ever tell you that you should cut down? Trouble - Have you ever gotten into trouble while using ETOH/drugs? 2 or more = serious problem
834
Most common contraceptive used by teens
Male condom 18% failure rate
835
All 50 states entitle adolescents to conset to care for which conditions?
Contraception Pregnancy STI Substance abuse Mental health
836
Screening for Type II DM in Children
Consider testing: Overweight or obese BMI \> 85th percentile + 2 or more risk fx Risk fx: Family hx of DM2 in first or second degree relative Race/ethnicity (other than Caucasian) Signs of, or condition associated w/, insulin resistance such as acanthosis nigricans, HTN, HL, PCOS, SGA Maternal DM or gestational DM **Initiate testing at age 10 years or at onset of puberty, early if puberty occurs earliet** **Frequency: every 3 years**
837
Lipid Screening and CV Health in children
Low-fat dairy products Diet and nutritional counseling Screen children and adolescents w/ positive family hx of HL or premature (55 years or younger for men, and 65 years or younger in women) CVD or dyslipidemia. Screen children whose family hx is not known or those w/ other CVD risk factors such as overweight, (BMI 85th percentile or higher), obesity (BMI 95th percentile or higher), cigarette smoking, DM **Use a fasting lipid profile; if normal repeat in 3-5 years** First screening should take place after 2 years of age but no later than 10 years of age Primary tx of high TG or low HDL and overweight - _weight mgmt_ (diet and nutrition) For pts 8 years and older with LDL =\> 190 (or =\>160 if family hx of early heart disease or =\>2 risk fx, or =\>130 in DM), _pharmacologic intervention should be considered._ Target initially is LDL Can be as low as LDL
838
Scarlatina-form or sandpaper rash Exudative pharyngitis Fever, headache tender anterior cervical lymphadenopathy Rash erupts on day 2 of pharyngitis and often peels a few days later Dx?
Scarlet fever Pathogen: S. pyogenes (GABHS) Tx: Penicillin first line PCN allergy: Azithro, clarithro, erithro
839
Discrete rosy-pink macular or maculopapular rash lasting hours to 3 days Follows a 3-7 days period of fever, often quite high 90% in children
Roseola Agent: Human herpesvirus 6 (HHV-6) Often in children 6-24 months Febrile seizures in 10% of children affected Supported tx
840
Mild sx Fever, sore throat, malaise, nasal discharge Diffuse maculopapular rash lasting 3 days Posterior cervical and postauricular lymphadenopathy beginning at 5-10 days PRIOR to onset of rash Arthralgia in 25% (most common in women) Dx
**Rubella** Agent: Rubella virus **"3 day measles"** aka: **German Measles** Incubation period: 14-21 days Transmissible 1 week prior to rash onset and 2 weeks after rash appears Generally mild, self-limiting illness Greatest risk to unborn child, especially w/ first trimester exposure (_80% of congenital rubella syndrome_) _Notifiable disease,_ usually to state/public health authorities, laboratory confirmatin w/ _serum rubella IgM_
841
Usually acute presentation w/ fever, nasal discharge, cough, generalized lymphadenopathy, conjunctivitis (copious clear discharge), photophobia Koplik spots appearing 2 days prior to onset of rash as white spots w/ blue rings help within red spots in oral mucose in 1/3 of pts Pharyngitis mild w/o exudate Maculopapular rash onset 3-4 days after onset of sx May coalesce to generalized erythema Dx
Measles Agent: Rubeola virus aka "Hard measles" Incubation period 10-14 days Transmissble for 1 week prior to onset of rash to 2-3 weeks after rash appears CNS and respiratory tract complications common Permanent neurologic impairment or death possible Supportive tx as well as intervention for complications Notifiable to state/public health Lab confirmation with serum rubeola IgM
842
Maculopapular rash in 20%, rare petechial Fever, "shaggy" purple-white exudative pharyngitis Malaise, marked diffuse lymphadenopathy Hepatic and splenic tenderness w/ occassional enlargement Dx?
Dx testing: Heterophil antibody test (Monospot), leukopenia w/ lymphocytosis and atypical lymphocytes Infectious Mononucleosis (IM) **Agent: Epstein Barr virus (human herpesvirus 4)** **Incubation period: 20-50 days** \>90% will develop a rash if given amoxicillin or ampicillin during the illness Potential for respiratory distress when enlarged tonsils and lymphoid tissue impinges on upper airway - _corticosteroids_ may be helpful Splenomegaly most often occurs between days 6-21 days after onset of illness _Avoid contact sport for at least 1 month_ d/t risk of splenic rupture
843
Fever, malaise, sore mouth, anorexia 1-2 days later, lesions Also can cause conjunctivitis, pharyngitis Duration of illness 2-7 days Dx?
Hand, foot, and mouth disease Agent: Coxsackie virus A16 Transmission via oral-fecal or droplet Highly contagious Incubation period of 2-6 weeks Supportive tx Analgesia important School exclusion typically until all blisters have dried
844
3-4 days of mild, flu-like illness Followed by 7-10 days of red rash that begins on face with "slapped cheek" appearance Spreads to trunk and extremities
Fifth's disease Agent: Human parvovirus B19 aka. erythema infectiosum Droplet transmission Leukopenia common Risk of hydrops fetalis w/ resulting pregnancy loss when contracted by woman during pregnancy Supportive tx Rash onset corresponds w/ disease immunity w/ patient Viremic and contagious prior to but not after onset of rash
845
Child w/ Maculopapular rash, fever, mild pharyngitis Ulcerating oral lesions Diarrhea Diffuse lymphadenopathy Dx
Acute HIV infection Agent: Human immunodeficiency virus Most likely to occur in response to infection w/ large viral load Consult w/ HIV specialist concerning initiation of antiretroviral Tx
846
Acute-phase usually lasts 11 days Fever T \> 104 F (40 C) lasting 5 or more days Polymorphic exanthem on trunk, flexor regions, and perineum Erythema of oral cavity ("strawberry tongue") w/ extensively chapped lips Bilateral conjunctivitis usually w/o eye discharge Cervical lymphadenopathy Edema and erythema of hands and feet w/ peeling skin (late finding, usually 1-2 weeks after onset of fever) Dx?
Kawasaki disease Agent: unknown Usually in ages 1-8 years M\>F Tx: IV immunoglobulin and PO ASA during acute phase Tx reduces rate of coronary abnormalities such as coronary artery dilation and coronary aneurysm Expert consultation and tx advice about ASA use and ongoign monitoring warranted
847
Most common anemia in childhood
Iron-deficiency (IDA) Hemogram: Microcytic, Hypochromic, elevated RDW Most common in children ages 12-30 months Major contributors: depletion of birth iron stores (usually lasts 6 months), initiation of lower-iron diet later in infancy, early toddler stage - Most calories in first year of life shoud be from iron-enriched infant formula or breast milk w/ iron supplementation starting at ages 4-6 months, depending on amount of iron-fortified formula intake **cow's milk \> 16 oz/day after 12 months of age = most potent risk fx for IDA** **In child**
848
Preterm infants and iron
If breastfed, should receive 2 mg/kg/d of elemental iron starting age 1 month through 12 months If formula fed, iron supplements could be required
849
Term infants and iron
If \> 1/2 of feedings as human milk, should receive 1 mg/kg/day of supplemental iron starting at age 4 months until introduction of complementary foods (fortified cereals, legumes, red meats, dark green vegetables, vitamin C) If formula fed, receives enough iron from formula w/ introduction of complementary foos after ages 4-6 months
850
IDA tx in children
Supplemental iron should be continued for about 2 months after correction of anemia to replenish body stores **All children should be screened for IDA through hemoglobin measurement at age 1 year** Hg With milder anemia (Hg 10-11 g/dL), an alternative evaluation plan includes treating w/ iron for 1 month. A rise in Hg 1g or more after 1 month confirms IDA.
851
Vitamin D supplementation infants
AAP: Breastfed: Vitamin D 400 IU/day starting first weeks of life Formula fed: If less than 800-1000mL/day of formula, supplement
852
Vitamin D requirements per age
Infants: 400 IU/day Children to adults age 70: 600 IU/day Age \> 70: 800 IU/day
853
Calcium requirement per age (children)
Toddler (age 1-3): 500 mg/day Preschool, younger school age (4-8 years): 800 mg/day Older children to teens (9-18 years): 1300 mg/day
854
Calcium foods
1 cup of milk/yogurt = 250 mg Ca 1 cup of collards = 357 mg Ca 1 cup of black-eyed peas = 211 mg Ca 3 oz of tofu = 163 mg ca 1 cup cottage cheese 1% milk fat = 138 mg Ca 1 cup of soy milk = 93 mg Ca 1 oz of almonds (24 nuts) = 70 mg of Ca
855
ADHD key dx
Sx must be present before age 12 Impairment must be present in at least 2 settings must have evidence of functional interference (socially, academically, or in extracurricular activities)
856
ADHD Inattention dx
Inattention: 5 or more must occur often: Fails to give close attention to details or makes careless mistakes in schoolwork, work, other activities Difficulty sustaining attention in tasks, play activities does not seem to listen when spoken to directly Does not follow through on instructions or fails to finish schoolwork, chores, or duties Difficulty organizing tasks and activities Easily distracted by extraneous stimuli Forgetful in daily activities
857
ADHD Hyperactivity-Impulsivity Dx
Fiver or more of the following must occur often: Fidgets w/ hands or feets or squirms in seat Leaves seat in classroom or in other situations in which remaining seated is expected Runs about or climbs excessively in situations when inappropriate Difficulty playing or engaging in leisure activities quietly Acts "on the go" or acts as if "driven by a motor" Talks excessively Blurts out answers before questions are completed Difficulty waiting turn Interrupts or intrudes on others
858
Croup
**Laryngotracheobronchitis** **Stridor** Caused by upper airway obstruction - getting air in more of a problem than getting air out Characteristic sound heard on inspiration Viral, allergic in origin Most common 6 months to 5 years **"Steeple" sign on frontal chest radiograph** **Tx Supportive** **Systemic corticosteroids**
859
Foreign body airway obstruction
Stridor - upper airway obstruction Acute onset from mechanical obstruction, most common in toddlers Tx: removal
860
Peritonsillar abscess
Stridor - upper airway obstruction Usually bacterial Most often in older child or adult Usually presents w/ "hot potato" voice Difficulty swallowing Trismus Contralateral uvula deviation Tx: Attention to airway Prompt ENT consult Antimicrobial therapy Usually inpatient admission Perhaps surgical intervention
861
Acute epiglottitis
Bacterial origin (most often H. influenzae type B) Most often in children age 2-7 years Abrupt onset of high-grade fever, sore throat, dysphagia, drooling Dx: Attention to airway maintenance Thumb sign on lateral soft-tissue radiograph of neck Prompt ENT consult Antimicrobial therapy Usually inpatient admission
862
Acute bronchiolitis
Often called **"disease of the happy wheezer"** Milder ill child **3 months to 3 years** Most viral etiology Most often from RSV less commonly from influenzae or adenovirus short-term acute illness w/ wheezing lasting about **3 weeks** Most serious in early infancy **(** Nearly all episodes occur between Novemenr and April Tx: Supportive Little evidence that inhaled bronchodilateros or inhaled/systemic corticosteroids are helpful Palivizumab (Synagis) often used to prevent RSV in fection in premature infants (first RSV season in infants born at
863
Acute bronchitis
Viral etiology Short-term, self-limiting Tx: Supportive Inhaled beta-agonist Oral anti-inflammatory tx
864
Wheeze DDx in Children
Acute bronchiolitis Acute bronchitis Asthma
865
DDx of stridor in children
Croup Foreign body Congenital obstruction Peritonsillar abscess Acute epiglottitis
866
Intermittent asthma children 0-4 years
Sx = Nighttime awakenings 0 SABA = No interference w/ normal activity Exacerbations requiring oral corticosteroids 0-1/year Step 1 Tx
867
Mild persistent asthma 0-4 years
Sx \> 2 days/week Nighttime awakenings 1-2x/month SABA \> 2 days/week but not daily Minor activity limitation 2 or more exacerbations in 6 months requiring oral corticosteroids or 4 or more wheezing episodes/year lasting \> 1 day Tx Step 2
868
Moderate Persistent asthma 0-4 years
Daily sx Nighttime awakenings 3-4x/month Daily SABA Some limitation to normal activity 2 or more exacerbations requiring oral prednisone in 6 months or 4 or more episodes/year of wheezing lasting \> 1 day Tx: Step 3
869
Severe persistent asthma 0-4 years
Sx throughout the day Nighttime awakenings : \> 1x/week SABA several times a day 2 or more exacerbation requiring oral prednisone in 6 months or 4 or more episodes of wheezing in 1 year lasting more than 1 day Tx: Step 3 and consider short course of corticosteroids
870
Step 1 asthma 0-4 years
SABA PRN
871
Step 2 asthma 0-4 years
Low-dose ICS SABA PRN Alternative: Cromolyn Montelukast
872
Step 3 asthma 0-4 years
Medium-dose ICS SABA PRN
873
Step 4 asthma 0-4 years
Medium-dose ICS + LABA or Montelukast SABA PRN
874
Step 5 asthma 0-4 years
High-dose ICS + LABA or Montelukast SABA PRN
875
Step 6 asthma 0-4 years
High-dose ICS + Montelukast or LABA AND Oral Systemic Corticosteroids
876
Intermittent asthma 5-11 years
Sx = Nighttime awakenings = SABA = No interference w/ activity Normal FEV1 between exacerbations FEV1 \> 80% predicted FEV1/FVC \> 85%
877
Mild Persistent Asthma 5-11 years
sx \> 2 days/week but not daily Nighttime awakenings 3-4x/month SABA \> 2 days/week but not daily Minor activity limitation FEV1 =\>80% predicted FEV1/FVC ration \> 80%
878
Moderate Persistent Asthma 5-11 years
Daily sx Nighttime awakenings \> 1x/week but not nightly Daily SABA Some activity limitation FEV1 60-80% predicted FEV1/FVC = 75-80%
879
Severe Persistent Asthma 5-11 years
Sx throughout day Nighttime awakenings often 7x/week SABA several times per day Extremely limited activity FEV1 FEV1/FVC
880
Step 1 asthma 5-11 years
SABA PRN
881
Step 2 asthma 5-11 years
Low-dose ICS **Alternative** Cromolyn LTRA Nedocromil Theophylline
882
Step 3 asthma 5-11 years
Low-dose ICS + LABA or LTRA or Theophylline **Alternative** Medium-dose ICS
883
Step 4 asthma 5-11 years
Medium dose ICS + LABA **Alternative:** Medium dose ICS + LTRA or Theophylline
884
Step 5 asthma 5-11 years
High-dose ICS + LABA **Alternative:** High-dose ICS + LTRA or Theophylline
885
Step 6 asthma 5-11 years
High dose ICS + LABA + Oral systemic corticosteroid **Alternative** High-dose ICS + LTRA or Theophylline + Oral systeic corticosteroid
886
Cogwheeling
Resistance to passive movement Best felt at elbow, wrist, neck Found in Parkinsons
887
Tzanck smear
Dx of herpes Tzanck smear will reveal giant multinucleated cells
888
RA susceptibility fx
heredity family hx female gender
889
Posterior nasal bleed
May hemorrhage send to ER
890
Most common cause of secondary HTN
renal conditions e.g. renal artery stenosis and renal failure
891
Acute glomerulonephritis tx
Avoid high potassium foods Treat inpatient until edema and HTN are under control Restrict protein in presence of azotemia and metabolic acidosis Fluid intake should be restricted to only the amount patient requires to replace lost fluids
892
BMI calculation
Divide person's weight by height squared
893
Hemorrhoid tx
Topical hydrocortisone can relieve pain, itching, inflamm Stool softener reduce straining during defecation Local analgesic spray, suppository, or cream provide pain relief
894
Peristalsis and progesterone
Decreased peristalsis from progesterone Physiologic change during pregnancy Results in GERD and constipation
895
Thelarche earliest onset
7 years
896
Pubarche earliest onset in females
8 years range 8-13 years
897
Male Age range onset of Tanner 2
9-14 years
898
Female Alteration in puberty
Idiopathic in 85% or higher Most common puberty disorder Continuous GnRH agonist analog option to delay progress - \> 13 years Multiple fx: nutrition (low weight), hormonal, genetic (Turner syndrome XO), others
899
Male Alterations in puberty
Idiopathic in CNS tumors most often implicated - \> 14 years Multiple fx: nutritional, hormonal, genetic, others
900
Infant tearing in both eyes Mucoid discharge dx?
Congenital lacrimal duct obstruction
901
Osteomalacia
Adult form of rickets Poor bone formation in children and softening of bones in adults Causes spine to bend and legs to become bowed Result of Calcium and Vitamin D deficiency
902
Gold standard of ectopic pregnancy sx
transvaginal U/S
903
Surgical consult abd pain indicators (5)
fever increased WBC tachycardia peritoneal signs advanced age
904
When to refer to burn center
if burns are \> 10% of TBSA in age 50 \> 20% TBSA in all other ages burns over a joint circumferential burns
905
Borborygmi
Hyperactive bowel sounds Rush of gurgling, tinkling sounds Typically loud
906
Most common cause of ED
DM
907
Multiple sclerosis adverse outcome predictors
older age at onset cerebellar involvement male gender persisting deficits in brain stem short first inter-attack interval
908
How many viral illnesses per year are common in infants and toddlers
Up to 10
909
Esotropia
Misalignment of one or both eyes (cross-eyed) Infants younger than 20 weeks may have intermitten esotropia, usually resolves spontaneously
910
coarctaion of the aorta
discrete narrowing of the aorta just opposite the site of the ductus arteriosus
911
Vitamin D deficiency risk fx
gastric bypass Limited sun exposure renal disease use of sunscreen use of phenobarbital hepatic disease
912
Baker cyst
swelling behind knee cystic swelling in popliteal space if bursa ruptures, acute swellling of lower leg might mimic DVT
913
Bulimia pharm tx
SSRIs, TCAs, CBT Avoid MAOI - potential for severe food interactions and HTN crisis
914
Acute bacterial meningitis tx
Infants: ampicillin + 3rd gen ceph Adults: 3rd gen ceph + chloramphenicol Adults \> 50: Amox + 3rd gen ceph
915
Which imaging test measures the accuracy of brain structure
CT - computerized tomography
916
Average American man lifetime risk of latent prostate cancer
40% risk of latent disease 10% risk of clinically significant disease 3% risk of dying from prostate ca
917
Drugs for seizures
Myoclonic and atonic seizures: Clonazepam Simple, Complex partial: carbamazepine, phenytoin, divalproex sodium, valproic acid
918
Campylobacter jejuni tx
Erythromycin
919
Salmonella tx
Ampicillin
920
Shigella tx
Trimethoprim-Sulfamethoxazole
921
Giardia lamblia tx
Metronidazole
922
BPH sx
urinary urgency, hesitancy dysuria incontinence
923
Lyme disease pathogen
Ixodes tick bite infected w/ Borrelia burgdorgeri
924
Aminoglycosides and pregnancy
can cause deafness Teratogen
925
Lithium in pregnancy
Teratogen Can cause cardiac defects
926
Cocaine in pregnance
Teratogen Can cause CVAs and mental retardation
927
Sulfa drugs in pregnancy
Contraindicated in the third trimester Can cause hemolysis in utero w/ resulting hyperbilirubinemia
928
AOM pathogens
No pathogen 4% Virus 70% Bacteria + virus 66% **Strep pneumo (gram +) in 49% of bacterial AOM** - Treatment target. Consider drug resistance risk. Mechanism of resistance: alters protein binding sites within bacterial cells. Low rate of 10-20% spontaneous resolution w/o abx **H. influenzae (Gram - bacillus) 29%** - Resistance via beta-lactamase production. Moderate rate of 50% spontaneous resolution w/o abx **M. catarrhalis (Gram - cocci) 28%** - Resistance via beta-lactamase production. Nearly **ALL** resolve w/o abx
929
Psoas sign
Appendicitis Pain in RLQ w/ passive right hip extension
930
Valgus stress test
tests MCL Bend knee INward
931
Varus stress test
tests LCL bend knee OUTward
932
Rovsing's Sign
RLQ pain illicited w/ LLQ pain palpation + appendicitis
933
Portal hypertension
r/t obstruction of portal blood flow which increases portal venous pressure resulting in: splenomegaly Ascite collateral venous channels para-umbilical and hemorrhoidal veins Cardia of the stomach and into esophagus
934
Analgesia definition
absence of pain sensation
935
hypalgesia definition
decreased sensitivity to pain
936
hyperalgesia definition
increased sensitivity to pain
937
anesthesia definition
absence of touch sensation
938
Flashing lights across field of vision or vitreous floaters Dx?
Detachment of vitreous from the retina
939
Palpable thrill in the LUSB suggest
pulmonary valve stenosis
940
palpable thrill in the right clavicular region or in the upper right sternal area suggest
aortic valve stenosis
941
thrill palpable in the LLSB suggest
ventricular septal defect
942
Infant weight gain
double by 6 months Triple by 1 year
943
Sacral lymph nodes receive lymphatic fluid from
prostate/cervix rectum urinary bladder posterior pelvic wall
944
Internal ileac lymph nodes receive lymphatic fluid from
all pelvic viscera deep part of perineum gluteal region
945
Tachypnea in newborn is
RR at rest is =\> 60 bpm
946
Frequency range close to conversation speech
512 Hz
947
How to assess pelvic floor muscle strength during bimanual
have pt squeeze around inserted fingers for as long as possible full strength = snug compression for 3 or more seconds
948
Peak bone mass is reached by what age
30
949
HCG
produced by the placenta supports progesterone syntehesis in the corpus luteum, effectively preventing early embryo from being lost to menstruation
950
dull, aching pain when attempting active or passive ROM to one shoulder localized tenderness w/ external rotation Dx?
Adhesive capsulitis
951
Global aphasia
difficulty speaking and understanding words and unable to read/write
952
Broca's aphasia
speech is confluent, slow few words laborious effort inflection and articulation are impaired but words are meaningful, w/ nouns, transitive verbs, and important adjectives small grammatical words are often dropped
953
Anomic aphasia
word-findingn difficulties struggles to find right words for speaking and writing
954
Wernicke's aphasia
speech is fluent, often rapid, voluble, and effortless Inflection and articulation are good BUT sendtences lack meaning and words are malformed (paraphasias) or invented (neologisms) Speech may be totally incomprehensible
955
Mental retardation levels
**Mild:** mental age 8-12 years **Moderate:** trainable up to 3-7 years IQ 35-55 **Severe:** IQ between 25-40, limited communication, capable of learning certain self-care activities, and mental age of toddler **Profound:** IQ
956
Palpable thrill in the left mid-sternal border would be consistent with
Tetralogy of Fallot
957
Extrusion reflex infant normal
disappears by 4 months
958
Babinski reflex normal
Disappears by 12 months or when walking
959
Medial epicondylitis aka
Golfer's elbow
960
Ankle joint aka
tibiotalar joint assessed through dorsi and plantar flexion
961
Pronator drift test
extend both arms and palms face upward for 20-30 sec forearm drifts downward = corticospinal lesion in the contralateral hemisphere forearm drifts upward = lesion in the cerebellum
962
Pain of duodenal or pancreatic origin refers to
the back
963
Referred pain from biliary tree
right shoulder or right posterior chest
964
Preterm SGA are more likely to experience
asphyxia hypoglycemia hypocalcemia
965
Preterm AGA (appropriate for gestational age) are prone to
respiratory distress syndrome apnea patent ductus arteriosus w/ left to right shunt infection
966
Akinesia definition
absence or loss of control of voluntary muscle movement
967
Dystonia definition
involuntary muscle spasms and twisting of limbs
968
Dyskinesia definition
presence of involuntary muscle movement such as tics or chorea can be seen in children w/ rheumatic fever
969
bradykinesia definition
impaired ability to adjust one's body position noted in Parkinson's
970
Dysesthesia definition
abnormal or unpleasant sense of touch
971
Why should pregnant pts avoid unpasteurized dairy, soft cheeses, raw egges, deli meats?
Risk of Listeria, Salmonella, toxosplasmosis
972
how to test for thumb opposition
touch thumb to each of the other fingertips
973
Postterm infants are at risk for
meconium aspiration asphyxia
974
Four classic structural defects in Tetralogy of Fallot
ventricular septal defect overriding aorta pulmonary stenosis right ventricular hypertrophy
975
Deciduous teeth and permanent teeth
20 deciduous teet between 6 months and 5 years of age Permanent teeth begin to erupt at 6 years of age when deciduous teeth begin to fall out All 32 permanent teeth usually erupt by late adolescence
976
Diminished breath sound in one side of the chest of a newborn suggests
Unilateral lesions e.g. congenital diaphragmatic hernia
977
Hormone implicated for increasing insulin resistance and hyperglycemia associated w/ gestational diabetes
Human placental lactogen
978
Daughters of women who took Diethylstilbestrol (DES) during pregnancy are at risk for:
columnar epithelium cover most or all of cervix vaginal adenosis circular collar or ridge of tissue, of varying shapes, between the cervix and vagina
979
Angle of Louis location
on the manubrium and body of sternum
980
Aphonia definition
loss of voice accompanies disease affecting larynx or its nerve sypply
981
Dysphonia definition
refers to less severe impairment in volume, quality, ptich of voice
982
Chronic pelvic pain definition
pelvic pain that lasts \> 6 months w/o response to tx
983
Severe epigastric pain that radiates to posterior trunk and entire abdomen is suggestive of
acute pancreatitis
984
Lateral epicondylitis aka
tennis elbow
985
Dx of AOM in children
Moderate or severe bulging of TM OR new onset of otorrhea not r/t OE w/ otalgia - Mild bulging TM AND recent (within 48 hours) onset of ear pain OR intense TM erythema w/ otalgia
986
Severe vs Nonsevere AOM
**Nonsevere:** Mild otalgia or Fever **Severe:** Moderate to severe otalgia or Otalgia \> 48 hours or Fever 39 C / 102.2 F or higher
987
Watchful waiting AOM
Analgesia w/o abx Indicated if low risk for adverse outcome w/o abx high rate of spontaneous AOM resolution Watchful waiting only appropriate for child 6 months of age and older w/ non-severe illness for unilateral AOM If used, follow up must be ensured w/ ability to start abx within 48-72 hours if child fails to improve or worsens 80% of children will be better in 7-10 days 70% within 2-3 days
988
AOM tx - first line
Amoxicillin 80-90 mg/kg/day in 2 divided doses OR Amox-Clav 90 mg/kg/d amox and 6.4mg/kg/d of clav in 2 divided doses PCN allergy: Cefdinir 14 mg/kg/day in 1 or 2 doses Cefuroxime Cefpodoxime Ceftriaxone 50 mg IM for 1-3 days
989
AOM tx after abx failure after 48-72 h
Amox clav 90 mg/kg/d amox w/ 6.4 mg/kg/d of clav in 2 divided doses Ceftriaxone 50 mg IM daily x 3 days **PCN allergy:** Ceftriaxone 50 mg IM daily x 3 days Clindamycin 30-40 mg/kg/d in 3 divided doses w/ or w/o 3rd gen ceph Consider tympanocentesis, referral to specialist
990
PCN allergy and cephalosporins
Avoid 1st generation and older 2nd generation cephalosporins minimal risk for reaction 1% cross-allergy risk Note: ceftriaxone has stronger strep pneumo coverage than other cephalosporins
991
OME
fluid in middle ear w/o infection formerly known as serous otitis Watchful waiting in majority 75-90% will resolve within 3 months w/o specific tx Consider audiologic eval if OME persists for at least 3 months, if concerns for hearing, speech, or language Tympanostomy and/or adenoidectomy reduced time w/ OME and improved hearing in short term but were associated w/ expected risk Persistent OME is the most common cause of TEMPORARY speech delay in early childhood
992
Mild Dehydration
3-5% Normal BP, pulse quality, HR, turgor, fontanels, eyes (tears present), cap refill ( Slightly dry lips thick saliva Slighly decrease urine output normal thirst to slightly increaseed
993
Moderate dehydration
6-9% Normal BP Normal to slightly decreaed pulse quality Normal to increased HR Turgor recoil Slightly depressed fontanels Dry lips and oral mucosa Slighly sunken eyes, decreased tears Delayed cap refill (1.5-3 seconds) Normal to fatigued/restless/irritable mental status Decreased urine output Moderately increased thirst
994
Severe dehydration
\> 10% Normal to reduced BP Moderately decreased pulse quality Increased HR (sometimes brady) Recoil \> 2 seconds/tenting turgor Depressed fontanels Very dry lips, oral mucosa Deeply sunken eyes, tears absent Delayed cap refill \> 3 seconds Apathetic, lethargic, unconscious Minimal urine output Very thirsty to too lethargic to assess
995
Rehydration tx minimal dehydration
Rehydration tx N/A sips of fluid frequently as tolerated to maintain circulating volume/hydration status **Replacement for ongoing losses:** \> 10 kg: 120-240 ml for each loss
996
Rehydration tx for mild to moderate dehydration
Rehydration Tx: ORT w/ ORS 50-100 mL/kg over 3-4 hours best tolerated in frequent, small volumes supply in office to demonstrate ability tolerate oral tx **Replacement for ongoing losses:** \> 10 kg: 120-240 ml for each loss
997
Rehydration Tx and vomiting
Consider premedication w/ 5-HT3 antagonist such as Ondansetron to minimize risk of further upper GI fluid loss
998
Rehydration Tx for severe dehydration
Lactated Ringers preferred over NS may use NS if LR not available Bolus 20 mL/kg until improvement then 100 mL/kg over 4 hours **Replacement for ongoing losses:** \> 10 kg: 120-240 ml for each loss If unable to drink, give through NG tube or give D5W1/4 NS w/ K+ 20 meq + IV
999
Febrile neonate
Tx w/ empiric parenteral abx admit to hospital for neonatal sepsis eval
1000
Sepsis work up
CBC w/ diff, blood culture, U/A and C&S via transurethral cath or suprapubic tap As indicated: LP for CSF analysis and culture, CXR, stool culture, fecal WBC count Note: tachypnea: PNA until proven otherwise
1001
Empiric CAP Tx
Presumed bacterial: Amox 90 mg/kg/d in 2 doses Alternative: Amox-Clav Presumed atypical: Azithromycin 10 mg/kg on day 1, followed by 5 mg/kg/d day 2-5) Alternative: Clarithro (15mg/kg/d in 2 doses x 7-14 days) Erythromycin (40mg/kg/d in 4 doses)
1002
Empiric CAP Tx 5-17 years old
Amox 90 mg/kg/d in 2 divided doses, max 4g/d May add macrolide to beta-lactam abx if unsure if atypical or not Alternative: Amox clav Presumed atypical: Azithro 10 mg/kg/d on day 1, 5 mg/kg/d day 2-5 Azithro max of 500 mg day 1, 250 mg day 2-5 Alternative: Clarithro/Eryhtro. Doxy if \> 7 years old
1003
Tx Influenza PNA children 3 months to 17 years
Oseltamivir **5 years and older:** Oseltamivir Zanamivir if children 7 years old or older Peramivir IV Zanamivir availabe for compassionate use
1004
UTI tx age 2-24 months
Amox 20-40 mg/kg/d x 3 doses Bactrim 6-12 mg TMP, 30-60 mg SMX per kg in 2 doses Cefixime 8 mg/kg/d in 2 doses Cefpodoxime 10 mg/kg/d in 2 doses Cefprozil 30 mg/kg/d in 2 doses Cephalexin 50-100 mg/kg/d in 4 doses Loracarbef 15-30 mg/kg/d in 2 doses
1005
Uncomplicated viral URI vs ABRS s/sx
Uncomplicated viral URI: nasal sx and/or cough, nasal discharge progresses from clear to purulent to w/o abx, usually within 10 days; Fever early in illness assoc. w/ constitional sx such as headaches, myalgias that resolve in 24-48 hours as the respiratory sx worsen When ABRS: (1 or more) Worsening URI course, such as double sickening (acute worsening of respiratory sx or new fever at day 6-7 of URI) Persistence of URI sx w/o improvement after 7-10 days, including nasal discharge, day time cough, bad breath, fatigue, headache, decreased appetite Acute onset of T: 102.2, purulent nasal discharge, ill appearance for 3-4 days
1006
ABRS tx in children
Acute URI w/ persistent illness or daytime cough \> 10 days w/o improvement: Abx or 3 days observation Worsening course, double sickening, severe onset fever, purulent nasal discharge \> 3 consecutive days: Abx tx Contrast CT of sinuses and/or MRI w/ contrast should be obtained if child is supected of having CNS or orbital complications Likely pathogens: S. Pneumo (30%) - decreased d/t pneumococcal vaccine Non-typeable H. influenzae (30%) M. Catarrhalis (10%) Sterile (no pathogen isolated, viral) 25% **Abx:** **Initital:** Amoxicillin 80-90 mg/kg/d w/ or w/o Clav **If no improvement or worse in 72 hours:** HD amox-clav **If initial tx HD amox-clav and no improvement in 72 hrs:** Clindamycin AND cefixime or Linezolid and cefixime or Levofloxacin
1007
Physiologic murmur
aka innocent/functional **Gr 1- 3/6 early to midsystolic murmur** heard best at **LSB** but usually audible over precordium **No radiation** beyond precordium Softens or **diseappears w/ STANDING** Increases in intentsity w/ activity, fever, anemia S1 S2 intact normal PMI Etiology: flows over aortic valve, heard in 80% of thin, healthy adults if examined in soundproof room Asymptomatic
1008
Aortic Stenosis
Gr 1-4/6 **systolic** murmur **crescendo-decrescendo** heard best at **2nd RICS, apex** softens w/ standing **radiates** to carotids may have diminished S2 slow-filling carotid pulse narrow pulse pressure Loud S4 heaving PMI later peak = greater stenosis In younger adults: congential bicuspid valve In older adults: calcific, rheumatic in nature **Ominous signs: dizziness, syncope = severe decreased CO**
1009
Aortic sclerosis
Gr 2-3/6 high **systolic** ejection murmur heard best at **2nd RICS** **Full carotid upstroke, not delayed** no S4 no symptoms **Benign** thickening and/or calcification of aortic valve leaflets No change in valve pressure gradient AKA: **"50 over 50" murmur** - foundin \> 50% of those over 50y
1010
Aortic regurgitation
Gr 1-3/4 **high-pitched blowing _diastolic_** murmur heard best at **3rd LICS** May be enhanced by forced expiration, leaning forward Usually w/ **S3** **Wide pulse pressure** Sustained thrusting apical pulse More common in MEN usually from rheumatic heart disease Occassionally d/t tertiary syphilis
1011
Mitral stenosis
Gr 1-3 **low-pitched late diastolic** murmur heard est at **apex**, localized short **crescendo-decrescendo** rumble like a bowling ball rolling down alley or distant thunder Often w/ opening snap, accentuated S1 in mitral area Enhanced by left lateral decubitus, squat, cough, immediately post Valsalva **Nearly all rheumatic** in origin Protracted latency period, then **gradual decrease in exercise tolerance** leading to rapid downhill course d/t **low CO** **AF common**
1012
Atrial septal defect (uncorrected)
Gr 1-3/6 **systolic ejection murmur** at the **pulmonic** area **Widely split S2**, right ventricular heave Typically w/o sx until middle age then present w/ **HF** Persisten ostium secundum in mid-septum Will resolve w/ ASD correction
1013
Pulmonary hypertension (PH)
**Narrow splitting S2** murmur of **tricuspid regurgitation** **Report of SOB** nearly universal Seen w/ **RVH**, as identified by ECG, echo Secondary PH might be consequence of Redux (fen-phen) use
1014
Mitral regurgitation
Gr 1-4 **high-pitched blowing systolic murmur** Often extending beyond S2 Sounds like long "haaa" "hooo" Heard best at **RLSB** **Radiates to axilla** Often **laterally displaced PMI** Decreased w/ standing, valsalva maneuver Increased by squate, hand grip Found in ischemic heart disease, endocarditis, RHD W/ RHD, often w/ other valve abnormalities such as AS, MS, AR
1015
Mitral Valve Prolapse
Gr 1-3/6 late **systolic** **crescendo** murmur **honking quality** heard best at **apex** **follows midsystolic click** click moves forward to earlier systole w/ Valsalva or standing, resulting in a longer-sounding murmur W/ hand grasp or squat, click moves back further into systole, resulting in shorter murmur Often seen w/ **minor thoracic deformities** (e.g. pectus excavatum, straight back, and shallow AP diameter. Chest pain somimes present but there is question at whether MVP is cause)
1016
Infective Endocarditis abx prophylaxis indication
Prosthetic cardiac valve of prosthetic material used for cardiac valve repair Previous IE Congenital heart disease Unrepaired cyanotic CHD including shunts/conduits Completed repaired heart defet w/ prosthetic material/device, during first 6 months after procedure Repaired CHD w/ residual defects at site or next to site of prosthetic pathc/device (which inhibit endotheliazation) Cardiac transplant
1017
Infective Endocarditis abx prophylaxis before respiratory tract or esophageal procedures
Give **30-60 minutes** before procedure **Adults:** Amox 2 g Ampicillin 2 g IM or IV Clindamycin 600 mg Cephalexin 2 g Azithro/Clarithro 500 mg Cefazolin or ceftriaxone 1 g IM/IV Clindamycin 600 mg IM/IV **Children:** Amox 50 mg/kg PO Ampicillin 50 mg/kg IM or IV Cefazolin or Ceftriaxone 50 mg/kg IM/IV Clindamycin 20 mg/kg Cephalexin 50 mg/kg Azithro/Clarithro 15 mg/kg Cefazolin or ceftriaxone 50 mg/kg IM or IV Clindamycin 20 mg/kg IM or IV
1018
Rheumatoid Arthritis Tx
**MANAGEMENT** Rheumatology referral PT/OT referral **Start DMARD therapy ASAP after dx** **Lab testing prior to therapy** CBC ESR CRP aminotransferase BUN Creatinine **NSAIDs until DMARD has taken effect** Example: Hydroxychloroquine (HCQ) 400 mg tablet, take 1 tablet orally with food or milk daily. Sulfasalazine (SSZ) enteric coated 500 mg tablets, take 1 tablet orally daily x 1 week, then 1 tablet twice a day for the second week, 2 tablets in the morning and 1 tablet at night for third week, then 2 tablets twice a day for the fourth week. **May use OTC Naproxen 500 mg orally twice a day until DMARD has taken effect. Discontinue as soon as possible.** HCQ commonly results in clinical improvement within 2-3 months, maximum effects may required up to 4-6 months. If anadequate response at 3 months, add an alterantive DMARD, usually MTX, or combine HCQ with other DMARDs such as SSZ and MTX. MTX dosing: 7.5 mg once weekly orally then adjust dose gradually not to exceed 20 mg once weekly. OR start at 10-15 mg once weekly, then go up by 5 mg every 2-4 weeks to a maximum to 30 mg once weekly. **Nonpharmacological tx/patient education:** Rest joint when inflamed but alternate rest periods w/ exercise to avoid loss of ROM/muscle atrophy Ensure adequate nutrition/dietary intake Stress reduction
1019
OA Tx
Nonpharm: exercise, weight loss, PT, orthoses, brace/splint, joint protection, moist superficial heat, psychosocial support **Pharm:** APAP PRN 650 every 4-6 hours do not exceed 3250 mg/day APAP 1000 mg every 6 hours do not exceed 3000 mg/day If inflammation/APAP inadequate: Try Naproxen first, if no effect after 2-4 weeks on max dose, try other NSAID Naproxen 500 to 1000 mg daily in 2 divided dose Etoricoxib 30-60 mg once daily Diclofenac Celecoxib Ibuprofen 400-800 mg 3-4x/day max 3.2g/day Obtain CBC, Bun, Creat and LFTs at least annually on pts on chronic NSAIDs May add Capsaicin as adjunct to NSAIDs Capsaicin patch - apply to affected area 3-4 x/day for 7 days, patch may remain in place for up to 8 hours
1020
Increased CVD risk d/t OA and NSAID use
Monitor BP Monitor for edema Encourage non-pharm measures Choose lowest effective dose Modulate antiHTN tx and diuretic tx as needed to maintain target BP/weight Change NSAIDs as needed to one w/ lower CV risk
1021
C5 nerve root
Biceps motor Biceps reflex Sensation lateral arm at/above elbow
1022
C6 nerve root
Thumb motor Brachioradialis reflex Sensation to forearm, thumb side
1023
C7 nerve root
Motor: 3rd finger Triceps reflex sensation to middle finger
1024
C8 nerve root
Motor: 4th finger Lateral sides of hand sensation
1025
T1 nerve root
Motor: 5th finger Sensation medial side of forearm
1026
Acute Gout tx
Acute: tx within 24 hours First line: NSAIDs Naproxen 500 mg BID or Indomethacin 50 mg TID x 5-7 days Avoid ASA - paradoxical effect on serum urate If cannot take NSAID: Colchicine 1.5 - 1.8 mg in 2-3 divided doses in first 24 hours then taper If cannot take NSAID/Colchicine: intraarticular corticosteroid injection If not candidate for joint injection, oral prednisone 30-50 mg until sx resolve then taper
1027
Prevention of Gout attack
Xanthine oxidase inhibitor (COI) tx w/ Allopurinol or febuxostat (Uloric) = first line urate-lowering tx Low-dose NSAID tx also appropraite for gout attack prophylaxis Serum urate should be lowered w/ target of Pegloticase (Krystexxa) is appropriate for pts w/ severe gout Pharmacological antiinflammatory prophylaxis is recommended for all gout pts when urate lowering tx is initiated, continue if clinical evidence of continuing gout disease and/or urate tarte has not yet been achieved
1028
AV banking
Ophthalmoscopic exam: vein is twisted on the distal side of the artery
1029
AV nicking
vein appears to stop abruptly on either side of artery
1030
normal eye AV ophthalmoscopic exam
vein appears to cross beneath artery
1031
AV tapering
vein appears to taper down either side of artery
1032
Argyll Robertsion pupil
pupils appear small and irregularly shaped accommodate but do NOT react to light
1033
CN III paralysis
dilated pupil fixed to light and near accommodation ptosis and lateral deviation of eye usually present
1034
Most important risk fx for cervical cancer
Persistent infection w/ high risk HPV subtypes 16 or 18
1035
Optimal position for rectal exam
lateral decubitus
1036
Bronchiectasis
Classic clinical presentation: cough and daily production of mucopurulent and tenacious sputum lasting months to years acquired disorder of major bronchi and brondhoiles Eval: CBC w/ diff, immunoglobulin quant, sputum culture, xray, PFTs Exacerbations caused usually by acute bacterial infections
1037
Insulin Tx DM2
**Step 1** Target fasting plasma glucose **FPG target: 70-130 mg/dL** HS basal insulin - start 10 units or 0.2 units/kg Increase dose 2 units every 3 days until FPG is 70-130 mg/dL Can increase by 4 units every 3 days if FPG \> 180 **Step 2** Target premeal glucose (1 target at a time) 70-130 mg/dL If pre-lunch \> 130, start 4 units bolus insulin before breakfast If pre-supper glucose \> 130, start 4 units bolus insulin before lunch OR add/increae morning NPH, detemir, glargine If bedtime glucose is above target (\>140), start 4 units bolus insulin before supper OR incrase evening NPH, detemir, or glargine \>\> **For all above** Increase bolus insulin by 2 units every 3 days Once insulin dose \> 10 units, egin to change insulin dose by 10-20% **Step 3** If A1C not at goal, target post-prandial glucose w/ bolus premeal insulin 2-hour post-prandial glucose target
1038
Jarisch-Herxheimer reaction
Occurs in 30% of pts tx for primary syphilis Occurs in 70% of pts tx for secondary syphilis within 24 hours of tx The Jarisch-Herxheimer reaction is an acute febrile reaction that usually occurs within the first 24 hours after any therapy for syphilis. The fever may be accompanied by headache, myalgias, rigors, sweating, hypotension, and the worsening of rash if initially present These symptoms often resolve without intervention within 12 to 24 hours
1039
West Nile Dx confirmative
CSF w/ IgM antibody for WNV WNV: viral infection causing febrile illness, rash, arthritis, myalgias, weakness, lymphadenopathy, meningoencephalitis
1040
DSM-IV Cognitive Dementia dx criterea
Multiple cognitive deficits, memory impairment one or more of the following: aphasia, apraxia, agnosia, disturbance of executive function
1041
Normal RBCs (in 1 mL of plasma)
M: 37-49% F: 36-46%
1042
Diverticulitis imaging
Abd CT w/ oral and IV contrast Identifies bowel wall thickening, complications such as fistulas and abscesses
1043
Cystic Fibrosis
Cough, maldigestion, excessive NaCl excretion in sweat and saliva Most common genetic disorder of the white population
1044
Causes of chronic pelvic pain
leiomyomas endometriosis malignancy of uterus, ovary, or colon adhesions interstitial cystitis
1045
PCV is not given after what age
7 years
1046
Tachyphylaxis
Progressive loss of effectiveness To minimize in steroid tx of eczema, use for 10 days then allow for 4 treatment free days
1047
Nateglinidie
Brand: Starlix Meglitinide analog short-acting oral antidiabetic stimulates insulin release glucose dependent quick onset but should not be taken if meal is skipped
1048
Molluscum contagiosum
Lesions usually subside w/o tx 6-9 months refer to derm if multiple lesions are unresponsive to tx
1049
Bulimia and Buproprion
should NOT be used for pts w/ bulimia can induce further binging or seizures in pts w/ bulimia (Wellbutrin)
1050
Varicella and analgesia
APAP best choice Avoid ASA in children w/ viral illness d/t Reye syndrome Avoid Ibupofen in varicella d/t risk of necrotizing fasciitis
1051
Whipples triad
low plasma glucose parasympathetic and sympathetic symptoms Relief w/ ingestion of carbohydrates
1052
Colchicine and interactions B12 Iron
Colchicine interacts w/ B12 by decreasing absorption Does not interact w/ iron therapy
1053
Iron therapy drug interactions common drugs
Antacids Caffeine Fluoroquinolones Tetracyclines some antihypertensives thyroid hormones histamine-2 receptor antangonists
1054
Impetigo pregnant woman tx
Penicillin VK Erythromycin
1055
Azithromycin side effects
nervousness, insomnia, decreased sense of smell and taste, ringing in the ears mild skin rash - if rash spreads or turns purple, immediate medical attention should be sought
1056
Gold standard for endometriosis dx
Laparoscopy
1057
T system breast ca T0 T1 T2 T3
T0 = no evidence of primary tumor T1 = Tumor 2 cm or less in greatest dimension T2 = Tumor \> 2 cm but no more than 5 cm in greatest dimension T3 - Tumor \> 5 cm in greatest dimension
1058
Tine unguium
Fungal nail infection
1059
Hidradenitis suppurativa
Bacterial infection of the sebaceous glands of the acilla by Gram + S. aureaus Marked by flare ups and resolution
1060
Bariatric sx teaching
Average weight loss from gastric band: 40-60% of body weight About 80% of pts lose a great deal of weight w/o major complications and maintain loss long-term Expected weight loss form gastric bypass: 70-80% of excess body weight
1061
Angle closure glaucoma sx
halos around light unilateral ocular pain blurred vision lacrimation photophobia frontal ipsilateral h/a N&V
1062
H. pylori when to test Alarm sx Test of choice
Only if clinician plans to offer tx for positive results pts w/ gastric MALT lymphoma, active peptic ulcer disease, OR past hx of documented peptic ulcer test and treat stratedgy effective for pts under age 55 w/ uninvestigated dyspepsia w/o alarm features Alarm features: bleeding, anemia, early satiety, unexplained weight loss, progressive dysphagia, odynophagia recurrent vomiting, family hx of GI ca, previous esophagogastric malignancy **Test of choice:** **Test for active infection w/ stool antigen or urea breath test** Serology has low value as it cannot differentiate between past or current infection **Endoscopy bx** For pts who are undergoing dx endoscopy and are found to have an ulcer and those who require endoscopy to follow up a gastric ulcer, or for dx/f/u of suspected MALT lymphoma - biopsy urease testing in pts not taking abx or PPIs (if taking, will interfere w/ test) **RE-TEST** Recommended to confirm eradication at least four weeks after treatment w/ stool and/or breath test
1063
MRSA tx skin/soft tissue infection
**Clindamycin** FDA approved to treat serious infections d/t S. aureus C-diff associated, uncommon, but more so than other agents **Tetracyclines** Doxy/Mino FDA-approved for staph Not recommended during pregnancy Not recommneded for children Unknown activity against A. strep **TMP/SMX** Not FDA-approved to treat any staph infection May not provided coverage for A strep (common cause of cellulitis) Not recommended for women in third trimester of pregnancy Not recommended for infants **Rifampin** Use only in combo w/ other agents Drug-drug interactions common **Linezolid** Consult w/ an ID FDA-approved for complicated skin infections including MRSA Assoc. w/ myelosuppresion, neuropathy, lactic acidosis w/ prolonged tx **IMPORTANT** MRSA is resistant to all currently available beta-lactams (PCN, ceph) Fluroquinolones (cipro, levo) and macrolides (erythro, clarithro, azithro) are not optima flr tx of MRSA SSTI d/t resistance
1064
H. Pylori Abx Tx
**No PCN allergy w/o hx of macrolide tx:** Standard dose PPI + Clarithro 500mg BID + Amox 1000 mg BID x 10-14d **PCN allergy w/o hx of macrolide tx or unable to tolerate bismuth quadruple tx:** Standard dose PPI + Clarithro 500mg BID + Metronidazole 500 mg BID x 10-14d **PCN allergy quad tx:** Bismuth subsalicylate 525 mg QID, Metronidazole 250 mg QID, Tetracycline 500 mg QID, Ranitidine 150 mg BID (or standard dose PPI QD-BID) x 10-14d **PPI examples:** Omeprazole 20 mg BID, Lanzoprazole 30 mg BID
1065
Hemangioma Clinical presentation
Benign tumor of endothelium, local proliferative process Perhaps genetic mutation of epithelial regulation Often not present at birth, rapid growth from first days of life to 6 months, slows down 6-12 months Involution phase from 12 months to age 3-6 years 1/3 present at birth as light port wine stain
1066
Hemangioma tx
Active nonintervention for uncomplicated hemangiomas that are not disfiguring: regular monitoring and attention to psychosocial effects Intervention for lesions at increased risk for complications, scarring, disfigurement Periorbital - refer to opththalmology, **oral propranolol 0.5 - 1mg/kg/day then gradually increase to target 2mg/kg/day** Refer to pediatric derm, vascular anomalies team etc. if tx **Oral propranolol** in addition to meticulous wound care and appropriate analgesia for the tx of ulcerate hemangiomas that may cause permanent disfigurement, interfere w/ daily activities, or do not response to wound care measures Uncommonly used tx: vincristine, interferon alpha, injected corticosteroids, laser therapy
1067
Port wine lesion clinical presentation patho
disorder of dermal capillaries and post capillary venules Occassionally assoc w/ other congenital or genetic syndromes (Sturge-Weber, or AV malformation syndrome) Present at birth BLANCHABLE from red/dark pink, grows proportionally w/ child Will darken and often become nodular as child grows, will not regress Lesions onf ace tend to follow branches of trigeminal nerve
1068
Port Wine Lesion Tx
Pulse dye laser therapy - standard, lightens lesion byt does not remove Referrals: Ophthalmology if eyelids involved d/t association w/ glaucoma Neurology if facial lesions assoc. w/ seizures
1069
Mongolian spot
Diffuse melanocytes within dermis, d/t interrupted movement during fetal development Non-tender, blue-black-gray macular, usually lower back and buttocks **Mgmt** Lighten over time and often disappear during childhood No tx required No malignancy potential
1070
Milia
Retention of keratin and sebaceous material Raised white bumps, mainly on nose and cheeks **Mgmt:** No tx Resolve spontaneously within a few weeks Parent/caregiver eassurance most important intervention Do not pick at lesions as may cause scarring
1071
Erythema Toxicum Neonatorum
Unknown etiology, thought to be immaturity of pilosebaceous glands Occassionally present at birth, usually appears within first 48 hours and resolves by day 5-7 Erythematous papules that progress to pustular **Mgmt:** Observation, no tx necessary Resolves spontaneously, reassure parents 30-70% of infants will experience these lesions
1072
Atopic Dermatitis Patho Presentation
Impaired epidermal layer, w/ impaired barrier allowing irritants into dermis Decreased water content d/t poor barriers Itch-scratch cycle worsend condition Believed to have genetic component 11% of children in the US - 60% first year of life - 85% by age 5 - 40% resolves by early adulthood Birth to 2 years: Red, crusty, extensor, face, scalp 2-12 years: Lichenification of flexure surfaces \> 12 years: similar to child but common on hands and feet
1073
Atopic Dermatitis Mgmt
3 prongs: Eliminate triggers Hydrate - thick creams/ointments. Avoid lotions Control itch - sedating antihistamines, topical corticosteroids to control flares
1074
Acne neonatorum
Results from stimulation of sebaceous glands by maternal/infant adrogens Present: face, forehead, nose, cheeks Acneiform lesions starting in the first month of life, usually lasts 1-2 months Affects 20% of infants **Mgmt:** Self-resolving Advise pts/caregive not to pick at lesions Benzoyl peroxide 2.5% applied to region once a day is acceptable
1075
Infant dyschezia
Ineffective defection, manifested by straining in the absence of constipation Funtional disorder defined as at least 10 minutes of straining/crying before successful passage of soft stool in an otherwise healthy infant Can occur up to 9 months of age Resolves spontaneously as infant matures Reassure parents
1076
Seborrheic dermatitis
Usually in areas of dense sebaceous glands (scalp, face, groin, underarms) Thought to be overstimulation of sebum production Possibly lipid-dependent yeast Erythematous plaque, appears greasy w/ yellow scales Commonly seen in infants but can be present through life **Mgmt:** Apply emollient (petrolatum, vegetable/mineral oil) overnight, then remove plaque w/ soft brush For other parts of nody: Ketoconazole 2% cream once daily x 1 week or low-dose hydrocortisone 1% daily x 1 week
1077
Keratosis Pilaris
Genetic disorder resulting in hyperkeratinization of hair follicles Rough skin texture, gooseflesh appearance/chicken skin Usually asymptomatic, occassional pruritus Worst w/ cold, dry weather **Mgmt** No cure/universally effective tx available Regular skin care regimen w/ lotions and creams can lead to improvement Use mild soap/cleansers, lubricate w/ moisturizer Lactic acid lotions, salicylic acid, alpha-hydroxy acid lotion, topical steroid, retinoid acid
1078
Low cardiac output sx
Dyspnea HF sx Syncope Note: when syncope is d/t cardiac, it it d/t bradycardia and/or obstruction
1079
ACS sx women
**95% reported sx weeks prior to event:** **Unusual fatigue (70%)**, sleep disturbance (48%), SOB (42%) Indigestion (39%), Anxiety (35%) **Sx of women during ACS:** SOB (58%) Weakness (55%) Unusualy fatigue (43%) Dipahoresis (39%) Dizziness (39%) Chest pain/pressure (30%) No chest discomfort (43%)
1080
ACS in elder
Clinical presentation =\> 75 years: Dyspnea, Neurological sx (syncope, weakness, acute confusion), Chest pain/prssure Be liberal in the EKG in the elder
1081
S1 and S2 valves and systole/diastole
**S1** Beginning of systole Closure of MITRAL and TRICUSPID **_LUB_**-dub **S2** End of systole Closure of AORTIC and PULMONIC lub-**_DUB_** **"MTAP"** Both heard best w/ diaphragm
1082
Physiologic split S2
Benign, document, no f/u needed Widening of normal interval between aortic and pulmonic valves Caused by delay of pulmonic component Heard best pulmonic region Split INcreases on patient INspiration Found in the majority of adults
1083
Only congenital heart defect found in more females than males F \> M
Atrial Septal Defect
1084
Pathologic Split S2
Fixed split, no change w/ inspiration Paradoxical split - narrows or closes w/ inspiration Heard best in pulmonic region Fixed split often found in uncorrected septal defect Paradoxical split often found in conditions that delay aortic closure such as LBBB Resolve w/ tx of underlying condition
1085
Pathologic S3
Marker of ventricular overload and/or systolic dysfunction Heard best in early diastole, can sound like it is "hooked on" to the back of S2 LOW pitch, best heard w/ bell For dx of HF, correlated w/ sx such as dyspnea, tachycardia, crackles Can resolve w/ tx of underlying condition May not be heard if pt is euvolemic
1086
Pathologic S4
Marker of poor diastolic function, most often found in poorly controlled HTN or recurrent MI Heard late in diastole, sounds like it is "hooked on" to front of S1 Sometimes called a "pre-sysolic" sound Soft, low-pitch but higher pitch than S3 Best heared w/ BELL of steth Can resolve w/ tx of underlying condition
1087
Grading of heart murmurs
I - very faint, may not be auscultated unless thin chest wall and ideal circumstances - typically no clinical consequence II - Quiet but immediatley heard III - Moderately loud w/o thrill - as loud as S1 and S2 IV - Loud w/ thrill V - Very loud w/ Thrill VI - Audible w/o stethoscope
1088
Murmur character and example
**Harsh** - heard well w/ both bell/diaphragm, aortic stenosis **Rumble** - LOW, heard best w/ bell, mitral stenosis **Blowing** - HIGH, heard best/ diaphragm, aortic regurgitation **Musical** - vibratory quality - Still murmur
1089
Systolic murmurs Benign s/sx
Likely benign **Consider benign if all noted:** Negative hx Lower grade (Grade III or lower) No radiation S1 S2 intact No heave/thrill PMI WNL Softens or disappears w/ supine to stand
1090
Systolic murmur Pathologic s/sx
Consider pathologic (order echocardiogram) until proven otherwise if =\> 1 of the following present: Abnormal Hx Higher grade \> Grade III Radiation S1 S2 obliterated w/ Thrill or heave PMI displaced Increases w/ intensity w/ supine to stand
1091
Radiating murmur vs Carotid artery bruit
Carotid bruit: usually softer, often unilateral, differtn sound than that of chest Radiating murmur: louder, bilateral, same sound and timing as found in chest
1092
Cardiac Arrest
**CVD 56%** - hypertrophic cardiomyopathy most commonly implicated, 1/3 of all deaths **Blunt trauma causing structural changes to heart 22% -** eg. cardiac concusion, likely induces VF, baseball, basketball most commonly associated **Commotio cordis 4% -** likkely underreported, a chest blow that interrupts cardiac rhythm WITHOUT visible cardiac injury **Heat stroke 2%** - likely d/t HYPERKALEMIA induced by extensive tissue damage
1093
How many weeks Uterus grapefruit size/softball size
12 weeks
1094
Risk fx for Gastric Ulcer
NSAID Corticosteroid use Cigarette smoking
1095
Aortic Regurgitation
High pitched Diastolic murmur heard best at R side of sternum 2nd ICS
1096
Normal serum creatinine
FEMALES: 0.6 - 1.1 MALES: 0.7 - 1.3
1097
Latex allergy cross reaction w/ what fruits
Kiwi Bananas Avocadoes
1098
Pregabalin
Lyrica FDA approved for pain reduction in fibromyalgia
1099
Tx goals endometriosis
Pain relief Controlling endometrial patch growth Preserving fertility Tx options: Hormonal contraception, Provera tabs PO, NSAIDs
1100
Blepharitis
Inflammation of the eyelids **Mgmt:** Good lid hygiene mainstay Warm compresses Lid massage Lid washing - very dilute baby shampoo Avoid vigorous washing Topical azithromycin 1% ophthalmic up to 4x/a day x 4 weeks an option to minimize bacterial overgrowth, may relieve s/sx. Ointment can blur vision after application Oral abx in severe cases - tetracyclines, azithro Doxy 100 mg daily x 2-4 weeks Z-pak
1101
PID complications
Infertility in 10-30% of pts after first episode of PID Increased risk of ectopic pregnancy d/t scarred fallopian tubes Fitz-Hugh-Curtis syndrome occurs in 5-30% of cases of pelvic infection (perihepatitis - severe RUQ abd pain pleuritic, might refer to right shoulder)
1102
Lipid abnormalities in chornic renal insufficiency
Elevated total cholesterol and TG
1103
Lipid abnormality in chronic inactivity
Low HDL
1104
Lipid abnormality w/ ETOH abuse
Elevated TG Elevated HDL Elevated LDL
1105
Lipid abnormality in untreated/undertreated hypothyroidism
Elevated total cholesterol Elevated TG Elevated LDL
1106
Rheumatic fever
Inflammatory disease that is most common cause of ACQUIRED heart diseae in children Usually affects aortic and mitral valves Associated w/ strep infection Collagen disease that injures heart, blood vessels, joints, and subcutaneous tissue
1107
Eating disorder s/sx
Orthostatic hypotension Yellowing of skin Brittle nails Pruritus Halitosis Decreased temp Bradycardia Arrhythmia
1108
PCOS tx
Spironolactone to decrease/control hirsutism Low-dose OCP to suppress ovaries Provera tablets to induce menses Glucophage to induce ovulation if pregnancy desired
1109
Diverticulitis s/sx
LLQ pain after eating Depressed owel sounds (increased if obstruction) Tender, firm, palpable mass in left iliac fossa tender rectum hemorrhoids
1110
S4 conditions
Most frequent observed in patients w/ decreased left ventricular distensibility Common in hypertensive heart disease, aortic stenosis, hypertrophic cardiomyopathy LVH - present in all these conditions
1111
S3 conditions
Occurs in high-output states such as thyrotoxicosis or pregnancy Almost always present in patients w/ hemodynamically significant chronic mitral regurgitation S3 gallop - important and early finding of HF assoc w/ dilated cardiomyopathy and may also be heard in pts w/ diastolic HF (S3 being heard in systolic HF more common)
1112
Bromocriptine pharm class
Dopamine agonist used in PD
1113
Glaucoma susceptibility risk fx
Corticosteroid tx Eye inflammation/trauma Neoplasm Neovascularization Increasing age
1114
Herbal/nutritional therapies for prostatic disease
Rye Palmetto Pumpkin pending further studies considered emerging tx by the AUA
1115
Paroxysmal stage pertussis
lingering cold Nasal sx are usually resolved Cough worsens because pathogen attached to respiratory cilia and produced toxins that paralyze cilia and induce inflammation of respiratory tract
1116
Hearing loss decibels
Mild hearing loss: 26-40 dB Moderate hearing loss: 41-55 dB Profound hearing loss: \> 91 dB
1117
Uterine fibroids dx imaging
Hysterosonogram Procedure - uterus is filled w/ saline and transvaginal pelvic U/S is performed
1118
Cholelithiasis risk fx
female gender Obesity HL rapid weight loss (e.g. in bariatric sx) age \> 50 years pregnancy genetic fx diet w/ high glycemic index
1119
corticosteroid tx of Osgood Schlatter?
**Do not use in OS** May weaken quadriceps tendon May produce cutaneous thinnking May produce depigmentation
1120
Preeclampsia Define
Disease of widespread vascular endothelial malfunction and vasospasm that develops after 20th week of pregnancy up to 4-6 weeks postpartum
1121
Preeclampsia Risk Fx
Age \> 40 First pregnancy Pregestational DM High BMI Primary HTN Renal Disease Family Hx Multiple gestation African ancestry Emerging risk fx: Vit D Def, Maternal periodontal disease
1122
Preeclampsia Clinical Presentation
Elevated **BP \> 140/90** or w/ preexisting HTN, if **SBP increased by 30 mmHg or DBP by 15mmHg** Must be on successive measurements 4-6 hours apart _within 1 week_ Proteinuria **\> 300 mg/24 h or 1+ on 2 random urines** at least 6 hours apart _within 1 week_ Sudden increase in edema or onset of facial **edema** suggestive of preeclampsia but not required for dx
1123
Preeclampasia Tx
Prompt recognition Rest Maternal and fetal monitoring Anti-HTN meds w/ \> 160/110 (either) Anticonvulsant meds including Mg Birth
1124
When is birth Tx for Preeclampsia
**Mom:** GA 37 weeks or \> Uncontrollable BP Platelet count Suspected abruption, ruptured membrane Pulmonary edema SOB or CP w/ O2 sat \> 94% on RA Deteriorating hepatic/renal function Persistent h/a, vision change, epigastric pain, N&V **Baby:** Severe growth restriction Non-reassurign fetal test results Oligohydramnios
1125
1-6 months language milestone
Coos in response to voice
1126
6-9 months language milestone
Babbles
1127
10-11 months language milestone
Imitates sounds, nonspecific mama, papa
1128
12 months language milestone
Specific mama, papa, 2-3 syllable words imitated
1129
13-15 months language milestone
4-7 words, jargon,
1130
16-18 months language milestone
Extensive jargon, 20-25% of speech understood by strangers
1131
19-21 months language milestone
20 words, 50% speech understood by strangers
1132
22-24 months language milestone
\> 50 words, 2-word phrases, less jargon, 60-70% of speech understood by strangers
1133
2-2.5 years language milestone
400 or \> words 2-3 word phrases, uses pronouns 75% speech understood by strangers
1134
3-4 years language milestone
3-6 word sentences asks questions, tells stories Nearly all speech understood by strangers
1135
4-5 years language milestone
6-8 word sentences Names 4 colors Counts 10 objects correctly
1136
Newborn Developmental Milestones
Moves all extremities Reacts to sound by blinking/turning Well-developed sense of **smell** Preference for **higher pitched voices** Reflexes: tonic neck, palmar grasp, babinski, rooting, suck Able to be calmed by feeding, cuddling Responds to cries of other neonates Reinforces presence of developmental tasks seen in exam room
1137
1-2 months developmental milestones
**Lifts head** Hold head erect **Follows objects through visual field** Moro reflex fading **Spontaneous smile** Recognizes parents
1138
3-5 months developmental milestones
**Reaches for objects** Brings objects ot mouth Raspberry sounds Sits w/ support Rolls back to sdie **Laughs** Recognizes food by sight
1139
6-8 months developmental milestones
**Sits briefly w/o support** Scoops small object w/ rake grip, some thumb use **Hand to hand transfer** Recognizes "no"
1140
9-11 months developmental milestones
Stands alone **Imitates peek-a-boo** Picks up small object w/ thumb and index finger **Cruises** Follows simple commands such as "Come here"
1141
12-15 months developmental milestones
**Walks solo** Neat pincher grasp Place cube in cup **Tower of 2 bricks** **Scribbles** spontaneously Indicates wants by pointing Hands over objects on request
1142
15-20 months developmental milestones
**Points to several body parts** Uses spoon w/ little spilling **Walks up and down steps** w/ help Understands 2-step commands Feeds self Seats self in chair Carries and hugs doll
1143
24 months developmental milestones
**Kicks ball upon request** **Jumps w/ both feet** Developing handedness Copies vertical and horizontal line Washes and dries hands **Parallel play**
1144
30 months developmental milestones
Walks backwards **Hops on one foot** Copies **circle** **Gives first and last name**
1145
36 months developmental milestone
Holds crayons w/ fingers **Walks down stairs w/ alternating steps** Rides **tricycle** Copies circles Dresses w/ supervision
1146
3-4 years developmental milestone
Responds to command to place object in, on, or under table Draws circle when one is shown Takes off jacket and shoes Washes and dries face **Cooperative play** Knows gender
1147
4-5 years developmental milestone
Runs and turns w/ balance Stands on 1 foot for at least 10 sec Counts to 4 **Draws person w/o torso** **Copies +** by imitation **Buttons clothes** Dresses self except tying shoes Can play w/o adult input for about 30 min Verbalizes activities to do when cold, hungry, tired
1148
5-6 years developmental milestones
**Catches ball** Knows age Knows right/left hand **draws person w/ 6-8 body parts including torso** Able to complete simple chores sense of gender **identifies best friend** Likes teacher
1149
6-7 years developmental milestone
**copies triangle** draws person w/ at least 12 parts **Prints name** reads multiple single syllable words counts to 30 or beyond **Ties shoes laces** generally plays well w/ peers no significant behavioral problems in school Names intended career
1150
7-8 years developmental milestone
**copies a diamond** **Able to read simple sentences** Draws a person w/ at least 16 parts Ties shoes Knows day of the week
1151
8-9 years developmental milestone
able to add, subtact, borrow, carry Understands concept of working as a team able to give response to question such as what to do if an object is accidentally broken
1152
Plumbism
Lead poisoning
1153
Plumbism most common source
Lead-based paint, found in majority of homes built before 1957 if not deleaded Banned since 1978 - lead paint use Risk increases if lead-based painted home is undergoing renovation
1154
Plumbism greatest risk group
Young child living in/frequently visiting a home w/ lead-based paint/built before 1957, undergoing renovation Less common is a young child w/ an adult whose hobby/work involves lead exposure or who lives near industrial area where lead release is likely
1155
Plumbism greatest risk age
2-3 years if lead-based paint is source all children 6 years and All ages at risk for non-paint source Plumbism from pain source uncommon in \> 4 years unless developmental disability or pica present Additional household Pb sources: unregulated toys, inexpensive jewelry
1156
Lead risk products/sources aside from paint folk remedies
Folk remedies (up to 30%) Great and Azarcon (aka alarcon, coral, luiga, maria luisa, rueda) are traditional remedies used in Latino communities to tx upset stomach. Fine orange powders w/ lead content as high as 90% Ghasard, Indian folk remedy used as tonic Ba-baw-san Chinese folk remedy used to tx colic Candies produced in Mexico may contain lead Lead-based products used in stained glass and bullet making
1157
Lead poisoning prevention
focus on child 6 years and Test at risk housing for lead-based paint If de-leading is moving not an option: keep child away from peeling paint or chewable surfaces, create barriers between living/play areas and lead sources, regularly wash children's hands and toys to remove paint dust, regularly wet-mop floors and wet-wipe window components to keep paint dust contained, prevent children from playing in bare soil, if possible provide sandboxes, soil around foundation of a building painted w/ lead based pain often contains high levels of lead
1158
Clinical presentation of lead poisoning
Few manifestations, if any Environmental hx is critical to identify children at risk Severe: anorexia, constipation, recurrent abd pain
1159
Plumbism tx
First line: remove Pb hazard Chelation tx for higher levels - mainstay for blood levels \> 45 ug/dL Expert in mgmt of lead chemotherapy should be consulted prior to use of chelation agents **Tx per blood level:** If 10-14 - Repeat and confirm within 1 month, avoid exposure, repeat testing in 3 months 15-19 - Repeat and confirm within 1 month, avoid exposure, repeat testing in 2 months 20-44 - Repeat to confirm within 1 week, aggressive hazard mgmt, environmental assessment by local health dept, intervention to reduce exposure **45-69 - Repeat to confirm within 2 days,** aggressive environmental intervention to reduce exposure, _chelation tx_ **\>69 - Medical emergency, r**epeat testing immediately to confirm, begin chelation tx, hospitalize patient, w/ care by experts in plumbism
1160
alterations in growth children
**BMI - age and gender specific** Overweight \> 95th percentile Risk of overweight 85-95th percentile Underweight **Indicators of nutritional status:** HC for age 95th percetile HC reflects brain size, often used to screen for potential developmental problems from birth to 24 months **Length or short stature for age** consider familial short stature Stunted growth d/t long-term malnutrition, delayed maturation, chronic illness, genetic disorder **Underweight for length** Recent or chronic malnutrition, dehydration, genetic disorder
1161
IUGR definition
Fetal weight less than 10th percentile for GA Typical initial finding: uterine size less than anticipated for GA
1162
SGA definition Small for gestational age
Infant weight
1163
What problems can occur at birth w/ IUGR?
Low Apgar Meconium aspiration Hypoglycemia Poor body temp regulation Polycythemia Intrauterine asphyxia
1164
Maternal fx contributing to IUGR
Any condition that can lead to decreased uterine and placental blood flow: stress, HTN, smoking, use of vasoconstrictors such as cocaine, meth, advanced DM w/ vascular disease, kidney disease Any condition that can lead to decreased oxygen carrying capability: poorly controlled asthma or other pulmonary disease, smoking, profound anemia, heart disease Other fx: insufficient prenatal, malnutrition of poor weight gain, chronic infection, placenta previa
1165
Infant fx contributing to IUGR
Chromosomal defects Multiparity
1166
Tx - IUGR
Confirm condition Continue to monitor w/ serial U/S and appropriate testing of fetal well-being (kick count, non-stress test, biophysical profile
1167
Macrosomia definition
Birth weight \> 90th percentile for GA after correcting for neonatal sex and ethnicity Typical initial finding - uterine size \> anticipated GA though of limited accuracy U/S eval positive predictive value of 30-44%
1168
What problems might occur at birth w/ macrosomic infant?
Most commonly: shoulder dystocia Perinatal asphyxia Respiratory distress syndrome In cases of poorly controlled maternal DM, additional fetal or neonal risks (e.g. hypoglycemia)
1169
Maternal fx contributing to macrosomia
Maternal DM w/ poor glycemic control Glucose intolerance Excessive maternal prepregnancy weight/stature Excessive weight gain during pregnancy Previous hx of macrosomic infant Postdate gestation
1170
Infant fx contributing to macrosomia
Multiparity Male fetus
1171
What monitoring or intervention is recommended for infant w/ macrosomia
Tight glycemic control Elective caesarean delivery (not supported in literture, though possibly indicated if fetal weight \> 4,500 g, hx of cesarean delivery and/or shoulder distocia)
1172
Age related changes % water percentage body
60% at age 20-30 to 53% at age 60-80
1173
Lean body mass reduction at age 60-80
=\>20% reduction
1174
Age related changes at age 60-80 Serum albumin Body fat % Kidney weight hepatic blood flow
Increased body fat 38-45% in women 36-38% in men Decreased serum albumin (avg 3.8g/dL from 4.7g/dL avg at 20-30y) 80% of relative kidney weight 55-60% relative hepatic blood flow
1175
Caffeine pharmacokinetics
Half life of 1.5 to 9 hours Cmax 15-100 min Minimum first pass effect CYP450 1A2 substrate - CYP450 isoenzyme levels can drop by up to 30% in elders by age 70 - CYP450 1A2 activity influence by estrogen in women
1176
Anticholinergics in Elderly
Avoid drugs w/ systemic anticholinergic effect Risk of confusion, urinary retention, constipation, visual disturbance, hypotension If unavoidable, choose product w/ least amount of this effect
1177
Medications w/ significant anticholinergic effects Examples
1st generation antihistamines (Chlorpherniramine, Diphenhydramine, Hydoxizine, Cyproheptadine, Promethazine) - clearance reduced w/ advanced age, tolerance develops if these products are used as a hypnotic Doxepin (Sinequan, Silenor) - sleep aid - avoid in elderly
1178
OAB drugs and anticholinergic effect in elderly
Desired effect for OAB Oxybutynin (Ditropan) - sustained release better tolerated w/ similar therapeutic efficacy
1179
TCAs in elderly Amitriptyline vs nortriptyline
Amitriptyline is prodrug of nortriptyline Nortriptyline is a metabolite of Amitriptyline **Nortriptyline has 50% less anticholinergic effect**
1180
Anticholinergic effect summary
Dry as a bone (dry mouth) Red as a beet (flushing) Mad as a hatter (confusion) Hot as a hare (hyperthermia) Can't see (vision changes) Can't pee (urinary retention) Can't spit (dry mouth) Can't shit (constipation)
1181
Antiarrhythmic drugs in Elderly
**Avoid** as first line tx of A-Fib **Rate control yields better balance** of benefits and harms than rhythm control in older adults **Amiodarone** is assoc. w/ multiple toxicities including thyroid dx, pulmonary disorders, and QT prolongation Irreversible pulmonary fibrosis long QT = sudden cardiac death risk V-Fib, V-Tach
1182
Topical vaginal cream in elderly
Topical low-dose intravaginal estrogen acceptable to tx dyspareunia, lower UTI, vaginal sx in elderly Typically do not tx asymptomatic bacteriuria in elderly low estrogen dose okay to use w/o progestin opposition in elderly
1183
ASA in elderly for cardiac events prevention
Lack of evidence of benefit vs risk at age 80 or \> Use w/ caution
1184
Dabigatran (Pradaxa) in Elderly
Greater risk of bleeding than w/ Warfarin in adults 75 years and \> Lack of evidence for efficacy and safety in pts with Cr Cl \> 30 mL/min (0.5 mL/s)
1185
A1C goal in elderly, frail, or life expectancy 5 years or
1186
Dietary supplements in elderly rate
50% rate of use Increase over time and w/ advancing age e.g. Ginkgo, ginseng, garlic - the 3 Gs w/ antiplatelet effect, problematic w/ prescription antiplatelet meds
1187
Most commonly used herbal product w/ antiplatelet effect
Ginkgo biloba Garlic Ginseng 3 G's
1188
St. John's Wort Pharmacodynamics Drug Drug
CYP450 3A4 inducer Potential for serotonin syndrome when taken w/ SSRI
1189
Valerian root
GABA agonist Sedating Not to be used w/ benzo, ETOH, sedative-hypnotics
1190
Kava
similar effect to benzo hepatotoxicity potential
1191
Echinacea
May have **immune stimulating effects** Evidence does not support efficacy in treating or preventing common cold **Not to be recommended** However, appears **relatively safe,** although GI side effects and allergic reactions have been reported May interfere w/ immunosuppressant tx
1192
Saw Palmetto
Large high quality studies have not shown saw plametto to be effective in tx of BPH Do not recommend Appears well-tolerated, rare serious side effects
1193
Zollinger Ellison syndrome short definition
Hyper acid secretion syndrome
1194
PPI long-term use adverse effects
Rebound hypersecretion in 60-90% using PPIs for more than 2 months Explains increaed GI sx w/ discontinuation Consider tapering medication w/ reducing dose, followed by QOD use, H2RA, antacid use w/ sx Potential decrease in absorption of select micronutrients such as Iron, B12 Supplementation needs not established Increased fx risk - calcium supplement - choose Calcium citrate as absorption is less affected by gastric acidity Decreased magnesium absorption - increased risk w/ Mg depleting med like Thiazides/Loop diuretics, Digoxin toxicity risk increased w/ low Mg
1195
H2 receptor antagonists use examples
Inhibit acid secretion by blocking histamine H2 receptors on the parietal cell Examples: cimetidine, ranitidine, famotidine, nizatidine Achieve less acid suppression than PPIs
1196
Hypomagenesemia sx
Muscle cramps, heart palpitations, dizziness, tremors, seizures Preferred dx: 24 hour urine Mg (Serum Mg very poor reflection of Mg status)
1197
Hypomagnesemia tx
Elemental Mg (lactate or gluconate preferred) 200-400 mg daily lower dose recommended in renal impairment
1198
PPI and plavix interaction
CYP450 2C19 inhibition by PPI = 20-40% decrease in antiplatelet effect **recommend: separate by 12-20 hours**
1199
Beta adrenergic agents and age related effects in elderly
Decreased therapeutic effect Beta 2 agonists such as albuterol Beta antagonists such as metropolol, carvedilol d/t decrease in beta receptors in aging (lungs and heart)
1200
Inhaled anticholinergic and elderly for bronchodilation
Add to bronchodilator in elderly less age-related impact e.g. tiotropium, ipratropium bromide
1201
CCBs in eldelry Dihydropyridines vs nonDPH
Dihydropyridines (DPH) such as Amlodipine = most powerful BP reduction regardless of race, preferred Non-DPH such as verapamil and diltiazem = increased sensitivity to PR-prolonging effects in the elder, blunts HR,
1202
Macrobid and renal impairment in elderly
If Cr Cl \> 50 mg/dL - standard dosing for tx of UTI If Cr Cl Decreased concentration of abx in urinary tract
1203
Cipro in renal impairment/elderly
If Cr Cl =\> 30 mL/min = no change in dose = 250-750 BID If Cr Cl
1204
Bactrim in Elderly/renal impairment
Cr Cl \> 30 ml/min = no change 1 DS tab BID Cr Cl 15-20 ml/min = 1 DS tab every 24 hr or 1 SS tab every 12 hours Cr Cl
1205
Fosfomycin use in UTI
Likely effective against ESBL producing strains, most often K. pneumo, E. coli, Acinetobacter Half life increases to 50 hours in renal impairment
1206
CrCl vs GFR
Cr Cl approximates GFR but might overestimate d/t creatinine secreted by proximal tubule, filtered by the glomerulus
1207
GFR in healthy young adult
150 mL/min
1208
GFR of 60 mL/min CKD?
Stage II-III CKD
1209
Fx that might effect Serum Creatinine concentration
Muscular bulk = increased d/t muscle metab Malnutrition, muscle wasting, amputation = reduced d/t reduced muscle mass and/or reduced protein intake Vegetarian diet = decrease in creatinine generation Ingestion of cooked meats = transient increase in creatinine generation, might be blunted w/ transient increase in GFR Older age = reduction in creatinine generation, age-related decline in muscle mass Female sex = reduced d/t reduced muscle mass Obesity = no change, excess mass is fat
1210
When should 24 hour urine collection for creatinine clearance be performed?
Extremes of age and body size Severe malnutrition/obesity Disease of skeletal muscle Paraplegia/quadriplegia Vegetarian diet Rapidly changing kidney function Pregnancy
1211
Impact of aging on kidney
Decreased renal blood flow d/t reduction in CO = Less reserve, increased risk of drug-induced nephrotoxicity
1212
ACEI and hyperkalemia intervention
Assure adequate hydration Take ACEI dose in the morning to allow for overnight excretion of renal potassium to avoid hyperkalemia
1213
Cholinesterase inhibitor use in Alzheimers Adverse effects
Increased risk for syncope, bradycardia, pacemaker insertion, hip fx Weigh against the drug's generally modest benefits in AD
1214
Second Generation Antipsychotics and the Elderly
Increased risk of death w/ SGA
1215
Celexa in elderly (citalopram)
If \> 40 mg (in all ages) = QT prolongation effect w/ no additional benefit Max dose of 20 mg/daily in elderly Contraindicated in: congenital long QT syndrome, bradycardia, hypokalemia, hypomagnesemia, recent acute MI, or uncompensated HF, other drugs that prolong QT Max dose of 20 mg/daily in: age \> 60y, hepatic impairment, concomitant cimetidine, many PPIs
1216
Citalopram and long QT when to discontinue
In pts found to have persistent QTc measurements \> 500 ms Discontinue Citalopram
1217
Enteric coated iron
all extended release products are released in the jejunum Decreased pH in the elder, reduced ability to dissolve the enteric coating Avoid!
1218
Fluroquinolones (-floxacins) and calcium supplements/antacids
Do not take within 2 hours of each other d/t chelation effect
1219
Somatization
expression of psychological stress through physical sx somatoform disorders demonstrate mind-body interactions that cause real distress to pt Eg. hypochondriasis, pain disorder, coversion disorder
1220
What part of the eye is used for color perception?
Cones
1221
complications from Lyme disease examples
Lyme carditis Lyme meningitis Facial nerve paralysis Lyme encephalitis Lyme arthritis
1222
Allegra and dietary interaction
Grapefruit and other citrus fruits are known to inhibit Allegra and reduce effectiveness
1223
Lyme disease tx pregnant
Amoxicillin 250-500 mg TID x 10-21d (for pregnant, lactation, and
1224
Ishihara chart
Used to test for color blindness
1225
Psoriasis - avoid what as it can cause rebound flares?
Systemic steroids
1226
Actinic keratosis f/u frequency
every 6 months New lesions frequently occur Development of skin ca can occur
1227
Infant with sickle cell f/u frequency
every 3 months until 2 years of age then every 6 months until age 5 then yearly
1228
Ankle brachial index severity levels
\> 0.9 normal 0. 6-0.8 moderate 0. 5 and
1229
Normal serum AST
5-50 u/L
1230
Normal ALT
10-35 iu/L
1231
32 y/o F Achy, nausea x 3 weeks Very dark urine Temp 100.7 F long-term hx of mulitple male sexual partners Suspected Dx?
Hep B Order Hep B surface antigen
1232
Herpangina
Acute viral illness causing fever, ulcerative mouth lesions, cough, coryza, and pharyngitis Seen more frequent in temperate climates (summer and fall) Fever may be as high as 106F Malaise, headache, backache, anorexia, drooling, vomiting, diarrhea Supportive Tx Resolution typically within 7 days
1233
Adam position
Dx for scoliosis Child bends forward w/ head and hands down Assess rib hump or prominence
1234
Rubella school exclusion
German measles Stay home from school for 7 days after onset of rash Supportive tx Rest and fluids
1235
Scarlet fever sx appear after infection
Rash and sx appear within a day or two of infection Scarlet fever produces flushed face, pinpoint red papules w/ a sandpaper-like rash Sx: sore throat, h/a, strawberry tongue
1236
Most common risk fx for bladder ca
Cigarette smoking
1237
Most common type of kidney stones
Calcium Can occur in two forms: Calcium oxalate or calcium phosphate
1238
Paroxysmal nocturnal dyspnea define
SOB that occurs at night, characterized by sudden awakening after few hours of sleep, w/ feeling of anxiety, breathlessness, and suffocation
1239
Risk fx for asthma death
Infants Previous severe exacerbations 2 or more hospitalizations in the past year 3 or more ER visits in the past year hospital/ER in the last month Poort patient perception of sx Lack of written asthma care plan Sensitivity to Alternaria Low socioeconomic status Illicit drug use Major psychosocial problems Comorbidities (CV, COPD) Major psychological disease
1240
Severe acne define
\> 5 nodules or Total inflammatory lesion count \> 50 Total lesion count \> 125
1241
Moderate acne define
20-100 comedones or 15-50 inflammatory lesions or total lesion count 30-125
1242
Mild acne define
Fewer than 15 inflammatory lesions or Total lesion count
1243
Pancreatitis dx imaging
**Abdominal CT** provides diagnostic view of inflamed pancreas Abd U/S can dx gallbladder disease but does not help with pancreatitis d/t limited view of the organ **If Amylase and Lipase are 3x the upper limit of normal** and gut perf/infarct have been ruled out, these lab values are diagnostic for pancreatitis **Concurrently order lipase w/ amylase** as amylase can e elevated in other conditions such as perforated duodenal ulcer and other abdominal emergencies, lipase will increase dx specificity for pancreatitis
1244
Most accurate dx test for DVT in a 2nd or 3rd trimester pregnant woman
**MRI** **MRI** is more accurate in the s_econd or third trimester of pregnancy_ than Duplex U/S because the _gravid uterus alters venous flow characteristics_
1245
How long should anticoagulant tx be after first DVT episode? Minimum
3-6 months If \> 1 episode, lifelong
1246
Fioricet drug components
Caffeine Butalbital Acetaminophen **- Inexpensive and generally well-tolerated h/a tx** Helps relieve migraine and tesion-type headache pain
1247
First line tx PTSD
SSRI (sertraline, venlafaxine) to treat arousal sx and associated depression
1248
Normal PSA level
1249
Common sites of fx in osteoporosis
hips, wrist, vertebrae
1250
HTN control reduces heart failure by %
50%
1251
HTN control reduces stroke incidence by %
35-40%
1252
HTN control reduces MI by %
20-30%
1253
Theories of aging psychosocial
Disengagement theory Activity theory Continuity theory
1254
Antacids when is it best taken w/ other drugs?
Antacids are most effecive when used _1-3 hours after meals and at bedtime_ Antacids neutralize that secreted acids and inactivate pepsin and bile salts Interact w/ many other medications, should be used at least 2 hours apart Fluroquinolones - antacid shoudl be used **2-4 hours before** or **4-6 hours after** the fluoroquinolone
1255
Contraception recommendation ratings
1 = No restriction 2 = Generally can use 3 = Generally do not use 4 = Do not use
1256
Woman is not pregant - reasonably certain
No sx of pregnancy AND No intercourse since start of last menses Correctly and considently using a reliable method of contraception Within 4 weeks postpartum Fully or nearly fully breastfeeding (\>85% of needs), amenorrheic, and
1257
How to start COC/Patch/Ring
**Sunday start** - start COC/patch/ring on Sunday after menses begin - so that menses occur during week not weekend if using hormone-free week monthly, back up for 7 days needed **First day of menses start -** No back up needed **Quick start** - not pregnant, start COC/patch/ring that day, back up for 7 days **Jump start -** unprotected intercourse since LMP, prescribe ECP, start COc, patch, ring that day, use back up for 7 days
1258
Abx and OCP
Do not interact, but abx reduces gut flora continue OCP Use back up for duration of abx + 7 days
1259
Progestin only pill and HTN woman \> 35 w/ adequate control Recommendation?
1 = no restriction
1260
Progestin only pill, HTN woman \> 35 w/ poor control Recommendation?
1 = no restriction SBP
1261
Rifampin CYP450 what?
Inducer
1262
Spotting on hormonal contraception while on an interacting med
OCP failure - spotting ocurs while on abx, woman thinks its her period and stop taking the pill! Teach: Continue to take OCP even if spotting occurs Use backup method for duration of time taking the interacting medication + 7 days
1263
Gastric bypass and OCP Category ?
Category 3 Exercise caution Gastric bypass = duodenum gets bypassed = decreased OCP absorption
1264
COC and postpartum
COC is NOT acceptable the first 3 weeks postpartum Post partum is a prothrombotic state May decrease quantity of breastmilk
1265
Copper containing IUD Mechanism of Action
Foreign body effect results in sterile inflammatory response that is toxic to sperm and ova impairs implantation Local uterine changes enhances by presence of copper Approved to remain in place for 10 years, likely effective up to 20 years
1266
Levonorgestrel containing IUD Mechanism of action
Foreign body effect Sterile inflammatory response that is toxic to sperm and ova imapirs implantation Local uterine changes = thickening of cervical mucus d/t progestin, results in physical barrier to prevent sperm from entering Progestin also induces endometrial thinning, discourages implantation Approved for 5 years - Mirena Approved for 3 years = Skyla
1267
Antiepileptics and OCPs
Systemic OCPs interact w/ many anti-seizure medications
1268
Mirena/Copper IUD 45 y/o nulliparous woman category?
2 = generally can use
1269
Mirena/Copper IUD 33 y/o who smoke 2 PPD Category?
1 = no restrictions
1270
Mirena/Copper IUD 25 y/o w/ seizure disorder Category ?
1 = no restrictions \*Systemic OCPs interact w/ seizure meds so not preferred in pts w/ seizure disorder
1271
Mirena/Copper IUD 33 y/o w/ HIV w/o AIDS defining illness Category ?
2 = generally can use
1272
Contraceptive Implant
Etonogestrel - Nexplanon/Implanon Provides daily constant release of low dose progestin Effective for at least 3 years Adverse effects: irregular bleeding, can be managed w/ COC use x 3 months, or timed NSAID use x 2 weeks - Naproxen 550 mg BID (anti-prostaglandin)
1273
What is the chance of getting pregnant from a single unprotected coital act?
7.2% Emergency contraception helps reduce this risk
1274
Emergency contraception candidates
Any time unprotected sexual intercourse occurs, including potential method failure (late or missed pills, late for Depo, dislodged/misplaced diaphragm, condom break/slippage, expelled IUD, etc.)
1275
Emergency contraception options
IUD - Copper Pregnancy rate if used as EC = 0.09% **ECPs:** - Ulipristal acetate (UPA) 30 mg x 1 dose) - Levonorgestrel 1-2 dose (1.5 if 1 dose) Similar effectiveness if within 3 days after unprotected intercourse in many circumstances UPA \> LNG between days 3 and 5 after unprotected intercourse
1276
Levonorgestrel mechanism of action as emergency contraception
Depending on time taken during menstrual cycle, interferes w/ fertilization by: Inhibit or delay ovulation (most likely effect) when given 2d prior to LH surge Once LH begins, levonorgestrel has no impact on ovulation Inhibits tubal transport of egg or sperm Unlikely mechanism of action: has minimal to no alteration to endometrium therefore unlikely to to inhibit implantation of a fertilized egg
1277
Plan B Adverse effects
Most common adverse effects: Nausea 14% Vomiting 1% Dose should be repeated if vomiting occurs within 2 hours of taking In 95% or \> of women, _next period would occur within 3 weeks of taking the medication_ _Obtain pregnancy test_ if menses delayed beyond 1 week of anticipated date of onset
1278
Plan B instructions
Take dose within 72 h but also effective up to 120 h after intercourse Improved efficacy when taken earlier in this time frame For two tab regimens: take both pills in single dose or 1 pill and then the second pill 12 hours later **Available OTC for purchase by anyone at any age** though some labeling will state not ot be used in women age Health insurance may cover expense
1279
ella (Ulipristal Acetate) Mechanism of action
Progesterone agonist/antagonist, thus direct inhibitory effech of follicular development and ovum release Changes endometrium possibly can alter likelihood of fertilized egg being implanted vs Plan B: Remains effective when administered immediately before obulation and when LH surger begins Give prior LH surge, inhibit 100% of follicular rupture Given after LH increase, follicular rupture fails to occur within 5-6 days in 50% of cases Given at LH peak, inhibits ovulation by 24-48 hours Approved for use up to 5 days (120 hours) post unprotected sex Rx only
1280
ella (Ulipristal Acetate) Instructionsn for use
Take 1 tablet as soon as possible w/ or w/o food within 120 hours of unprotected sex/known contraceptive failure If vomiting occurs within 3 hours, consider repeating dose
1281
Copper IUD as EC Mechanism of Action Contraindication
Same as contraceptive mechanism action - foreign body effect, sterile inflammatory response toxic to sperm and ova, impairs implantation Advantage: can be left in place for 10 years for highly reliable contraception Contraindication: Active uterine infection
1282
Obesity and EC
Issues of lower efficacy in LNG EC option Not noted w/ EC use of copper IUD in obesity
1283
Perimenopause Define
Time surrounding menopause Onset of beginning of sx and ends w/ cessation of menses Average onset of perimenopause is 40-45 years Occurs earlier in cigarette smokers Lasts an average of 4 years Can range from a few months to 10 years
1284
Menopause Define Avg age?
Menopause when no period for 12 months Average age of menopause for a woman in North America is 51.3 years
1285
Perimenopause sx
Menstural irregularity common Ovulation more erratic but pregnancy still possible Hot flashes and sleep problems usually worse week before menses - reported in 65-75% - hormonal shifts are more dramatic Estrogen levels are usually normal at this stage, but FSH is elevated
1286
Perimenopause - hormonal levels
LH and FSH increase (anterior lobe of pituitary) in an attempt to induce ovulation Ovaries fail to respond, sometimes leading to heavy, anovulatory menstural bleeding Levels of estrogen forms and androgens are reduced Hot flashes become more frequent/severe in part d/t FSH surge Surgical menopause = more severe sx
1287
Postmenopausal hormone therapy for hot flashes
When given during the first 5 years after menopause, reduction of hot flashes 80% to 95% is expected All types/routes of estrogen are effective Even low-doses are often effected Higher doses (1mg oral estradiol) provide relief in 4 weeks Lower dose provide relief in abotu 8-12 weeks Low dose better tolerated w/ less breast tenderness and uterine bleeding Low dose and short duration as possible for sx
1288
post menopausal hormone therapy adverse effects
**Endometrial ca risk w/ unopposed estrogen** 5 year use risk of 2%, 10 year use risk of 4% Must take progestin w/ estrogen to minimize this risk unless woman has no uterus **Increased risk of breast ca w/ long term use** Avoid supplemental estrogen in women who has hx or high risk for CVD, breast ca, uterine ca, venous thromboembolic events, active liver disease Compared w/ oral form, transdermal estrogen use is assoc w/ lower thromboembolic risk in short-term studies
1289
Atrophic vaginitis
Many women who use oral HT continue to have sx the addition of topical estrogen via an estrogen containing vaginal cream/ring/tab can be helpful increasing dose of oral estrogen is seldome helpful, likely increases HT adverse effects Vaginal entroitus remains colonized w/ protective flora when HT is used = lower rates of urogenital atrophy and UTIs in women using this tx, whether systemic or local
1290
Significant vasomotor sx in postmenopause cannot/does not use HT for relief tx option
Low-dose antidepressant (SSRI and SSNRI) can reduce frequency and severity of hot flashes by 35% E.g. SNRI - Venlafaxine (Effexor) SSRI - Sertraline (Zoloft), Paroxetine (Paxil) Typically in lower dose for vasomotor sx than for dose use for depression Adverse effects: sexual dysfunction including anorgasmia **Gabapentin** has also demonstrated efficacy in reducing vasomotor sx Others: Methyldopa (aldomet), Clonidine (Catapres)
1291
In woman who is still menstruating w/ significant perimenopausal sx options
low-dose OCP can be helpful for sx relief and cycle regulation OCPs contain 3-4x estrogen dose compared to usual dose HT
1292
Postmenopausal women w/ low libido Tx options
Androgen supplementation in the form of low-dose testosterone can be helpful in women w/ low libido postmenopause, and in women w/ continue hot flashes despite HT - particularly problematic in younger women who has undergone surgical menopause Adverse effects: acne, hirsutism, alopecia, vocal changes, clitoral enlargement
1293
Absolute contraindication to Post menopausal Estrogen Tx
Unexplained vaginal bleeding Acute liver diseae Chronic impaired liver function Thrombotic disease Neuro-ophthalmologic vascular disease Endometrial ca (short-term might be aceptable) Breast ca (short-term might be acdeptable)
1294
Postmenopausal Estrogen Tx Use w/ Caution (not absolute contraindication)
Seizure disorder (d/t potential drug-drug interaction) Dyslipidemia - particularly hypertrigyceridemia (transdermal, intravaginal HT has limited lipid impact)
1295
Postmenopausal HT and bone density
When taken w/ calcium supplements, post menopausal HT can help reduce risk of postmenopausal fx by 50% Minimizes further bone loss HT should not be used for this purpose solely, however, other medications available
1296
Nutritional supplements for menopausal sx
Few high quality studies support (e.g. phytoestrogens from apples/carrots/coffee/potatoes etc) OTC topical creams of wild yam, phytoprogesterone etc.; However, w/ poor bioavailability
1297
Hot Flash triggers
Spicy foods, chocolate ETOH Elevated ambient temp/humidity Tight, restrictive clothing Cigarette smoking Hot baths/showers Not relaxed state
1298
Piriformis Syndrome
Piriformis muscle irritates the transversing sciatic nerve Causing pain, tingling, and numbness in the buttock and leg Can mimic sciatica Stretching can reduce pain
1299
McMurray's Test
Meniscus Tear Positive = audible click is felt over meniscus as knee is brought from full flexion to 90 degree flexion
1300
Plantar Fasciitis Dx Test
**Sine qua non:** Sharp heel pain w/ the first couple of steps in the morning Palpation over medial tubercle of calcaneus usually reproduces pain **Other provocative measures:** Passive dorsiflexion of toes (windlass test) Have pt stand on tiptoes and toe walk
1301
Finkelstein's Test
DeQuervain's Tenosynovitis Patient flexes thumb across palm and the clinician applies ulnar deviation to the wrist reproducing pain
1302
Empty Can for rotator cuff
It is performed by having the patient place a straight arm in about 90 degrees of abduction and 30 degrees of forward flexion, and then internally rotating the arm completely (ie, thumb pointing down) Patient then resists the clinician's attempts to depress the arm. Pain without weakness is consistent with tendinopathy, while pain with weakness is consistent with partial or complete tendon tear.
1303
Cystoplasmic pattern ANA is often found in the presence of what codition?
Biliary cirrhosis
1304
Kidney stones type that form when urine is persistently acidic
Uric acid stone occur in people who do not drink enough fluids or who lose too much fluid, eat a high-protein diet, or who have gout
1305
Kidney stones type causes by high calcium excretion and oxalate excretion
calcium oxalate stones
1306
Kidney stones type that is caused by high urine calcium and alkaline urine
Calcium phosphate stones
1307
Kidney stones that result from kidney infections
Struvite stones
1308
Drop Arm Test
Rotator cuff Tests ability to lower arms from a full abducted position + of pt unable to lower arm w/ same coordianted motion as the unaffected arm
1309
Neer Test
For rotator cuff Passive painful arc Passively flexing glenohumeral joint while preventing shoulder from shrugging Used to assess degree of impingment Degree of rotator cuff tendinopathy is determined by angle which the arc becomes painful
1310
Spurling test
Foraminal compression test Confirms cervical radiculapathy Position pt w/ neck extended and head rotated apply downward pressure on head + if pain radiates to limb ipsilateral to which head is rotated 93% specific, 30% sensitive in dx acute radiculopathy
1311
Nerve root compromise L4
Weak extension of quadriceps Test: squat and rise Knee jerk diminished Pain from posterior upper glute and goes around thigh to front of leg
1312
Nerve root compromise L5
Pain lateral side of LE numbness lateral lower leg Weak dorsiflexion of great tow and foot Test: heel walk
1313
Nerve root compromise S1
Pain posterior LE all the way down Numbness to calf area/back of leg Weak plantar flexion of great toe and foot Test: walk on toes Ankle jerk reflex diminished
1314
Where would you auscultate: VSD or tricuspid valve?
LLSB
1315
Left to right shunting cyanotic or acyanotic?
Acyanotic
1316
Right to left shunting cyanotic or acyanotic?
Cyanotic
1317
Acyanotic heart defects examples
Left to right shunting Atrial Septal Defect Ventricular Septal Defecet
1318
Cyanotic heart defects
Right to Left shunting Transposition of the great arteries Tetralogy of Fallot Tricuspid atresia
1319
Common genetic syndrome and their cardiac anomalies DiGeorge Down Syndrome Marfan Turner
DiGeorge: aortic arch anomalies Down Syndrome: VSD \> ASD Marfan: Aortic regurg, MVP Turner: coarctation, tricuspid aortic valve
1320
Egg on a string x-ray
Transposition of the great arteries right to left shunting Cyanotic ECG: RVH X-ray: egg on a string, w/ cardiomegaly and increased pulmonary vascular markings
1321
Boot-shaped heart x-ray
**Tetralogy of Fallot** **Four Defects:** Large VSD RVH Overriding aorta Pulmonary stenosis
1322
Injuries cause approximately % of child deaths?
50% highest rate in adolescents, infants, males, low-income, rural areas, native american, african american
1323
Tdap common side effects
h/a, stomach ache, nausea typically subside quickly
1324
Steven Johnson Syndrome manifestation
acute onset of vesicular to bullous lesions all over body range from hives to blisters and hemorrhagic lesions Mucosal involvement w/ blisters on conjunctiva, mouth, and genitals also possible Hx of recent abx can precede onset
1325
Aortic Regurgitation sx
Long asymptomatic period, followed by exercise tolerance, then dyspnea at rest Left ventricular failure eventually occurs
1326
How many months infant will turn head to locate sounds
about 3 months
1327
Magnesium food sources
dried beans whole grains nuts
1328
Trigeminal neuralgia
h/a caused by impingement of trigeminal nerve Rare before age 35, peaks at age of 60 F \> M Pain lasts a few seconds and only stops when offending activity ceases
1329
What does the following labs say about kidney BUN Creat Urine volume and osmolality/specific gravity
BUN = renal perfusion Creat = actual tubular function Urine volume, osmolality, specific gravity = ability excrete and concentrate flulid
1330
Epistaxis
Anterior epistaxis usually result of localized nasal mucosa dryness/trauma Most episodes managed w/ simple pressure to area superior to the nasal alar cartilage
1331
Genu valgum
knock knees can be seen in children ages 2-4 Corrects w/o tx by the time child reaches 10 years of age
1332
Normal TG
Normal 150-200 borderline high \> 200 high \> 500 extremely high
1333
Prenatal appt frequency
6-28 weeks - every month 28-34 weeks - every 2 weeks 34-41 weeks - every week
1334
Six cardinal features of Parkinson's Disease
Bradykinesia Rigidity Tremor at rest Masklike facies Loss of postural reflexes Flexed posture
1335
Glasgow coma scale levels
13-15 = Mild brain injury 9-12 = Moderate brain injury 8 or less = severe brain injury and coma in 90% of pts
1336
High reticulocyte count conditions
G6PD deficiency Autoimmune hemolysis sickle cell anemia Rh isoimmunization
1337
Stage II HTN
SBP \> 160 DBP \> 100
1338
When can CVS be done
between 10 and 13 weeks after LMP
1339
Decribe regurgitant murmurs
Usually are more pure, uniform sound
1340
% of bladder ca have persistent microscopic hematuria
20% Other sx: irritative voiding sx and urinary frequency
1341
Milwaukee brace
Scoliosis Tx Should be worn 23 hours per day Worn over a T-shirt to minimize skin discomfort/irritation Assess skin for irritation/breakdown often
1342
How many teeth by 18 months of age
14 ## Footnote **Expected teeth can be calculated by subtracting 4 from age of child in months**
1343
Constipation tx in 2 month old infant
AAP does not recommend changing to a low-iron formula in constipation Typical tx: adding dark corn syrup, nonstarchy vegetables, and more water Juices that are recommended are apple, prune, and pear Avoid rice cereal
1344
Depression relapse risk fx
Onset before 20 years or after 50 years of age poor recovery between episodes Family hx of depression Dysthymia preceding episode of depression
1345
Bronchiolitis f/u
3-5 days Most cases expect reduction of sx in 3-5 days cough might continue for 1-2 weeks
1346
CN assoc. w/ gag reflex and soft palate
CN 9 and 10 Glosspharyngeal and Vagus Assoc w/ gag reflex, symmetrical soft palate, uvula, and voice quality
1347
Shotty lymph nodes definition
Small, pellet-like nodes that are movable, cool, nontender, and discrete Range in size up to 3 mm in diameter
1348
Positive PPD in children
Induration 10 mm or \>
1349
Stage II Hodgkin's disease
2 or more node groups on the same side of the diaphragm 5 year survival rate is 90%
1350
SLE incidence/epi
Most common in 15-45 years old persons Incidence is 10-15x more frequent in women Childhood onset is more severe Common in Klinefelter's Incidence is 1 in 1000 whites and 1 in 250 in black age 18-65
1351
Scurvy
Vitamin C deficiency Common among elderly patients and bedbound Found in fresh fruits/juices Regular smoker risk increases
1352
Absorption topical agents lotion vs gel vs ointment vs cream
generally, the less viscous the vehicle, less absorption ointment, cream \> gel, lotion
1353
Dysmenorrhea risk fx
nulliparity smoking earlier menarche longer menstrual periods obesity ETOH stress
1354
Fontaine Classification of PVD Stages
Stage 1 = silent Stage 2 = intermittent claudification Stage 3 = rest ischemia Stage 4 = ulceration/gangrene
1355
Prozac weight change
SSRIs like Prozac are more likely to cause lack of appetite and weight LOSS Digestive upsets, constipation, and diarrhea common side effects Insomnia, vivid dreams may also occur
1356
Anti-anxiety w/ most rapid onset of action?
**Diazepam** Rapid onset of action and relatively sustained effect
1357
Abx contraindicated in pregnancy
Quinolones and tetracyclines
1358
Strabismus
Deviation of one or both eyes Latent strabismus occurs only under monocular conditions Manifest strabistmus under binocular conditiosn
1359
Seborrheic keratosis
May be itchy, round lesion Appear suddenly Brown w/ waxy apperance and scaly surface
1360
Normal weight gain for pregnancy Underweight Normal weight
Underweight: 28-40 lbs Normal weight: 25-35 lbs
1361
1362
1363